Processing 00000000.tx.1: Calpains Play a Role in Insulin Secretion and Action Seamus K. 

Phrase: "Calpains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a Role in Insulin Secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "Action Seamus K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.2: Sreenan1, Yun-Ping Zhou1, Kenichi Otani1,8, Polly A. 

Phrase: "Sreenan1,"

Phrase: "Yun-Ping Zhou1,"

Phrase: "Kenichi Otani1,"

Phrase: "8,"

Phrase: "Polly A."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332197:absence [Quantitative Concept]
   861   C1689985:Absence [Anatomical Abnormality]
   789 E C2699517:ABSENT [Finding]
Processing 00000000.tx.3: Hansen6, Kevin P.M. 

Phrase: "Hansen6,"

Phrase: "Kevin P.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.4: Currie2, Chien-Yuan Pan2, Jean-Pyo Lee1, Diane M. 

Phrase: "Currie2,"

Phrase: "Chien-Yuan Pan2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1426579:PAN2 [Gene or Genome]
   827   C1426662:PAN2 [Gene or Genome]
   827   C1427798:PAN2 [Gene or Genome]

Phrase: "Jean-Pyo Lee1,"

Phrase: "Diane M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.5: Ostrega1, William Pugh1, Yukio Horikawa3,5, Nancy J. 

Phrase: "Ostrega1,"

Phrase: "William Pugh1,"

Phrase: "Yukio Horikawa3,"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "Nancy J."
Processing 00000000.tx.6: Cox1,4, Craig L. 

Phrase: "Cox1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0389003:COX-1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0445467:Coxi [Intellectual Product]

Phrase: "4,"

Phrase: "Craig L."
Processing 00000000.tx.7: Hanis7, Charles F. 

Phrase: "Hanis7,"

Phrase: "Charles F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.8: Burant6, Aaron P. 

Phrase: "Burant6,"

Phrase: "Aaron P."
Processing 00000000.tx.9: Fox2, Graeme I. 

Phrase: "Fox2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419304:FOX2 [Gene or Genome]

Phrase: "Graeme I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.10: Bell1,3,4,5, and Kenneth S. 

Phrase: "Bell1,"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4,"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "Kenneth S."
Processing 00000000.tx.11: Polonsky8 1 Medicine 2 Neurobiology, Pharmacology and Physiology 3 Biochemistry and Molecular Biology, and 4 Human Genetics, and the 5 Howard Hughes Medical Institute, the University of Chicago, Chicago, Illinois 6 Department of Cell Biology, Parke-Davis Pharmaceutical Research Division/Warner-Lambert Company, Ann Arbor, Michigan 7 Human Genetics Center, the University of Texas Health Science Center at Houston, Houston, Texas 8 Department of Medicine, Washington University, St. 

Phrase: "Polonsky8 1 Medicine 2 Neurobiology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0027817:Neurobiology [Biomedical Occupation or Discipline]

Phrase: "Pharmacology"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031330:Pharmacology [Biomedical Occupation or Discipline]
  1000   C1524059:pharmacology [Functional Concept]
   928 E C0205464:Pharmacologic [Functional Concept]

Phrase: "and"

Phrase: "Physiology 3 Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "4 Human Genetics,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0020124:Human Genetics [Biomedical Occupation or Discipline]
   827   C0017398:Genetics [Biomedical Occupation or Discipline]
   827   C0017399:genetics [Biologic Function]
   827   C0086418:Human [Human]

Phrase: "and"

Phrase: "the 5 Howard Hughes Medical Institute,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0021622:institute [Organization]
   804   C0205476:Medical [Functional Concept]
   804   C1272753:Institute [Idea or Concept]
   804   C1551730:Hughes [Population Group]

Phrase: "the University of Chicago,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0008044:Chicago [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Chicago,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008044:Chicago [Geographic Area]

Phrase: "Illinois 6 Department of Cell Biology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704729:Department [Organization]

Phrase: "Parke-Davis Pharmaceutical Research Division/Warner-Lambert Company,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   864   C0815266:Pharmaceutical Company [Health Care Related Organization]
   793   C0683757:Company [Manufactured Object,Organization]

Phrase: "Ann Arbor,"

Phrase: "Michigan 7 Human Genetics"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020124:Human Genetics [Biomedical Occupation or Discipline]
   812   C0017398:Genetics [Biomedical Occupation or Discipline]
   812   C0017399:genetics [Biologic Function]
   812   C0086418:Human [Human]

Phrase: "Center"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205099:Center [Spatial Concept]

Phrase: ","

Phrase: "the University of Texas Health Science Center at Houston,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C0475309:Health center [Health Care Related Organization,Manufactured Object]
   742   C0018684:Health [Idea or Concept]
   742   C0036397:Science [Occupation or Discipline]
   742   C0039711:Texas [Geographic Area]
   742   C0041740:University [Manufactured Object,Organization]
   742   C0205099:Center [Spatial Concept]

Phrase: "Houston,"

Phrase: "Texas 8 Department of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "Washington University,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041740:University [Manufactured Object,Organization]
   861   C0043038:Washington [Geographic Area]

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.12: Louis, Missouri  ABSTRACT TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Studies of the genetic basis of type 2 diabetes suggest that variation in the calpain-10 gene affects susceptibility to this common disorder, raising the possibility that calpain-sensitive pathways may play a role in regulating insulin secretion and/or action. 

Phrase: "Louis,"

Phrase: "Missouri  ABSTRACT TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C0035171:Research Design [Research Activity]
   795   C0035168:research [Research Activity]
   795   C0242481:Research [Research Activity]
   795   C1707689:Design [Activity]
   795   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1514811:Reference [Idea or Concept]
   779   C1706462:Reference [Conceptual Entity]

Phrase: "Studies of the genetic basis of type 2 diabetes"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   790   C0011860:Type 2 Diabetes [Disease or Syndrome]
   764   C0441730:Type 2 [Classification]
   762   C0035171:Study Type [Research Activity]
   762   C1320657:Diabetes type [Finding]
   762   C2827447:Genetic Study [Research Activity]
   762   C2985227:Study Type [Research Activity]
   742   C0011847:Diabetes [Disease or Syndrome]
   742   C0011849:Diabetes [Disease or Syndrome]
   742   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   742   C0314603:Genetic [Functional Concept]
   742   C0332307:Type [Qualitative Concept]
   742   C0557651:Study [Manufactured Object]
   742   C0947630:studies [Laboratory Procedure]
   742   C1527178:Basis [Functional Concept]
   742   C1547052:*Type [Quantitative Concept]
   742   C1874451:Basis [Pharmacologic Substance]
   742   C2603343:Study [Research Activity]
   734   C0260581:birth type [Health Care Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that variation in the calpain-10 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205419:Variation [Qualitative Concept]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "susceptibility to this common disorder,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0012655:Susceptibility [Clinical Attribute]
   760   C0220898:Susceptibility [Organism Attribute]
   760   C1264642:Susceptibility [Functional Concept]
   760   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "raising"

Phrase: "the possibility"

Phrase: "that calpain-sensitive pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035820:Role [Social Behavior]
   790   C1705810:Role [Conceptual Entity]

Phrase: "regulating"

Phrase: "insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and/or"

Phrase: "action."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441472:Action [Functional Concept]
  1000   C3266814:Action [Activity]
Processing 00000000.tx.13: Calpains are ubiquitously expressed cysteine proteases that are thought to regulate a variety of normal cellular functions. 

Phrase: "Calpains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "ubiquitously expressed cysteine proteases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C2717970:Cysteine Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   844 E C0758959:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   844 E C0769345:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C1947941:Proteases [Enzyme]

Phrase: "that"

Phrase: "are"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "regulate"

Phrase: "a variety of normal cellular functions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1883525:Variety [Conceptual Entity]
   753   C2346866:Variety [Conceptual Entity]
Processing 00000000.tx.14: Here, we report that short-term (4-h) exposure to the cell-permeable calpain inhibitors calpain inhibitor II and E-64-d increases the insulin secretory response to glucose in mouse pancreatic islets. 

Phrase: "Here,"

Phrase: "we"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that short-term"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0443303:Short-term [Temporal Concept]
   861   C1282927:short [Qualitative Concept]
   861   C1515273:Term [Temporal Concept]
   861   C1705313:Term [Idea or Concept]
   861   C1806781:Short [Quantitative Concept]
   861   C2350002:Short [Quantitative Concept]
   861   C2826302:TERM [Intellectual Product]

Phrase: "(4-h) exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0274281:Exposure, NOS [Injury or Poisoning]
   827   C0332157:Exposure [Clinical Attribute]

Phrase: "to the cell-permeable calpain inhibitors calpain inhibitor II"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006786:Calpain II [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "E-64-d"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0058882:E 64 [Organic Chemical,Pharmacologic Substance]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the insulin secretory response to glucose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "in mouse pancreatic islets."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1522528:Mouse Islets [Tissue]
   901   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
Processing 00000000.tx.15: This dose-dependent effect is observed at glucose concentrations above 8 mmol/l. 

Phrase: "This dose-dependent effect"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1280500:Effect [Qualitative Concept]
   827   C2348382:Effect [Qualitative Concept]
   734   C1512045:Dose-dependent [Quantitative Concept]

Phrase: "is"

Phrase: "observed at glucose concentrations"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   819   C0427743:concentrations glucose [Laboratory Procedure]
   819   C1287281:concentrations glucose [Laboratory or Test Result]
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0086045:Concentrations [Mental Process]
   770   C1441672:Observed [Functional Concept]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "above 8 mmol/l."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1532563:mmol/L [Quantitative Concept]
Processing 00000000.tx.16: This effect was also seen with other calpain inhibitors with different mechanisms of action but not with cathepsin inhibitors or other protease inhibitors. 

Phrase: "This effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "also"

Phrase: "seen with other calpain inhibitors"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   806   C0054533:calpain inhibitors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0205397:Seen [Qualitative Concept]
   760   C0243077:inhibitors [Chemical Viewed Functionally]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]
   726 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "with different mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "of action"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441472:Action [Functional Concept]
  1000   C3266814:Action [Activity]

Phrase: "but"

Phrase: "not with cathepsin inhibitors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0243077:inhibitors [Chemical Viewed Functionally]
   770   C1518422:Not [Functional Concept]
   737 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "or"

Phrase: "other protease inhibitors."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   966 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1947941:Protease [Enzyme]
   827 E C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.17: Enhancement of insulin secretion with short-term exposure to calpain inhibitors is not mediated by increased responses in intracellular Ca2+ or increased glucose metabolism in islets but by accelerated exocytosis of insulin granules. 

Phrase: "Enhancement of insulin secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   770   C2349975:Enhancement [Activity]

Phrase: "with short-term exposure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0274281:Exposure, NOS [Injury or Poisoning]
   827   C0332157:Exposure [Clinical Attribute]
   734   C0443303:Short-term [Temporal Concept]

Phrase: "to calpain inhibitors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0054533:calpain inhibitors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "mediated by increased responses"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   819   C0870868:mediated responses [Mental Process]
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C0871261:responses [Organism Attribute]
   737 E C1704632:Response [Finding]
   737 E C1706817:Response [Intellectual Product]
   737 E C2911692:Response [Mental Process]

Phrase: "in intracellular Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "or"

Phrase: "increased glucose metabolism in islets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0596620:glucose metabolism [Molecular Function]
   760   C0025519:Metabolism [Organism Function]
   760   C0025520:metabolism [Functional Concept]

Phrase: "but by accelerated exocytosis of insulin granules."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0010837:Granules [Cell Component]
   748   C0015283:Exocytosis [Cell Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0233535:but [Mental or Behavioral Dysfunction]
   748   C0521110:Accelerated [Functional Concept]
   748   C0993609:Granules [Biomedical or Dental Material]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.18: In muscle strips and adipocytes, exposure to both calpain inhibitor II and E-64-d reduced insulin-mediated glucose transport. 

Phrase: "In muscle strips"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1321564:strips [Medical Device]

Phrase: "and"

Phrase: "adipocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206131:Adipocytes [Cell]

Phrase: "exposure to both calpain inhibitor II"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332157:Exposure to [Clinical Attribute]
           Exposure
   753   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "and"

Phrase: "E-64-d"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0058882:E 64 [Organic Chemical,Pharmacologic Substance]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "insulin-mediated glucose transport."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C2984428:Insulin-mediated glucose transport [Functional Concept]
   861   C0178666:glucose transport [Cell Function]
   812   C0005528:Transport, NOS [Cell Function]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C1317949:Transport [Manufactured Object]
   812   C3495449:transport [Medical Device]
Processing 00000000.tx.19: Incorporation of glucose into glycogen in muscle also was reduced. 

Phrase: "Incorporation of glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0243126:incorporation [Functional Concept]

Phrase: "into glycogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]

Phrase: "in muscle also"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026845:Muscle [Tissue]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "was"

Phrase: "reduced."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]
Processing 00000000.tx.20: These results are consistent with a role for calpains in the regulation of insulin secretion and insulin action.  

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "consistent with a role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "for calpains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin action."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0441472:Action [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C3266814:Action [Activity]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.21: INTRODUCTION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Type 2 diabetes is a complex metabolic disorder characterized by defects in both insulin secretion and insulin action (1). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "is"

Phrase: "a complex metabolic disorder"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0025517:Metabolic disorder [Disease or Syndrome]
   827   C0012634:Disorder [Disease or Syndrome]

Phrase: "characterized by defects"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0243067:defects [Functional Concept]
   790   C1880022:Characterized [Activity]
   756 E C1457869:Defect [Functional Concept]
   756 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "in both insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin action"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0441472:Action [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C3266814:Action [Activity]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.22: A combination of genetic predisposition and environmental factors influences its development. 

Phrase: "A combination of genetic predisposition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205195:Combination [Qualitative Concept]
   760   C1947911:Combination [Physical Object]

Phrase: "and"

Phrase: "environmental factors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1516998:Environmental Factors [Functional Concept]
   983 E C0686732:Environmental Factor [Qualitative Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "influences"

Phrase: "its development."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]
Processing 00000000.tx.23: Recent studies have shown that variation in the gene encoding calpain-10 is associated with type 2 diabetes (2). 

Phrase: "Recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that variation in the gene encoding calpain-10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205419:Variation [Qualitative Concept]

Phrase: "is"

Phrase: "associated with type 2 diabetes"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.24: In addition, the diabetes-associated DNA polymorphism in the calpain-10 gene is associated with decreased levels of calpain-10 mRNA in skeletal muscle and insulin resistance in nondiabetic subjects (3), suggesting one mechanism by which calpain-10 may increase susceptibility to type 2 diabetes. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the diabetes-associated DNA polymorphism in the calpain-10 gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0678951:gene polymorphism [Genetic Function]
   739   C0032529:Polymorphism [Genetic Function]
   739   C1882417:Polymorphism [Qualitative Concept]

Phrase: "is"

Phrase: "associated with decreased levels of calpain-10 mRNA"
Meta Candidates (Total=16; Excluded=6; Pruned=0; Remaining=10)
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0961737:calpain 10 [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1413110:CALPAIN 10 [Gene or Genome]
   744   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0205216:Decreased [Quantitative Concept]
   744   C0392756:Decreased [Qualitative Concept]
   744   C0441889:Levels [Qualitative Concept]
   744   C0442797:decreased [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C0547047:Decrease [Quantitative Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1547707:Level [Geographic Area]
   711 E C1706221:Associate [Professional or Occupational Group]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "in skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "and"

Phrase: "insulin resistance in nondiabetic subjects"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0021655:Insulin Resistance [Pathologic Function]
   806   C2700570:INSULIN RESISTANCE [Gene or Genome]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0237834:Resistance [Mental Process]
   760   C1514892:Resistance [Physiologic Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "one mechanism by which calpain-10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]

Phrase: "may"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "susceptibility to type 2 diabetes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0012655:Susceptibility [Clinical Attribute]
   760   C0220898:Susceptibility [Organism Attribute]
   760   C1264642:Susceptibility [Functional Concept]
   760   C1547045:*Susceptibility [Quantitative Concept]
Processing 00000000.tx.25: Calpains, or calcium-activated neutral proteases, are a family of nonlysosomal cysteine proteases that catalyze the endoproteolytic cleavage of specific substrates and thereby regulate pathways that affect intracellular signaling, proliferation, and differentiation (4,5). 

Phrase: "Calpains,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "calcium-activated neutral proteases,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   966   C0006784:Calcium-Activated Neutral Protease [Amino Acid, Peptide, or Protein,Enzyme]
           Calcium-Activated Protease
   812   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   812   C0006726:Calcium [Inorganic Chemical]
   812   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C1879547:Activated [Activity]
   812   C1882074:Neutral [Qualitative Concept]
   812   C1947941:Proteases [Enzyme]
   812   C2825492:Neutral [Phenomenon or Process]
   812   C2936886:Calcium [Pharmacologic Substance]
   779 E C1515877:Activate [Functional Concept]

Phrase: "are"

Phrase: "a family of nonlysosomal cysteine proteases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0015576:Family [Family Group]
   753   C1704727:Family [Conceptual Entity]

Phrase: "that"

Phrase: "catalyze"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007382:catalyse [Natural Phenomenon or Process]

Phrase: "the endoproteolytic cleavage of specific substrates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: "and"

Phrase: "thereby"

Phrase: "regulate"

Phrase: "pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathways [Molecular Function]
  1000   C1705987:Pathways [Conceptual Entity]

Phrase: "that"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "intracellular signaling,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]

Phrase: "proliferation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "(4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.26: As a first step in determining the biochemical pathways that may be controlled by calpain-10 and other calpains, we examined the effects of cell-permeable calpain inhibitors on insulin secretion and insulin action in isolated islets, muscle strips, and adipocytes.  

Phrase: "As a first step in determining"

Phrase: "the biochemical pathways"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0243123:biochemical pathways [Qualitative Concept]
   966 E C1704259:Biochemical Pathway [Molecular Function]
           Pathways
   861   C0205474:Biochemical [Functional Concept]
   861   C1705987:Pathways [Conceptual Entity]

Phrase: "that"

Phrase: "may"

Phrase: "be"

Phrase: "controlled by calpain-10"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   833   C0332298:Controlled by [Functional Concept]
   833   C0961737:calpain 10 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1413110:CALPAIN 10 [Gene or Genome]
   770   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
   770   C2587213:Controlled [Functional Concept]
   737 E C0243148:control [Qualitative Concept]
   737 E C1550141:Control [Substance]
   737 E C1882979:Control [Conceptual Entity]
   737 E C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "other calpains,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the effects of cell-permeable calpain inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin action in isolated islets,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0441472:Action [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C3266814:Action [Activity]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "muscle strips,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1321564:strips [Medical Device]

Phrase: "and"

Phrase: "adipocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206131:Adipocytes [Cell]
Processing 00000000.tx.27: RESEARCH DESIGN AND METHODS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Animals. 

Phrase: "RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035171:Research Design [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   876   C0086912:methods research [Research Activity]
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]
Processing 00000000.tx.28: Pancreatic islets were isolated from nonfasted 9- to 13-week-old C57BL/6J mice (Jackson, Bar Harbor, ME). 

Phrase: "Pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "isolated from nonfasted 9-"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0205409:Isolated [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "to 13-week-old C57BL/6J mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   839   C0025921:Mice, C57BL [Mammal]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "(Jackson,"

Phrase: "Bar Harbor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0475311:Harbor [Manufactured Object]

Phrase: "ME"

Phrase: ")."
Processing 00000000.tx.29: Soleus muscle strips and adipocytes were isolated from 8- to 12-week-old male Wistar rats (Harlan Sprague-Dawley, Indianapolis, IN). 

Phrase: "Soleus muscle strips"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1321564:strips [Medical Device]
   734   C0242694:Soleus Muscle [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206131:Adipocytes [Cell]

Phrase: "were"

Phrase: "isolated from 8-"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0205409:Isolated [Functional Concept]
   790   C1548221:Isolated [Idea or Concept]
   756 E C0370215:Isolate [Substance]
   756 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "to 12-week-old male Wistar rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0034716:Rats, Wistar [Mammal]
   799   C0034693:rats [Mammal]
   799   C0034721:Rats [Mammal]
   799   C2700262:Wistar [Mammal]

Phrase: "(Harlan Sprague-Dawley, Indianapolis,"

Phrase: "IN"

Phrase: ")."
Processing 00000000.tx.30: These studies were approved by the Animal Care and Use Committee of the University of Chicago. 

Phrase: "These studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "approved by the Animal Care"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0178478:animal care [Occupation or Discipline]
   760   C0003062:Animal [Animal]
   760   C0205540:Approved [Qualitative Concept]
   760   C1947933:Care [Activity]

Phrase: "and"

Phrase: "Use Committee of the University of Chicago."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2699414:Committee [Group]
Processing 00000000.tx.31: Static incubation of isolated pancreatic islets. 

Phrase: "Static incubation of isolated pancreatic islets."
Processing 00000000.tx.32: Isolation of mouse pancreatic islets was accomplished as described previously (6). 

Phrase: "Isolation of mouse pancreatic islets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0204727:Isolation [Therapeutic or Preventive Procedure]
   760   C0205409:Isolation [Functional Concept]
   760   C0220862:isolation [Laboratory Procedure]

Phrase: "was"

Phrase: "accomplished"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.33: After overnight incubation in RPMI-1640 medium (11.6 mmol/l glucose), islets were exposed to inhibitors in the same medium for 4 h at 37C. 

Phrase: "After overnight incubation"

Phrase: "in RPMI-1640 medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "(11.6 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "islets"

Phrase: "were"

Phrase: "exposed to inhibitors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332157:Exposed to [Clinical Attribute]
           Exposed
   790   C0243077:inhibitors [Chemical Viewed Functionally]
   756 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "in the same medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "for 4 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 37C."
Processing 00000000.tx.34: The protease inhibitors used were ALLM (calpain inhibitor II, N-Ac-Leu-Leu-methioninal), ALLN (calpain inhibitor I, N-Ac-Leu-Leu-norleucinal), cathepsin B inhibitor II, (Calbiochem-Novabiochem, San Diego, CA), E-64-d (ethyl (+)-(2S,3S)-3-[(S)-3-Methyl-1-(3-methylbutylcarbamoyl)butyl-carbamoyl]-2-oxiranecarboxylate;Matreya,Pleasant Gap, PA), PD147631 (a gift from Dr. Kevin Wang, Parke-Davis, Ann Arbor, MI), and CA074ME (Peptides International, Louisville, KY). 

Phrase: "The protease inhibitors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   966 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1947941:Protease [Enzyme]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "ALLM"

Phrase: "(calpain inhibitor II,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0006786:Calpain II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0054533:calpain inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "N-Ac-Leu-Leu-methioninal"

Phrase: ")"

Phrase: ","

Phrase: "ALLN"

Phrase: "(calpain inhibitor I,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0901518:calpain inhibitor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0006785:Calpain I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   734   C0054533:calpain inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "N-Ac-Leu-Leu-norleucinal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0081446:N-Ac-Leu-Leu-norleucinal [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "cathepsin B inhibitor II,"

Phrase: "(Calbiochem-Novabiochem,"

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA),"

Phrase: "E-64-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0058882:E 64 [Organic Chemical,Pharmacologic Substance]

Phrase: "d ("

Phrase: "ethyl"

Phrase: "(+"

Phrase: ")"

Phrase: "-"

Phrase: "(2S,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552116:2s [Body Part, Organ, or Organ Component]

Phrase: "3S"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552117:3s [Body Part, Organ, or Organ Component]

Phrase: ")-"

Phrase: "3-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "["

Phrase: "("

Phrase: "S)-"

Phrase: "3-Methyl-1-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439086:<3 [Quantitative Concept]
   827   C2827736:3+ [Quantitative Concept]
   827   C2981702:3+ [Classification]

Phrase: "(3-methylbutylcarbamoyl"

Phrase: ")"

Phrase: "butyl-carbamoyl"

Phrase: "]-2-oxiranecarboxylate"

Phrase: ";Matreya,"

Phrase: "Pleasant Gap,"

Phrase: "PA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541314:PA [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "PD147631"

Phrase: "("

Phrase: "a gift from Dr. Kevin Wang,"

Phrase: "Parke-Davis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331885:Parke-Davis [Health Care Related Organization]

Phrase: "Ann Arbor,"

Phrase: "MI),"

Phrase: "and"

Phrase: "CA074ME"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0910208:CA074Me [Organic Chemical]

Phrase: "(Peptides International, Louisville,"

Phrase: "KY"

Phrase: ")."
Processing 00000000.tx.35: GLP-1 (736 amide) was from Peninsula Laboratory (Belmont, CA). 

Phrase: "GLP-1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0061355:GLP-1 [Amino Acid, Peptide, or Protein]
  1000   C1999257:GLP-1 [Gene or Genome]
  1000   C3539623:GLP-1 [Gene or Genome]
  1000   C3539624:GLP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018301:GLP [Geographic Area]
   861   C1422069:GLP [Gene or Genome]
   861   C1425391:GLP [Gene or Genome]
   861   C2697611:GLP [Amino Acid, Peptide, or Protein]

Phrase: "(736 amide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002482:Amide [Organic Chemical]

Phrase: ")"

Phrase: "was from Peninsula Laboratory"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0022877:Laboratory [Manufactured Object,Organization]
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1421478:WAS [Gene or Genome]
   770   C3244292:laboratory [Functional Concept]

Phrase: "(Belmont,"

Phrase: "CA)."
Processing 00000000.tx.36: Other reagents were from Sigma Chemical (St. Louis, MO). 

Phrase: "Other reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "were from Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1719918:Sigma [Intellectual Product]

Phrase: "Chemical"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220806:Chemical [Chemical]
  1000   C3272558:Chemical [Intellectual Product]

Phrase: "(St. Louis,"

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.37: The calpain inhibitors were dissolved in DMSO, which also was added to control cultured islets at the concentration of 0.1%. 

Phrase: "The calpain inhibitors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0054533:calpain inhibitors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "were"

Phrase: "dissolved in DMSO,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0012403:DMSO [Organic Chemical,Pharmacologic Substance]
   756   C1549535:Dissolve [Functional Concept]

Phrase: "which also"

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "cultured islets at the concentration of 0.1%."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   750   C1416480:ISLET 1 [Gene or Genome]
Processing 00000000.tx.38: Islets were preincubated in Krebs-Ringers buffer (KRB) containing 2 mmol/l glucose and similar concentrations of inhibitors for 60 min at 37C. 

Phrase: "Islets"

Phrase: "were"

Phrase: "preincubated in Krebs-Ringers buffer (KRB)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   726   C1875730:RINGER'S [Organic Chemical,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "2 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "similar concentrations of inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "for 60 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at 37C."
Processing 00000000.tx.39: Triplicate groups of five islets then were incubated in borosilicate tubes containing 1 ml of KRB with the same concentration of inhibitor and various insulin secretagogues for 1 h in a moving water bath at 37C. 

Phrase: "Triplicate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205174:Triplicate [Quantitative Concept]

Phrase: "groups of five islets then"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1552839:groups [Idea or Concept]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "incubated in borosilicate tubes"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0175730:tubes [Medical Device]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1547937:Tubes [Intellectual Product]
   770   C1704474:Tubes [Quantitative Concept]
   737 E C1561954:tube [Conceptual Entity]
   737 E C1704730:TUBE [Medical Device]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1 ml of KRB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439526:/mL [Quantitative Concept]

Phrase: "with the same concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "various insulin secretagogues for 1 h"

Phrase: "in a moving water bath"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   827   C0150141:Bath [Therapeutic or Preventive Procedure]
   827   C0599638:WATER [Substance]
   827   C1550678:Water [Inorganic Chemical]
   755 E C0443350:Watery [Qualitative Concept]

Phrase: "at 37C."
Processing 00000000.tx.40: Insulin concentrations were measured in aliquots of the incubation buffer by radioimmunoassay (7). 

Phrase: "Insulin concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "measured in aliquots of the incubation buffer"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0444706:Measured [Qualitative Concept]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]
   714   C1510844:Aliquot [Quantitative Concept]

Phrase: "by radioimmunoassay"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034580:Radioimmunoassay [Laboratory Procedure]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.41: Insulin secretion from perifused islets. 

Phrase: "Insulin secretion from perifused islets."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C1256369:insulin secretion [Cell Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.42: Insulin secretion from perifused islets was measured using a modification of a previously described protocol (6,7). 

Phrase: "Insulin secretion from perifused islets"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C1256369:insulin secretion [Cell Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a modification of a previously described protocol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392747:Modification [Functional Concept]
   748   C1554963:modification [Qualitative Concept]

Phrase: "(6,"

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.43: Measurement of islet [Ca2+]i, NADPH, and calpain activity in isolated islets. 

Phrase: "Measurement of islet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0242485:Measurement [Functional Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "NADPH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027303:NADPH [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "calpain activity in isolated islets."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1150129:calpain activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.44: [Ca2+]i and NADPH responses to glucose or other secretagogues and calpain activity were measured in islets plated on glass coverslips and cultured in RPMI-1640 for 24 days to allow islets to adhere to the coverslips before the 4-h treatment with calpain inhibitors. 

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "NADPH responses to glucose"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0871261:responses [Organism Attribute]
   737 E C1704632:Response [Finding]
   737 E C1706817:Response [Intellectual Product]
   737 E C2911692:Response [Mental Process]

Phrase: "or"

Phrase: "other secretagogues"

Phrase: "and"

Phrase: "calpain activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150129:calpain activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "measured in islets"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "plated on glass coverslips"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0017596:Glass [Manufactured Object]
   770   C1947936:Glass [Medical Device]
   737   C0005971:Plate [Medical Device]
   737   C1139930:plate [Medical Device]
   737   C3537155:Plate [Manufactured Object]

Phrase: "and"

Phrase: "cultured in RPMI-1640"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "for 24 days to"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0439228:days [Temporal Concept]
   793 E C0332173:/day [Temporal Concept]
   793 E C0439505:/day [Temporal Concept]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "islets to"

Phrase: "adhere to the coverslips"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0231441:Adhere [Finding]

Phrase: "before the 4-h treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "with calpain inhibitors."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0054533:calpain inhibitors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.45: We measured [Ca2+]i responses to glucose and other secretagogues using fura-2 as described (6). 

Phrase: "We"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i responses to glucose"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0871261:responses [Organism Attribute]
   737 E C1704632:Response [Finding]
   737 E C1706817:Response [Intellectual Product]
   737 E C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "other secretagogues"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "fura-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079389:Fura-2 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.46: Intracellular NADPH responses to glucose were monitored by the changes in the autofluorescence at 460 nm (8). 

Phrase: "Intracellular NADPH responses to glucose"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0871261:responses [Organism Attribute]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]

Phrase: "were"

Phrase: "monitored by the changes"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737   C0030695:monitor [Health Care Activity]
   737   C0150369:monitor [Health Care Activity]
   737   C0181904:Monitor [Medical Device]
   737   C0596972:Monitor [Medical Device]
   737   C1521743:Monitor [Professional or Occupational Group]
   737   C1704646:Monitor [Manufactured Object]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "in the autofluorescence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0544711:Autofluorescence [Finding]

Phrase: "at 460 nm (8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: ")."
Processing 00000000.tx.47: For measurements of calpain activity, islets were loaded with the fluorogenic, membrane-permeant calpain substrate t-butoxycarbonyl-Leu-Met-7-amino-4-chloromethylcoumarin (Boc-Leu-Met-CMAC [10 mol/l]; Molecular Probes, Eugene, OR) (9) in HEPES-buffered (10 mmol/l) KRB with 2 mmol/l glucose. 

Phrase: "For measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:measurements [Functional Concept]

Phrase: "of calpain activity,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150129:calpain activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "islets"

Phrase: "were"

Phrase: "loaded"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708715:Loaded [Activity]
   966 E C1550025:Load [Idea or Concept]
   966 E C1704782:Load [Manufactured Object]

Phrase: "with the fluorogenic, membrane-permeant calpain substrate t-butoxycarbonyl-Leu-Met-7-amino-4-chloromethylcoumarin"

Phrase: "(Boc-Leu-Met-CMAC [10 mol/l]"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   818   C0347982:mol/L [Quantitative Concept]

Phrase: "; Molecular Probes,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "Eugene,"

Phrase: "OR) (9"

Phrase: ")"

Phrase: "in HEPES-buffered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(10 mmol/l) KRB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "with 2 mmol/l glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.48: The fluorescence emitted from the proteolytic product in islets was measured with a bandpass combination between 400 and 500 nm after excitation by light at 340 nm. 

Phrase: "The fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "emitted from the proteolytic product"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0597304:Proteolytic [Molecular Function]
   760   C1514468:product [Entity]
   760   C1704444:Product [Quantitative Concept]
   760   C1947941:proteolytic [Enzyme]
   726   C0162676:EMIT [Laboratory Procedure]
   726   C1623049:EMIT [Laboratory Procedure]

Phrase: "in islets"

Phrase: "was"

Phrase: "measured with a bandpass combination"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0205195:Combination [Qualitative Concept]
   760   C0444706:Measured [Qualitative Concept]
   760   C1947911:Combination [Physical Object]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "between 400"

Phrase: "and"

Phrase: "500 nm after excitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0312860:NM [Cell Function]

Phrase: "by light"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023693:Light [Natural Phenomenon or Process]
  1000   C1306462:Light [Functional Concept]
  1000   C1881376:Light [Qualitative Concept]

Phrase: "at 340 nm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]
Processing 00000000.tx.49: Experiments were performed after a 4-h incubation in the presence of 200 mol/l ALLM, 200 mol/l E-64-d, or vehicle. 

Phrase: "Experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed after a 4-h incubation"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   753   C0884358:Performed [Functional Concept]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 200 mol/l ALLM,"

Phrase: "200 mol/l E-64-d,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   876   C0439428:mol/d [Quantitative Concept]

Phrase: "or"

Phrase: "vehicle."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042444:Vehicle [Biomedical or Dental Material]
  1000   C0348005:Vehicle [Manufactured Object]
   928 E C0445373:Vehicular [Functional Concept]
Processing 00000000.tx.50: During these measurements, islets on coverslips were perifused continuously with oxygenated KRB medium containing the inhibitors at 37C. 

Phrase: "During these measurements,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:measurements [Functional Concept]

Phrase: "islets on coverslips"

Phrase: "were"

Phrase: "perifused"

Phrase: "continuously with oxygenated KRB medium"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0009458:Medium [Intellectual Product]
   748   C0439536:Medium [Quantitative Concept]
   748   C1705217:Medium [Substance]
   748   C3244283:medium [Intellectual Product]
   714   C1875730:RINGER'S [Organic Chemical,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the inhibitors at 37C."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0243077:inhibitors [Chemical Viewed Functionally]
   737 E C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.51: A computer-driven imaging system (MetaFluor 4.0; Universal Imaging, West Chester, PA) was used to capture and store images after ultraviolet excitation. 

Phrase: "A computer-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0009622:Computer [Manufactured Object]

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0449913:System [Functional Concept]
  1000   C1553451:System [Manufactured Object]
  1000   C1704459:System [Medical Device]
   928 E C0205373:Systemic [Functional Concept]

Phrase: "(MetaFluor 4.0"

Phrase: "; Universal Imaging, West Chester,"

Phrase: "PA)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541314:PA [Idea or Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "capture"

Phrase: "and"

Phrase: "store images after ultraviolet excitation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1704254:Image [Intellectual Product]
   726   C1704922:Image [Entity]
   726   C3542466:Image [Intellectual Product]
Processing 00000000.tx.52: Glucose utilization and oxidation rates. 

Phrase: "Glucose utilization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0042153:utilization [Functional Concept]

Phrase: "and"

Phrase: "oxidation rates."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0030011:Oxidation [Molecular Function]
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.53: Glucose utilization and oxidation rates were measured (8,10) in mouse islets cultured in the presence or absence of calpain inhibitors for 4 h as described above. 

Phrase: "Glucose utilization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0042153:utilization [Functional Concept]

Phrase: "and"

Phrase: "oxidation rates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0030011:Oxidation [Molecular Function]
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "(8,"

Phrase: "10"

Phrase: ")"

Phrase: "in mouse islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522528:Mouse Islets [Tissue]

Phrase: "cultured in the presence"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "or"

Phrase: "absence of calpain inhibitors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "for 4 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "as described above."
Processing 00000000.tx.54: Calcium current recording in dispersed pancreatic -cells. 

Phrase: "Calcium current recording in dispersed pancreatic -cells."
Processing 00000000.tx.55: Isolated islets were dispersed into single -cells by gentle trituration in Ca2+ and Mg2+-free phosphate-buffered saline containing 0.025% trypsin-0.1 mmol/l EDTA. 

Phrase: "Isolated islets"

Phrase: "were"

Phrase: "dispersed into single -cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0007634:Cells [Cell]
   770   C0037179:Single [Population Group]
   770   C0087136:single [Finding]
   770   C0205171:Single [Quantitative Concept]
   770   C0332624:Dispersed [Spatial Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "by gentle trituration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0885614:trituration [Inorganic Chemical]

Phrase: "in Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "Mg2+-free phosphate-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   823   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   804   C0031701:phosphate [Organophosphorus Compound]
   804   C0036082:Saline [Substance]
   804   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.025% trypsin-0.1 mmol/l EDTA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.56: Cells were plated on glass coverslips and maintained in culture in RPMI-1640 containing 11.6 mmol/l glucose for 4896 h before being treated with inhibitors. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated on glass coverslips"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0017596:Glass [Manufactured Object]
   770   C1947936:Glass [Medical Device]
   737   C0005971:Plate [Medical Device]
   737   C1139930:plate [Medical Device]
   737   C3537155:Plate [Manufactured Object]

Phrase: "and"

Phrase: "maintained in culture"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0010453:Culture [Idea or Concept]
   790   C0220814:culture [Functional Concept]
   790   C0430400:Culture [Laboratory Procedure]
   790   C1314677:Maintained [Functional Concept]
   790   C2242979:Culture [Laboratory Procedure]
   756 E C0024501:Maintain [Activity]

Phrase: "in RPMI-1640"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "11.6 mmol/l glucose for 4896 h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "before"

Phrase: "being"

Phrase: "treated with inhibitors."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0243077:inhibitors [Chemical Viewed Functionally]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]
   756 E C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.57: Calcium current measurements were obtained in the whole-cell patch-clamp configuration. 

Phrase: "Calcium current measurements"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0201925:calcium measurements [Laboratory Procedure]
   827   C0242485:measurements [Functional Concept]

Phrase: "were"

Phrase: "obtained in the whole-cell patch-clamp configuration."
Meta Candidates (Total=20; Excluded=1; Pruned=0; Remaining=19)
   770   C0920630:patch clamp [Research Activity]
   744   C0007634:Cell [Cell]
   744   C0175721:Clamp [Medical Device]
   744   C0332461:Patch [Finding]
   744   C0444667:Whole [Quantitative Concept]
   744   C0445403:Patch [Biomedical or Dental Material]
   744   C0449830:Configuration [Spatial Concept]
   744   C0991556:Patch [Medical Device]
   744   C1269647:Cell [Cell]
   744   C1301820:Obtained [Functional Concept]
   744   C1305400:Patch [Medical Device]
   744   C1533128:Patch [Biomedical or Dental Material]
   744   C1704653:Cell [Medical Device]
   744   C1705942:Clamp [Manufactured Object]
   744   C1706366:{Patch} [Quantitative Concept]
   744   C1707974:Patch [Biomedical or Dental Material]
   744   C1883710:Clamp [Functional Concept]
   744   C1948049:Cell [Spatial Concept]
   744   C2827597:Configuration [Conceptual Entity]
   711 E C1706701:Obtain [Activity]
Processing 00000000.tx.58: Calcium currents were activated by step depolarizations to either +10 or +20 mV for either 20 or 100 ms, from a holding potential (HP) of -80 mV. 

Phrase: "Calcium currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0521116:currents [Temporal Concept]
   827 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "were"

Phrase: "activated by step depolarizations"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C1261552:Step [Conceptual Entity]
   770   C1704379:Step [Functional Concept]
   770   C1705117:Step [Quantitative Concept]
   770   C1879547:Activated [Activity]
   770   C2825408:Step [Manufactured Object]
   737 E C1515877:Activate [Functional Concept]

Phrase: "to either +10 or +20 mV"

Phrase: "for either 20"

Phrase: "or"

Phrase: "100 ms,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]

Phrase: "from a holding potential (HP) of -80 mV."
Processing 00000000.tx.59: All current records were corrected for leak and capacitance. 

Phrase: "All current records"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034869:Records [Intellectual Product]
   861   C1548330:Records [Idea or Concept]
   861   C1553414:Records [Qualitative Concept]

Phrase: "were"

Phrase: "corrected for leak"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0205202:Corrected [Qualitative Concept]
   790   C0332234:Leak [Functional Concept]
   790   C1608322:Leak NOS [Finding]
   790   C1881366:LEAK [Phenomenon or Process]
   756 E C2349182:Correct [Qualitative Concept]

Phrase: "and"

Phrase: "capacitance."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242264:capacitance [Quantitative Concept]
Processing 00000000.tx.60: The data were filtered at 2 kHz and then sampled every 100 s. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "filtered"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   966   C0180860:Filter [Manufactured Object]
   966   C0581406:Filter [Medical Device]
   966   C1522664:Filter [Intellectual Product]
   966   C1704449:Filter [Conceptual Entity]
   966   C1704684:Filter [Medical Device]
   966   C1875155:FILTER [Medical Device]
   928 E C0080194:Strain [Injury or Poisoning]
   928 E C0442694:Straining [Physiologic Function]
   928 E C0456178:strain [Intellectual Product]
   928 E C1518614:Strain [Organism]
   928 E C2987481:Strain [Mental Process]

Phrase: "at 2 kHz"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0556965:kHz [Quantitative Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "sampled"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0441621:sampled [Diagnostic Procedure]
  1000   C0870078:sampled [Idea or Concept]
   966 E C0370003:Sample [Substance]
   966 E C2347026:Sample [Conceptual Entity]

Phrase: "every 100 s."
Processing 00000000.tx.61: Pipette resistances were 1.52.5 M. 

Phrase: "Pipette resistances"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   777 E C0332325:Resistant [Functional Concept]
   777 E C1550464:resistent [Idea or Concept]
   777 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "were"

Phrase: "1.52.5 M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]
   708   C0450316:1/5 [Quantitative Concept]
Processing 00000000.tx.62: Series resistance was partially compensated (80%) using the compensation circuit of the Axopatch-1C amplifier. 

Phrase: "Series resistance"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0205549:Series [Quantitative Concept]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C2348044:Series [Intellectual Product]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "was"

Phrase: "partially"

Phrase: "compensated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205432:Compensated [Qualitative Concept]

Phrase: "(80%"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the compensation circuit of the Axopatch-1C amplifier."
Processing 00000000.tx.63: Cells were incubated for 4 h in RPMI-1640 at 37C in either 0.1% DMSO (control) or 100 mol/l ALLM and then transferred for an additional 12 h to KRB containing similar concentrations of DMSO or ALLM. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated for 4 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "in RPMI-1640"

Phrase: "at 37C"

Phrase: "in either 0.1% DMSO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0012403:DMSO [Organic Chemical,Pharmacologic Substance]

Phrase: "(control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "or"

Phrase: "100 mol/l ALLM"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "transferred for an additional 12 h"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0348011:transferred [Functional Concept]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   753   C1524062:Additional [Functional Concept]
   719 E C0040671:Transfer [Mental Process]
   719 E C1705822:Transfer [Activity]

Phrase: "to KRB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "similar concentrations of DMSO"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "or"

Phrase: "ALLM."
Processing 00000000.tx.64: For recording, cells were bathed in a solution containing (in mmol/l) 145 NaCl, 2 KCl, 1 MgCl2, 2 glucose, 10 HEPES, 10 CaCl2 (pH 7.3; adjusted with NaOH), and either DMSO or ALLM. 

Phrase: "For recording,"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "bathed in a solution"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0037633:Solution [Substance]
   770   C0150141:bathed [Therapeutic or Preventive Procedure]
   770   C0525069:Solution [Biomedical or Dental Material]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "("

Phrase: "in mmol/l) 145 NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C1959973:% NaCl [Quantitative Concept]

Phrase: "2 KCl,"

Phrase: "1 MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "2 glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "10 HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "10 CaCl2"

Phrase: "(pH 7.3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0601906:PH 3 [Pharmacologic Substance]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ";"

Phrase: "adjusted with NaOH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0456081:Adjusted [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "either DMSO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012403:DMSO [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "ALLM."
Processing 00000000.tx.65: After the whole-cell configuration was established, the bath solution was exchanged for a tetraethylammonium (TEA)-based recording medium that contained (in mmol/l) 155 TEA-Cl, 2 glucose, 10 HEPES, 10 CaCl2 and 100 nmol/l TTX (pH 7.3; adjusted with TEA-OH), and either DMSO or ALLM. 

Phrase: "After the whole-cell configuration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449830:Configuration [Spatial Concept]
   827   C2827597:Configuration [Conceptual Entity]

Phrase: "was"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: ","

Phrase: "the bath solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "was"

Phrase: "exchanged for a tetraethylammonium (TEA)-based recording medium"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   748   C0009458:Medium [Intellectual Product]
   748   C0076252:Tetraethylammonium [Organic Chemical,Pharmacologic Substance]
   748   C0439536:Medium [Quantitative Concept]
   748   C1527178:Based [Functional Concept]
   748   C1705217:Medium [Substance]
   748   C1705938:Based [Idea or Concept]
   748   C3244283:medium [Intellectual Product]
   714 E C0002055:base [Inorganic Chemical]
   714   C0034869:Record [Intellectual Product]
   714 E C0178499:Base [Chemical Viewed Functionally]
   714   C0678640:exchange [Social Behavior]
   714 E C1880279:Base [Biomedical or Dental Material]

Phrase: "that contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "("

Phrase: "in mmol/l) 155 TEA-Cl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "2 glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "10 HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "10 CaCl2"

Phrase: "and"

Phrase: "100 nmol/l TTX"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0039705:TTX [Biologically Active Substance,Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "(pH 7.3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0601906:PH 3 [Pharmacologic Substance]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ";"

Phrase: "adjusted with TEA-OH"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0076252:Tetraethylammonium [Organic Chemical,Pharmacologic Substance]
   770   C0220853:OH- [Element, Ion, or Isotope]
   770   C0456081:Adjusted [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "either DMSO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012403:DMSO [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "ALLM."
Processing 00000000.tx.66: The intracellular pipette solution consisted of (in mmol/l) 110 CsCl, 4 MgCl2, 20 HEPES, 10 EGTA, 0.35 guanosine triphosphate, 4 ATP, and 14 creatine phosphate (pH 7.3; adjusted with CsOH). 

Phrase: "The intracellular pipette solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037633:Solution [Substance]
   827   C0525069:Solution [Biomedical or Dental Material]

Phrase: "consisted"

Phrase: "of (in mmol/l) 110 CsCl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332285:Of [Spatial Concept]

Phrase: "4 MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "20 HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "10 EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "0.35 guanosine triphosphate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0018353:Guanosine Triphosphate [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   812   C0146894:triphosphate [Inorganic Chemical]

Phrase: "4 ATP,"

Phrase: "and"

Phrase: "14 creatine phosphate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0031634:Creatine Phosphate [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0010286:Creatine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(pH 7.3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0601906:PH 3 [Pharmacologic Substance]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ";"

Phrase: "adjusted with CsOH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0456081:Adjusted [Functional Concept]

Phrase: ")."
Processing 00000000.tx.67: Membrane capacitance measurements. 

Phrase: "Membrane capacitance measurements."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0242485:measurements [Functional Concept]
Processing 00000000.tx.68: Membrane capacitance changes in dispersed pancreatic -cells were used to assess insulin exocytosis and were carried out in the perforated whole-cell configuration. 

Phrase: "Membrane capacitance"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0025255:Membrane [Tissue]
   861   C0242264:capacitance [Quantitative Concept]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "changes in dispersed pancreatic -cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0007634:Cells [Cell]
   760   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   760   C0332624:Dispersed [Spatial Concept]
   760   C0392747:Change [Functional Concept]
   760   C0443172:change [Quantitative Concept]
   760   C1705241:Change [Quantitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "insulin exocytosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015283:Exocytosis [Cell Function]

Phrase: "and"

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in the perforated whole-cell configuration."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   748   C0007634:Cell [Cell]
   748   C0439787:Out [Spatial Concept]
   748   C0444667:Whole [Quantitative Concept]
   748   C0449830:Configuration [Spatial Concept]
   748   C0549099:Perforated [Finding]
   748   C0849355:Out [Qualitative Concept]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C2827597:Configuration [Conceptual Entity]
Processing 00000000.tx.69: For these experiments, the phase-tracking technique (11) was used, whereby a 60-mV peak-to-peak sine wave was superimposed on a holding potential of -80 mV (12), as described previously (13). 

Phrase: "For these experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "the phase-tracking technique"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0449851:Technique [Functional Concept]
   743 E C0025664:techniques [Intellectual Product]

Phrase: "(11"

Phrase: ")"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ","

Phrase: "whereby"

Phrase: "a 60-mV peak-to-peak sine wave"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   818   C0445259:Sine wave [Spatial Concept]
   795   C0600477:SINE [Nucleotide Sequence]
   795   C0678544:wave [Natural Phenomenon or Process]
   795   C1421479:WAVE [Gene or Genome]

Phrase: "was"

Phrase: "superimposed on a holding potential of -80 mV (12"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C3245505:Potential [Qualitative Concept]
   708   C1553387:Hold [Idea or Concept]
   708   C1948035:Hold [Activity]

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.70: -cells were stimulated with a train of 10-step depolarizations to +20 mV (HP = -80 mV). 

Phrase: "-cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stimulated with a train"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0336809:Train [Manufactured Object]
   770   C1552514:Train [Manufactured Object]
   770   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "of 10-step depolarizations to +20 mV (HP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C3245505:Potential [Qualitative Concept]
   760   C1553387:Hold [Idea or Concept]
   760   C1948035:Hold [Activity]

Phrase: "= -80 mV"

Phrase: ")."
Processing 00000000.tx.71: Each step depolarization lasted 150 ms and was separated by a 400-ms interpulse duration. 

Phrase: "Each step depolarization"

Phrase: "lasted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1517741:Last [Qualitative Concept]

Phrase: "150 ms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]

Phrase: "and"

Phrase: "was"

Phrase: "separated by a 400-ms interpulse duration."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0086972:Separated [Finding]
   748   C0443299:separated [Spatial Concept]
   748   C0449238:Duration [Temporal Concept]
   748   C0687118:Separated [Functional Concept]
   748   C2349943:Ms. [Conceptual Entity]
   748   C2926735:Duration [Pharmacologic Substance]
   748   C3539704:MS [Gene or Genome]
Processing 00000000.tx.72: The data were collected at a 500-s sampling rate and filtered at 5 kHz. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "collected at a 500-s sampling rate"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   748   C0441621:Sampling [Diagnostic Procedure]
   748   C0870078:Sampling [Idea or Concept]
   748   C0871208:Rate [Activity]
   748   C1516695:Collected [Idea or Concept]
   748   C1516698:Collected [Functional Concept]
   748   C1521828:Rate [Quantitative Concept]
   714 E C0370003:Sample [Substance]
   714 E C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "filtered at 5 kHz."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0556965:kHz [Quantitative Concept]
   737   C0180860:Filter [Manufactured Object]
   737   C0581406:Filter [Medical Device]
   737   C1522664:Filter [Intellectual Product]
   737   C1704449:Filter [Conceptual Entity]
   737   C1704684:Filter [Medical Device]
   737   C1875155:FILTER [Medical Device]
Processing 00000000.tx.73: Recordings with series resistance of >20 M were discarded. 

Phrase: "Recordings with series resistance of >20 M"

Phrase: "were"

Phrase: "discarded."
Processing 00000000.tx.74: Series resistance compensation was applied in all recordings. 

Phrase: "Series resistance compensation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0152057:Compensation [Mental Process]
   827   C0152058:Compensation [Physiologic Function]
   827   C0220808:Compensation [Quantitative Concept]

Phrase: "was"

Phrase: "applied in all recordings."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0185125:Applied [Health Care Activity]
   737 E C1632850:Apply [Functional Concept]
   737 E C1879355:Apply [Functional Concept]
Processing 00000000.tx.75: The extracellular solution for the capacitance measurements contained (in mmol/l) 130 NaCl, 2 glucose, 10 Na-HEPES, 1 MgCl2, 2 KCl, and 5 CaCl2 (pH 7.3) with NaOH. 

Phrase: "The extracellular solution for the capacitance measurements"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0037633:Solution [Substance]
   748   C0525069:Solution [Biomedical or Dental Material]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "("

Phrase: "in mmol/l) 130 NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C1959973:% NaCl [Quantitative Concept]

Phrase: "2 glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "10 Na-HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "1 MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "2 KCl,"

Phrase: "and"

Phrase: "5 CaCl2"

Phrase: "(pH 7.3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0601906:PH 3 [Pharmacologic Substance]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "with NaOH."
Processing 00000000.tx.76: The pipette solution contained (in mmol/l) 135 Cs-glutamate, 10 Na-HEPES, 9.5 NaCl, 0.5 TEA-Cl, and 0.5 CaCl2 (pH 7.3) with CsOH. 

Phrase: "The pipette solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "("

Phrase: "in mmol/l) 135 Cs-glutamate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   804   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "10 Na-HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "9.5 NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "0.5 TEA-Cl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "0.5 CaCl2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0444499:0/5 [Quantitative Concept]

Phrase: "(pH 7.3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0601906:PH 3 [Pharmacologic Substance]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "with CsOH."
Processing 00000000.tx.77: The pipettes were backfilled with an identical solution to which amphotericin B (final concentration of 0.5 mg/ml) was added and then sonicated. 

Phrase: "The pipettes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0182301:pipettes [Medical Device]
   966 E C1706407:Pipette [Medical Device]

Phrase: "were"

Phrase: "backfilled with an identical solution"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0037633:Solution [Substance]
   760   C0205280:Identical [Qualitative Concept]
   760   C0525069:Solution [Biomedical or Dental Material]

Phrase: "to which amphotericin B"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0002679:Amphotericin B [Antibiotic,Organic Chemical]
   944 E C0812405:Fungizone [Antibiotic,Organic Chemical]
   861   C0085795:Amphotericin [Antibiotic,Carbohydrate,Pharmacologic Substance]

Phrase: "(final concentration of 0.5 mg/"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]

Phrase: "ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "sonicated."
Processing 00000000.tx.78: The amphotericin B stock solution (125 mg/ml) was kept frozen at -20C and used for 1 week. 

Phrase: "The amphotericin B stock solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037633:Solution [Substance]
   812   C0525069:Solution [Biomedical or Dental Material]

Phrase: "(125 mg/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "was"

Phrase: "kept"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0333118:Keep [Functional Concept]

Phrase: "frozen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016701:Frozen [Natural Phenomenon or Process]
  1000   C0677542:Frozen [Functional Concept]

Phrase: "at -20C"

Phrase: "and"

Phrase: "used for 1 week."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0332174:/week [Temporal Concept]
   770   C0439230:week [Temporal Concept]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.79: ALLM pretreatment was as described above. 

Phrase: "ALLM pretreatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1550147:Pretreatment [Substance]
   861   C2709094:pre treatment [Temporal Concept]
   861   C3539075:Pretreatment [Temporal Concept]
   861   C3539076:Pretreatment [Activity]

Phrase: "was"

Phrase: "as"

Phrase: "described above."
Processing 00000000.tx.80: All electrophysiological recordings were carried out at room temperature (2224C). 

Phrase: "All electrophysiological recordings"

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out at room temperature"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C0439787:Out [Spatial Concept]
   770   C0849355:Out [Qualitative Concept]
   770   C1547703:Room [Spatial Concept]

Phrase: "(2224C"

Phrase: ")."
Processing 00000000.tx.81: Glycogen synthesis rates in skeletal muscle. 

Phrase: "Glycogen synthesis rates in skeletal muscle."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0871208:Rate [Activity]
   719   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.82: Measurement of glycogen synthesis rates was performed using a modification of a previously described protocol (14). 

Phrase: "Measurement of glycogen synthesis rates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0201785:Rate measurement [Laboratory Procedure]
   760   C0242485:Measurement [Functional Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a modification of a previously described protocol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392747:Modification [Functional Concept]
   748   C1554963:modification [Qualitative Concept]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.83: Soleus muscle strips were isolated from nonfasted male rats and incubated in KRB5 mmol/l glucose10 mmol/l HEPES, 0.2% BSA in the presence and absence of 100 mol/l ALLM, 200 mol/l E-64-d, or vehicle. 

Phrase: "Soleus muscle strips"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1321564:strips [Medical Device]
   734   C0242694:Soleus Muscle [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "isolated from nonfasted male rats"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   760   C0024554:Male [Finding]
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0086582:male [Population Group]
   760   C0205409:Isolated [Functional Concept]
   760   C1548221:Isolated [Idea or Concept]
   760   C1706180:Male [Qualitative Concept]
   760   C1706428:Male [Qualitative Concept]
   760   C1706429:Male [Organism Attribute]
   726 E C0370215:Isolate [Substance]
   726 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "incubated in KRB5 mmol/l glucose10 mmol/l HEPES,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C1532563:mmol/L [Quantitative Concept]
   762   C1960955:mmol/mmol [Quantitative Concept]
   742   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   742   C0439190:MMOLE [Quantitative Concept]
   742   C1439852:Incubated [Laboratory Procedure]

Phrase: "0.2% BSA in the presence"

Phrase: "and"

Phrase: "absence of 100 mol/l ALLM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "200 mol/l E-64-d,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   876   C0439428:mol/d [Quantitative Concept]

Phrase: "or"

Phrase: "vehicle."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042444:Vehicle [Biomedical or Dental Material]
  1000   C0348005:Vehicle [Manufactured Object]
   928 E C0445373:Vehicular [Functional Concept]
Processing 00000000.tx.84: 2-Deoxyglucose uptake into skeletal muscle and adipose tissue. 

Phrase: "2-Deoxyglucose uptake into skeletal muscle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243144:Uptake [Physiologic Function]
   753   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "adipose tissue."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001527:Adipose tissue [Tissue]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
   789   C0028754:Adiposity [Disease or Syndrome]
   789   C1563743:adiposity [Organism Attribute]
Processing 00000000.tx.85: 2-deoxyglucose (2-DOG) uptake by isolated soleus muscle strips from male rats was measured using a modification of a previously described protocol (14). 

Phrase: "2-deoxyglucose (2-DOG) uptake by isolated soleus muscle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0243144:Uptake [Physiologic Function]
   748   C0347980:% uptake [Quantitative Concept]

Phrase: "strips from male rats"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0024554:Male [Finding]
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]
   770   C0086582:male [Population Group]
   770   C1321564:Strip [Medical Device]
   770   C1706180:Male [Qualitative Concept]
   770   C1706428:Male [Qualitative Concept]
   770   C1706429:Male [Organism Attribute]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a modification of a previously described protocol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392747:Modification [Functional Concept]
   748   C1554963:modification [Qualitative Concept]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.86: After a 30-min preincubation in KRB containing no glucose, 2 mmol/l pyruvate, 10 mmol/l HEPES, 0.2% BSA, and 100 mol/l ALLM or 200 mol/l E-64-d, the muscle strips were transferred to identical medium containing 0.1 mmol/l 2-deoxy-[2,6-3H]glucose (0.5 Ci/ml) and 0.1 mmol/l [14C]sucrose (0.2 Ci/ml) and incubated for another 30 min at 37C. 

Phrase: "After a 30-min preincubation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0456693:/30 min [Temporal Concept]
   734   C1442458:30 min [Temporal Concept]

Phrase: "in KRB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "no glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "2 mmol/l pyruvate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0034354:pyruvate [Organic Chemical]
   812   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "10 mmol/l HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "0.2% BSA,"

Phrase: "and"

Phrase: "100 mol/l ALLM"

Phrase: "or"

Phrase: "200 mol/l E-64-d,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   876   C0439428:mol/d [Quantitative Concept]

Phrase: "the muscle strips"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1321564:strips [Medical Device]

Phrase: "were"

Phrase: "transferred to identical medium"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0009458:Medium [Intellectual Product]
   770   C0205280:Identical [Qualitative Concept]
   770   C0348011:transferred [Functional Concept]
   770   C0439536:Medium [Quantitative Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]
   737 E C0040671:Transfer [Mental Process]
   737 E C1705822:Transfer [Activity]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.1 mmol/l 2-deoxy-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0069851:dE-oxy [Amino Acid, Peptide, or Protein]

Phrase: "[2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "6-3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442460:3H [Temporal Concept]

Phrase: "]glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(0.5 Ci/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0444499:0/5 [Quantitative Concept]

Phrase: "ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "0.1 mmol/l [14C"

Phrase: "]sucrose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
  1000   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "(0.2 Ci/"

Phrase: "ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "incubated for another 30 min"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0456693:/30 min [Temporal Concept]
   806   C1442458:30 min [Temporal Concept]
   760   C0702093:/min [Temporal Concept]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 37C."
Processing 00000000.tx.87: The uptake of 2-DOG was calculated as described previously (14). 

Phrase: "The uptake of 2-DOG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243144:Uptake [Physiologic Function]
   760   C0347980:% uptake [Quantitative Concept]

Phrase: "was"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.88: Adipocytes were isolated from epididymal fat pads (15). 

Phrase: "Adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206131:Adipocytes [Cell]

Phrase: "were"

Phrase: "isolated from epididymal fat pads"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   806   C0154270:fat pads [Finding]
   806   C0935625:Fat pads [Tissue]
   760   C0014533:Epididymal [Body Part, Organ, or Organ Component]
   760   C0182158:Pads [Medical Device]
   760   C0205409:Isolated [Functional Concept]
   760   C0332568:Pad [Neoplastic Process]
   760   C0424612:FAT [Organism Attribute]
   760   C1548221:Isolated [Idea or Concept]
   760   C1706529:Pads [Biomedical or Dental Material]
   760   C3540603:PAD [Gene or Genome]
   726 E C0370215:Isolate [Substance]
   726 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.89: For the measurement of basal and insulin-stimulated transport of glucose, aliquots of 200 l of adipocytes (2 x 105 cells/ml) were incubated for 120 min at 37C in KRB with different concentrations of insulin either with or without 100 mol/l ALLM or E-64-d. 

Phrase: "For the measurement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:Measurement [Functional Concept]

Phrase: "of basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "insulin-stimulated transport of glucose,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0178666:glucose transport [Cell Function]
   760   C0005528:Transport, NOS [Cell Function]
   760   C1317949:Transport [Manufactured Object]
   760   C3495449:transport [Medical Device]

Phrase: "aliquots of 200 l of adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1510844:Aliquot [Quantitative Concept]

Phrase: "(2 x 105 cells/ml)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C2699156:Cells/mL [Quantitative Concept]
   804   C0439526:/mL [Quantitative Concept]

Phrase: "were"

Phrase: "incubated for 120 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0702093:/min [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 37C"

Phrase: "in KRB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "with different concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of insulin either"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "with"

Phrase: "or without 100 mol/l ALLM"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0347982:mol/L [Quantitative Concept]
   753   C0027960:Mole [Neoplastic Process]
   753   C0324740:Mole [Mammal]
   753   C0439189:Mole [Quantitative Concept]
   753   C1456781:mole [Neoplastic Process]
   753   C1824986:mol [Gene or Genome]

Phrase: "or"

Phrase: "E-64-d."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0058882:E 64 [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.90: Then, another 50 l of KRB containing 5 mmol/l 2-DOG (final concentration 1 mmol/l), 0.5 Ci of 2-deoxy-[2,6-3H]glucose was added and cells were incubated for an additional 5 min at 25C. 

Phrase: "Then,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "another 50 l of KRB"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5 mmol/l 2-DOG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0011501:Deoxyglucose [Carbohydrate,Pharmacologic Substance]

Phrase: "(final concentration 1 mmol/l), 0.5 Ci"

Phrase: "of 2-deoxy-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0069851:dE-oxy [Amino Acid, Peptide, or Protein]

Phrase: "[2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "6-3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442460:3H [Temporal Concept]

Phrase: "]glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated for an additional 5 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0702093:/min [Temporal Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1524062:Additional [Functional Concept]

Phrase: "at 25C."
Processing 00000000.tx.91: The transport was stopped by addition of cytochalasin B (final concentration 50 mol/l), and cells were spun through 250 l of dinonyl phthalate oil (Fisher Scientific, Pittsburgh, PA). 

Phrase: "The transport"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005528:Transport, NOS [Cell Function]
  1000   C1317949:Transport [Manufactured Object]
  1000   C3495449:transport [Medical Device]

Phrase: "was"

Phrase: "stopped by addition of cytochalasin B"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0010737:Cytochalasin B [Biologically Active Substance,Pharmacologic Substance]
   753   C0010739:Cytochalasin [Biologically Active Substance,Pharmacologic Substance]
   753   C1272691:stopped [Qualitative Concept]
   753   C1883712:Addition [Functional Concept]
   719 E C1947925:Stop [Activity]
   719 E C2746065:Stop [Temporal Concept]

Phrase: "(final concentration 50 mol/l),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   840   C0347982:mol/L [Quantitative Concept]

Phrase: "and"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "spun through 250 l of dinonyl phthalate oil"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   744   C0028908:Oil [Lipid]
   744   C0136960:phthalate [Organic Chemical]
   744   C0220894:phthalate [Organic Chemical]
   744   C1446863:Spun [Laboratory Procedure]
   744   C1517288:Oil [Food,Lipid]
   711 E C1415347:SPIN [Gene or Genome]
   711 E C1823107:SPIN [Gene or Genome]

Phrase: "(Fisher Scientific, Pittsburgh,"

Phrase: "PA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541314:PA [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.92: Cells then were transferred to scintillation vials for counting. 

Phrase: "Cells then"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transferred to scintillation vials"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0184301:vials [Medical Device]
   770   C0348011:transferred [Functional Concept]
   770   C0678573:scintillation [Natural Phenomenon or Process]
   770   C1533199:Vials [Quantitative Concept]
   737 E C0040671:Transfer [Mental Process]
   737 E C1705822:Transfer [Activity]
   737 E C1706497:VIAL [Medical Device]

Phrase: "for counting."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.93: Measurement of 3-O-methyl-D-glucose uptake. 

Phrase: "Measurement of 3-O-methyl-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0242485:Measurement [Functional Concept]

Phrase: "D-"

Phrase: "glucose uptake."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1159527:glucose uptake [Cell Function]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]
Processing 00000000.tx.94: Epitrochlearis muscles were isolated from overnight fasted rats and were incubated for 1 h at 35C in 3 ml of oxygenated Krebs-Henseleit buffer (KHB) supplemented with 5 mmol/l glucose, 15 mmol/l mannitol, 0.1% BSA, with or without 100 mol/l ALLM. 

Phrase: "Epitrochlearis muscles"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0026845:Muscles [Tissue]
   861   C1995013:Muscles [Body Part, Organ, or Organ Component]
   777 E C0442025:Muscular [Spatial Concept]

Phrase: "were"

Phrase: "isolated from overnight fasted rats"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0205409:Isolated [Functional Concept]
   760   C0439583:Overnight [Temporal Concept]
   760   C1548221:Isolated [Idea or Concept]
   726   C0015663:Fast [Finding]
   726 E C0370215:Isolate [Substance]
   726   C0456962:Fast [Qualitative Concept]
   726 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "were"

Phrase: "incubated for 1 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0700308:h 1 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 35C"

Phrase: "in 3 ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "of oxygenated Krebs-Henseleit buffer (KHB)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C0167250:Krebs-Henseleit buffer [Biomedical or Dental Material,Organic Chemical]
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "supplemented with 5 mmol/l glucose,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1532563:mmol/L [Quantitative Concept]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0439190:MMOLE [Quantitative Concept]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "15 mmol/l mannitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024730:Mannitol [Carbohydrate,Pharmacologic Substance]

Phrase: "0.1% BSA,"

Phrase: "with"

Phrase: "or without 100 mol/l ALLM."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0347982:mol/L [Quantitative Concept]
   753   C0027960:Mole [Neoplastic Process]
   753   C0324740:Mole [Mammal]
   753   C0439189:Mole [Quantitative Concept]
   753   C1456781:mole [Neoplastic Process]
   753   C1824986:mol [Gene or Genome]
Processing 00000000.tx.95: Muscle strips then were incubated in identical media with or without 12 nmol of insulin or were transferred to KHB medium gassed with 95% N25% CO2 for 80 min. 

Phrase: "Muscle"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026845:Muscle [Tissue]
   928 E C0442025:Muscular [Spatial Concept]

Phrase: "strips"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1321564:Strip [Medical Device]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "were"

Phrase: "incubated in identical media"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C0205280:Identical [Qualitative Concept]
   770   C1254021:Media [Tissue]
   770   C1439852:Incubated [Laboratory Procedure]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737 E C3244283:medium [Intellectual Product]

Phrase: "with"

Phrase: "or without 12 nmol of insulin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0439191:NMOLE [Quantitative Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "or"

Phrase: "were"

Phrase: "transferred to KHB medium"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0167250:Krebs-Henseleit buffer [Biomedical or Dental Material,Organic Chemical]
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0009458:Medium [Intellectual Product]
   753   C0348011:transferred [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]
   719 E C0040671:Transfer [Mental Process]
   719 E C1705822:Transfer [Activity]

Phrase: "gassed with 95% N25% CO2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C2347816:Co2+ [Element, Ion, or Isotope]
   726   C0017110:Gas [Chemical Viewed Structurally]
   726   C0596601:Gas [Sign or Symptom]

Phrase: "for 80 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.96: Muscle glucose transport activity was measured using minor modifications of previously described methods (16). 

Phrase: "Muscle glucose transport activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   867   C0231484:Muscular activity [Organ or Tissue Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "minor modifications of previously described methods"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0392747:Modification [Functional Concept]
   719   C1554963:modification [Qualitative Concept]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.97: After the initial incubations, all muscles were washed for 15 min at 30C in 3 ml of KHB containing 20 mmol/l mannitol and 0.1% BSA to remove glucose from the extracellular space. 

Phrase: "After the initial incubations,"

Phrase: "all muscles"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0026845:Muscles [Tissue]
  1000   C1995013:Muscles [Body Part, Organ, or Organ Component]
   916 E C0442025:Muscular [Spatial Concept]

Phrase: "were"

Phrase: "washed for 15 min"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0702093:/min [Temporal Concept]
   770   C1548982:Washed [Idea or Concept]
   737 E C0441648:Wash [Activity]

Phrase: "at 30C"

Phrase: "in 3 ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "of KHB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0167250:Krebs-Henseleit buffer [Biomedical or Dental Material,Organic Chemical]
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "20 mmol/l mannitol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024730:Mannitol [Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.1% BSA to"

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "glucose from the extracellular space."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.98: Muscles then were transferred to 1.5 ml of KHB containing 8 mmol/l 3-O-[3H]methyl-D-glucose (3-MG, 2 Ci/ml), 12 mmol/l [U-14C] mannitol (0.2 Ci/ml), and 0.1% BSA at 30C for 10 min. 

Phrase: "Muscles then"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0026845:Muscles [Tissue]
   861   C1995013:Muscles [Body Part, Organ, or Organ Component]
   777 E C0442025:Muscular [Spatial Concept]

Phrase: "were"

Phrase: "transferred to 1.5 ml of KHB"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0167250:Krebs-Henseleit buffer [Biomedical or Dental Material,Organic Chemical]
   742   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   742   C0348011:transferred [Functional Concept]
   742   C0439526:/mL [Quantitative Concept]
   708 E C0040671:Transfer [Mental Process]
   708 E C1705822:Transfer [Activity]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "8 mmol/l 3-O-[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1442460:3H [Temporal Concept]

Phrase: "]methyl-"

Phrase: "D-"

Phrase: "glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(3-MG,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "2 Ci/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2348025:Ci/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "12 mmol/l [U-14C"

Phrase: "] mannitol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024730:Mannitol [Carbohydrate,Pharmacologic Substance]

Phrase: "(0.2 Ci/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2348025:Ci/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "0.1% BSA at 30C"

Phrase: "for 10 min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.99: When present during the previous incubations, insulin and ALLM also were added to the media for the wash step and transport assay. 

Phrase: "When"

Phrase: "present during the previous incubations,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "ALLM also"

Phrase: "were"

Phrase: "added to the media"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C1254021:Media [Tissue]
   770   C1524062:Added [Functional Concept]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737 E C1883712:Add [Functional Concept]
   737 E C3244283:medium [Intellectual Product]

Phrase: "for the wash step"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1261552:Step [Conceptual Entity]
   861   C1704379:Step [Functional Concept]
   861   C1705117:Step [Quantitative Concept]
   861   C2825408:Step [Manufactured Object]

Phrase: "and"

Phrase: "transport assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.100: Extracellular space and intracellular 3-MG concentrations (mol  ml intracellular water1) were determined as described previously (16). 

Phrase: "Extracellular space"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015352:Extracellular Space [Body Space or Junction]
   861   C1883067:Space [Spatial Concept]

Phrase: "and"

Phrase: "intracellular 3-MG concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0086045:Concentrations [Mental Process]
   779 E C1446561:Concentration [Quantitative Concept]
   729 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(mol  ml intracellular water1"

Phrase: ")"

Phrase: "were"

Phrase: "determined"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.101: Statistical analyses. 

Phrase: "Statistical analyses."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C0871424:statistical analysis [Research Activity]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
Processing 00000000.tx.102: Data are expressed as mean  SE. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as mean  SE."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0444504:Mean [Quantitative Concept]
   770   C2347634:Mean [Quantitative Concept]
   770   C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.103: The statistical significance of differences was assessed at the 5% level. 

Phrase: "The statistical significance of differences"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0237881:Statistical Significance [Quantitative Concept]
           Significance
   806   C1709380:Statistical Significance [Quantitative Concept]
   760   C0038215:Statistical [Occupation or Discipline]
   760   C0750502:Significance [Idea or Concept]

Phrase: "was"

Phrase: "assessed at the 5% level."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0456951:Level 5 [Qualitative Concept]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1516048:Assessed [Activity]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.104: Differences between two groups were tested using the nonpaired Students t test when the data were normally distributed or the Wilcoxons rank-sum test when the data were not normally distributed. 

Phrase: "Differences between two groups"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "were"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the nonpaired Students t test"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0022885:Test [Laboratory Procedure]
   812   C0038492:Students [Professional or Occupational Group]
   812   C0039593:Test [Functional Concept]
   812   C0392366:test [Intellectual Product]
   779 E C1551041:student [Idea or Concept]
   779 E C1552573:student [Intellectual Product]

Phrase: "when"

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "normally"

Phrase: "distributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704711:Distributed [Functional Concept]

Phrase: "or"

Phrase: "the Wilcoxons rank-sum test"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0242928:Test, Rank-Sum [Quantitative Concept]
   912   C0242931:Wilcoxon Rank Test [Quantitative Concept]
   886   C0871608:Wilcoxon Test [Intellectual Product]
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0392366:test [Intellectual Product]
   812   C0699794:Rank [Intellectual Product]
   812   C1515051:Sum [Quantitative Concept]

Phrase: "when"

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "not normally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "distributed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704711:Distributed [Functional Concept]
Processing 00000000.tx.105: A paired t test was used when differences between responses in two aliquots of islets from the same mouse incubated under different conditions were being tested. 

Phrase: "A"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "paired"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709450:Paired [Qualitative Concept]

Phrase: "t test"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0871472:t-Test [Intellectual Product]
   861   C0022885:Test [Laboratory Procedure]
   861   C0039593:Test [Functional Concept]
   861   C0392366:test [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "when"

Phrase: "differences between responses"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "in two aliquots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1510844:Aliquot [Quantitative Concept]

Phrase: "of islets"

Phrase: "from the same mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]

Phrase: "incubated under different conditions"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1705242:Different [Qualitative Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "were"

Phrase: "being"

Phrase: "tested."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]
Processing 00000000.tx.106: Analysis of variance (ANOVA) was used to test differences among more than two groups.  

Phrase: "Analysis of variance (ANOVA)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "differences among more"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "than two groups."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
Processing 00000000.tx.107: RESULTS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  A 4-h exposure to calpain inhibitors stimulates insulin secretion. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "A 4-h exposure to calpain inhibitors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0332157:Exposure to [Clinical Attribute]
           Exposure
   748   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "stimulates"

Phrase: "insulin secretion."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.108: Exposure to calpain inhibitor II (ALLM, 250 mol/l) and E-64-d (200 mol/l) enhanced the insulin secretory responses to 20 mmol/l glucose in islets 1.97  0.3-fold (n = 5, P < 0.01, paired t test) and 1.77  0.1-fold (n = 6, P < 0.001), compared with islets exposed to 20 mmol/l glucose without the inhibitors. 

Phrase: "Exposure to calpain inhibitor II"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332157:Exposure to [Clinical Attribute]
           Exposure
   760   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "(ALLM,"

Phrase: "250 mol/l)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0347982:mol/L [Quantitative Concept]

Phrase: "and"

Phrase: "E-64-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0058882:E 64 [Organic Chemical,Pharmacologic Substance]

Phrase: "d ("

Phrase: "200 mol/l)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0347982:mol/L [Quantitative Concept]

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "the insulin secretory responses to 20 mmol/l glucose"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   742   C0871261:responses [Organism Attribute]
   708 E C1704632:Response [Finding]
   708 E C1706817:Response [Intellectual Product]
   708 E C2911692:Response [Mental Process]

Phrase: "in islets 1.97  0.3-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0332462:Fold [Spatial Concept]
   799   C1880834:FOLD [Phenomenon or Process]

Phrase: "(n = 5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P < 0.01,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "paired t test"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1709451:Paired t-Test [Intellectual Product]
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "1.77  0.1-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332462:Fold [Spatial Concept]
   804   C1880834:FOLD [Phenomenon or Process]

Phrase: "(n = 6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "compared with islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "exposed to 20 mmol/l glucose"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0332157:Exposed to [Clinical Attribute]
           Exposed
   790   C1532563:mmol/L [Quantitative Concept]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0439190:MMOLE [Quantitative Concept]

Phrase: "without the inhibitors."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0243077:inhibitors [Chemical Viewed Functionally]
   966 E C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.109: No effect was observed on basal insulin secretion (at 2 mmol/l glucose). 

Phrase: "No effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "observed on basal insulin secretion"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0650607:Basal insulin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   806   C1256369:insulin secretion [Cell Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
   760   C0205112:Basal [Spatial Concept]
   760   C1441672:Observed [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(at 2 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.110: Significant effects of ALLM and E-64-d on the insulin secretory response to 20 mmol/l glucose were seen at inhibitor concentrations >100 mol/l (Figs. 1A and B, Table 1). 

Phrase: "Significant effects of ALLM"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "E-64-d on the insulin secretory response"

Phrase: "to 20 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "were"

Phrase: "seen at inhibitor concentrations"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0086045:Concentrations [Mental Process]
   770   C0205397:Seen [Qualitative Concept]
   770   C1999216:Inhibitor [Qualitative Concept]
   737 E C0042789:see [Organism Function]
   737 E C1446561:Concentration [Quantitative Concept]
   737 E C1947903:See [Activity]

Phrase: ">100 mol/l (Figs. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0450344:1A [Intellectual Product]
   804   C1553633:1a [Medical Device]

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.111: Pretreatment of islets with calpain inhibitor I (ALLN, 100 mol/l) resulted in a 2.7-fold increase and with the nonpeptide -mercaptoacrylic acid derivative PD 147631 (a relatively specific nonpeptidic inhibitor of calpain with an IC50 value for calpain that is >100 times less than that for cathepsin B and other cysteine proteases; K. Wang, personal communication) resulted in a 1.8-fold increase in the response to 20 mmol/l glucose compared with control experiments performed in the absence of inhibitors (Table 1). 

Phrase: "Pretreatment of islets"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1550147:Pretreatment [Substance]
   790   C2709094:pre treatment [Temporal Concept]
   790   C3539075:Pretreatment [Temporal Concept]
   790   C3539076:Pretreatment [Activity]

Phrase: "with calpain inhibitor I (ALLN,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0901518:calpain inhibitor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0006785:Calpain I [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "100 mol/l)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0347982:mol/L [Quantitative Concept]

Phrase: "resulted in a 2.7-fold increase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0332462:Fold [Spatial Concept]
   748   C0442805:Increase [Functional Concept]
   748   C1880834:FOLD [Phenomenon or Process]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "and with the nonpeptide -mercaptoacrylic acid derivative PD 147631"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0001128:Acid [Chemical]
   742   C0202406:Acid [Laboratory Procedure]
   742   C1515981:And [Idea or Concept]
   742   C1527240:Derivative [Functional Concept]

Phrase: "("

Phrase: "a relatively specific nonpeptidic inhibitor of calpain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0054533:calpain inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1999216:Inhibitor [Qualitative Concept]

Phrase: "with an IC50 value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1522609:Value [Quantitative Concept]

Phrase: "for calpain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that is >100 times less than that"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0040223:times [Temporal Concept]
   748   C1632851:Times [Quantitative Concept]
   714 E C3541383:Time [Temporal Concept]

Phrase: "for cathepsin B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0699919:Cathepsin B [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332804:CATHEPSIN B [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "other cysteine proteases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C2717970:Cysteine Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   983 E C0758959:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   983 E C0769345:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Proteases [Enzyme]

Phrase: "; K. Wang,"

Phrase: "personal communication"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086792:Personal Communication [Social Behavior]
   861   C0009452:Communication [Social Behavior]

Phrase: ")"

Phrase: "resulted in a 1.8-fold increase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0332462:Fold [Spatial Concept]
   748   C0442805:Increase [Functional Concept]
   748   C1880834:FOLD [Phenomenon or Process]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "in the response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to 20 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "compared with control experiments"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0009932:control experiments [Group]
   770   C0243148:control [Qualitative Concept]
   770   C0681814:Experiments [Research Activity]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "performed in the absence of inhibitors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0243077:inhibitors [Chemical Viewed Functionally]
   753   C0332197:absence [Quantitative Concept]
   753   C0884358:Performed [Functional Concept]
   753   C1689985:Absence [Anatomical Abnormality]
   719 E C1999216:Inhibitor [Qualitative Concept]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.112: Enhancement of the insulin secretory response to glucose by ALLM was observed only at glucose concentrations >8 mmol/l (Fig. 1C) and also was observed in a dynamic islet perifusion system (Fig. 1D). 

Phrase: "Enhancement of the insulin secretory response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   753   C2349975:Enhancement [Activity]

Phrase: "to glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "by ALLM"

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "only at glucose concentrations"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   819   C0427743:concentrations glucose [Laboratory Procedure]
   819   C1287281:concentrations glucose [Laboratory or Test Result]
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0086045:Concentrations [Mental Process]
   770   C0205171:Only [Quantitative Concept]
   770   C1720467:Only [Intellectual Product]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: ">8 mmol/l (Fig. 1C"

Phrase: ")"

Phrase: "and"

Phrase: "also"

Phrase: "was"

Phrase: "observed in a dynamic islet perifusion system"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0449913:System [Functional Concept]
   748   C0729333:Dynamic [Functional Concept]
   748   C1441672:Observed [Functional Concept]
   748   C1553451:System [Manufactured Object]
   748   C1704459:System [Medical Device]

Phrase: "(Fig. 1D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416886:1D [Gene or Genome]
   861   C1442449:1D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.113: Islet insulin content was unchanged after a 4-h exposure to 100 mol/l ALLM in the presence of either 2 or 20 mmol/l (2 mmol/l glucose: 30.9  1.6 vs. 

Phrase: "Islet insulin content"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "unchanged after a 4-h exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0442739:Unchanged [Finding]
   753   C2346711:Unchanged [Qualitative Concept]

Phrase: "to 100 mol/l ALLM"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of either 2"

Phrase: "or"

Phrase: "20 mmol/l (2 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ":"

Phrase: "30.9  1.6"

Phrase: "vs."
Processing 00000000.tx.114: 31.7  3.0 ng/islet in ALLM and control, respectively; 

Phrase: "31.7  3.0 ng/islet in ALLM"

Phrase: "and"

Phrase: "control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "respectively"

Phrase: ";"
Processing 00000000.tx.115: 20 mmol/l glucose: 28.3  4.7 vs. 

Phrase: "20 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ":"

Phrase: "28.3  4.7"

Phrase: "vs."
Processing 00000000.tx.116: 32.4  2.0 ng/islet in ALLM- and control-treated islets, respectively). 

Phrase: "32.4  2.0 ng/islet in ALLM-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   767   C1425576:ISLET 2 [Gene or Genome]

Phrase: "and"

Phrase: "control-treated islets,"

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.117: View larger version (31K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(31K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.118: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.119: Effect of protease inhibitors on the insulin secretory response to glucose in mouse pancreatic islets. 

Phrase: "Effect of protease inhibitors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on the insulin secretory response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "to glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "in mouse pancreatic islets."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1522528:Mouse Islets [Tissue]
   901   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
Processing 00000000.tx.120: A and B: Effect of increasing concentrations (mol/l) of E-64-d (A) and ALLM (B) on the insulin secretory response to 2 mmol/l glucose () and 20 mmol/l glucose (). 

Phrase: "A"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "Effect of increasing concentrations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "(mol/l) of E-64-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   806   C0347982:mol/L [Quantitative Concept]

Phrase: "d ("

Phrase: "A"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: ")"

Phrase: "and"

Phrase: "ALLM"

Phrase: "(B) on the insulin secretory response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0291665:B-insulin [Amino Acid, Peptide, or Protein]
   753   C2347469:/B [Quantitative Concept]

Phrase: "to 2 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "("

Phrase: ")"

Phrase: "and"

Phrase: "20 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "("

Phrase: ")."
Processing 00000000.tx.121: Results are mean  SE of five to six experiments in each group. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "mean  SE of five"

Phrase: "to six experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "in each group."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]
Processing 00000000.tx.122: *P < 0.05 compared with islets incubated in the absence of calpain inhibitors. 

Phrase: "*P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared with islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "incubated in the absence of calpain inhibitors."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C0054533:calpain inhibitors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0243077:inhibitors [Chemical Viewed Functionally]
   748   C0332197:absence [Quantitative Concept]
   748   C1439852:Incubated [Laboratory Procedure]
   748   C1689985:Absence [Anatomical Abnormality]
   714 E C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.123: C: Insulin secretion by islets incubated at various glucose concentrations in the absence () and presence () of 100 mol/l ALLM. 

Phrase: "C"

Phrase: ":"

Phrase: "Insulin secretion by islets"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C1256369:insulin secretion [Cell Function]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "incubated at various glucose concentrations"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   797   C0427743:concentrations glucose [Laboratory Procedure]
   797   C1287281:concentrations glucose [Laboratory or Test Result]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0086045:Concentrations [Mental Process]
   760   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   760   C1439852:Incubated [Laboratory Procedure]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "("

Phrase: ")"

Phrase: "and"

Phrase: "presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "("

Phrase: ")"

Phrase: "of 100 mol/l ALLM."
Processing 00000000.tx.124: Results are mean  SE of four to seven experiments per group. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "mean  SE of four"

Phrase: "to seven experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "per group."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]
Processing 00000000.tx.125: *P < 0.05 compared with islets incubated in the absence of ALLM (using paired t test comparing data from islets incubated in the presence of ALLM with those incubated in the absence of the inhibitor at each glucose concentration). 

Phrase: "*P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared with islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "incubated in the absence of ALLM"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0332197:absence [Quantitative Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "("

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "paired t test comparing data from islets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C2825412:Paired Data [Idea or Concept]
   748   C1511726:Data [Idea or Concept]
   748   C3245479:data [Medical Device]

Phrase: "incubated in the presence of ALLM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "with those"

Phrase: "incubated in the absence of the inhibitor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0332197:absence [Quantitative Concept]
   748   C1439852:Incubated [Laboratory Procedure]
   748   C1689985:Absence [Anatomical Abnormality]
   748   C1999216:Inhibitor [Qualitative Concept]

Phrase: "at each glucose concentration"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0427743:Glucose concentration [Laboratory Procedure]
  1000   C1287281:Glucose concentration [Laboratory or Test Result]
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: ")."
Processing 00000000.tx.126: D: Insulin secretion by perifused islets in response to stimulation with 20 mmol/l glucose. 

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ":"

Phrase: "Insulin secretion by perifused islets"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C1256369:insulin secretion [Cell Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "with 20 mmol/l glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.127: The perifusate contained 2 mmol/l glucose except where shown. 

Phrase: "The perifusate"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "2 mmol/l glucose except where"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.128: Islets were preincubated for 4 h. 

Phrase: "Islets"

Phrase: "were"

Phrase: "preincubated for 4 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.129: In experiments involving inhibitors, ALLM (100 mol/l) was present throughout the experiment, but E-64-d (200 mol/l), which is an irreversible calpain inhibitor, was present only during the preincubation. 

Phrase: "In experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "inhibitors,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0243077:inhibitors [Chemical Viewed Functionally]
   966 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "ALLM"

Phrase: "(100 mol/l)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0347982:mol/L [Quantitative Concept]

Phrase: "was"

Phrase: "present throughout the experiment,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "but"

Phrase: "E-64-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0058882:E 64 [Organic Chemical,Pharmacologic Substance]

Phrase: "d ("

Phrase: "200 mol/l),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0347982:mol/L [Quantitative Concept]

Phrase: "which"

Phrase: "is"

Phrase: "an irreversible calpain inhibitor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0054533:calpain inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: "was"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "only during the preincubation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205171:Only [Quantitative Concept]
   770   C1720467:Only [Intellectual Product]
Processing 00000000.tx.130: Results are mean  SE of four to five experiments in each group. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "mean  SE of four to five experiments"

Phrase: "in each group."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]
Processing 00000000.tx.131: The AUC of insulin secretion was compared between groups using ANOVA and post hoc Duncan test. 

Phrase: "The AUC of insulin secretion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   815   C0376690:Area under the curve [Quantitative Concept]
           Area Under Curve
   744   C0017446:Area [Geographic Area]
   744   C0205146:Area [Spatial Concept]

Phrase: "was"

Phrase: "compared between groups"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0441833:Group [Idea or Concept]
   790   C0687744:group [Population Group]
   790   C1257890:Group [Population Group]
   790   C1552516:Group [Health Care Related Organization]
   790   C1552839:groups [Idea or Concept]
   790   C1705428:Group [Conceptual Entity]
   790   C1705429:Group [Population Group]
   790   C1707455:Compared [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ANOVA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "post hoc Duncan test."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0392366:test [Intellectual Product]
Processing 00000000.tx.132: Responses were 2.4-fold greater in ALLM-treated islets compared with control (P < 0.05) and, although the AUC was 2-fold higher in E-64-dtreated islets, this difference was not statistically significant.  

Phrase: "Responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0871261:responses [Organism Attribute]
   966 E C1704632:Response [Finding]
   966 E C1706817:Response [Intellectual Product]
   966 E C2911692:Response [Mental Process]

Phrase: "were"

Phrase: "2.4-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "greater in ALLM-treated islets"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0443228:greater [Quantitative Concept]
   760   C1704243:Greater [Quantitative Concept]
   726 E C0549177:Great [Quantitative Concept]

Phrase: "compared with control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1707455:Compared [Activity]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: ","

Phrase: "although"

Phrase: "the AUC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   882   C0376690:Area under the curve [Quantitative Concept]
           Area Under Curve
   760   C0017446:Area [Geographic Area]
   760   C0205146:Area [Spatial Concept]

Phrase: "was"

Phrase: "2-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "higher in E-64-dtreated islets,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "this difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "was"

Phrase: "not statistically significant."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   913   C1273937:Not significant [Finding]
   901   C0237881:statistically significant [Quantitative Concept]
           significant
   829 E C1709380:Statistical Significance [Quantitative Concept]
   827   C0038215:Statistically [Occupation or Discipline]
   827   C0750502:Significant [Idea or Concept]
   827   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.133: View this table: [in this window] [in a new window]  TABLE 1 Effect of protease inhibitors on insulin secretory response of isolated mouse islets to 20 mmol/l glucose  ALLM produced a 1.55  0.2fold (n = 6, P < 0.05, paired t test) increase in the insulin secretory response to 50 nmol/l GLP-1, an agent that promotes insulin secretion through its effects on adenyl cyclase and resulting increase in cAMP (17). 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 1 Effect of protease inhibitors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on insulin secretory response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "of isolated mouse islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1522528:Mouse Islets [Tissue]

Phrase: "to 20 mmol/l glucose  ALLM"

Phrase: "produced"

Phrase: "a 1.55  0.2fold"

Phrase: "(n = 6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P < 0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "paired t test"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1709451:Paired t-Test [Intellectual Product]
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]

Phrase: ")"

Phrase: "increase in the insulin secretory response"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   783   C0020459:INSULIN INCREASE [Disease or Syndrome]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0442805:Increase [Functional Concept]
   753   C0871261:Response [Organism Attribute]
   753   C1327616:Secretory [Cell Function]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "to 50 nmol/l GLP-1,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   840   C0061355:GLP-1 [Amino Acid, Peptide, or Protein]
   840   C1999257:GLP-1 [Gene or Genome]
   840   C3539623:GLP-1 [Gene or Genome]
   840   C3539624:GLP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018301:GLP [Geographic Area]
   804   C1422069:GLP [Gene or Genome]
   804   C1425391:GLP [Gene or Genome]
   804   C2697611:GLP [Amino Acid, Peptide, or Protein]

Phrase: "an agent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0450442:Agent [Chemical Viewed Functionally]
  1000   C1254351:Agent [Pharmacologic Substance]
  1000   C1521826:Agent [Intellectual Product]

Phrase: "that"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "insulin secretion through its effects"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C1256369:insulin secretion [Cell Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "on adenyl cyclase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001492:Adenyl Cyclase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "resulting increase in cAMP (17"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: ")."
Processing 00000000.tx.134: ALLM did not, however, significantly increase the insulin secretory responses to 30 mmol/l KCl, an agent that directly depolarizes the -cell or 100 mol/l carbachol that mobilizes Ca2+ from intracellular stores (18) (data not shown). 

Phrase: "ALLM"

Phrase: "did"

Phrase: "not,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "however,"

Phrase: "significantly"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the insulin secretory responses to 30 mmol/l KCl,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   742   C0871261:responses [Organism Attribute]
   708 E C1704632:Response [Finding]
   708 E C1706817:Response [Intellectual Product]
   708 E C2911692:Response [Mental Process]

Phrase: "an agent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0450442:Agent [Chemical Viewed Functionally]
  1000   C1254351:Agent [Pharmacologic Substance]
  1000   C1521826:Agent [Intellectual Product]

Phrase: "that directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "depolarizes"

Phrase: "the -cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "100 mol/l carbachol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006945:Carbachol [Organic Chemical,Pharmacologic Substance]

Phrase: "that"

Phrase: "mobilizes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0185112:mobilize [Therapeutic or Preventive Procedure]
  1000   C0578718:Mobilizes [Finding]

Phrase: "Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "from intracellular stores"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1698986:Store [Functional Concept]

Phrase: "(18"

Phrase: ")"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.135: We also examined the effects of other protease inhibitors on insulin secretion. 

Phrase: "We also"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the effects of other protease inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "on insulin secretion."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.136: Insulin secretory responses to 20 mmol/l glucose were not altered in the presence of pepstatin A (100 mol/l), an aspartyl protease inhibitor, or cathepsin B inhibitor II (100 mol/l), a lysosomal cysteine protease inhibitor, indicating that the stimulatory effects of ALLM and E-64-d on insulin secretion are specific to these protease inhibitors (Table 1). 

Phrase: "Insulin secretory responses to 20 mmol/l glucose"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0871261:responses [Organism Attribute]
   711 E C1704632:Response [Finding]
   711 E C1706817:Response [Intellectual Product]
   711 E C2911692:Response [Mental Process]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "altered in the presence of pepstatin A"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0332197:absence [Quantitative Concept]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C0392747:Altered [Functional Concept]
   748   C1689985:Absence [Anatomical Abnormality]
   702   C1709643:Present Absent [Conceptual Entity]

Phrase: "(100 mol/l),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0347982:mol/L [Quantitative Concept]

Phrase: "an aspartyl protease inhibitor,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0033607:Protease Inhibitor [Biologically Active Substance,Pharmacologic Substance]
   901   C0078989:aspartyl protease [Amino Acid, Peptide, or Protein,Enzyme]
   901   C2717969:Aspartyl Protease [Amino Acid, Peptide, or Protein,Enzyme]
   901   C3536890:Protease Inhibitor [Pharmacologic Substance]
   827   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C1947941:Protease [Enzyme]
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: "or"

Phrase: "cathepsin B inhibitor II"

Phrase: "(100 mol/l),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0347982:mol/L [Quantitative Concept]

Phrase: "a lysosomal cysteine protease inhibitor,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0033607:Protease Inhibitor [Biologically Active Substance,Pharmacologic Substance]
   861   C0758959:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0769345:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2717970:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3536890:Protease Inhibitor [Pharmacologic Substance]
   812   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C1947941:Protease [Enzyme]
   812   C1999216:Inhibitor [Qualitative Concept]

Phrase: "indicating"

Phrase: "that"

Phrase: "the stimulatory effects of ALLM"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "E-64-d on insulin secretion"

Phrase: "are"

Phrase: "specific to these protease inhibitors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205369:Specific [Qualitative Concept]
   760   C1552740:specific [Intellectual Product]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.137: A 4-h exposure to calpain inhibitors does not affect glucose utilization or NADPH levels. 

Phrase: "A 4-h exposure to calpain inhibitors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0332157:Exposure to [Clinical Attribute]
           Exposure
   748   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "glucose utilization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0042153:utilization [Functional Concept]

Phrase: "or"

Phrase: "NADPH levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.138: Exposure of islets to calpain inhibitors for 4 h did not have any significant effects on glucose utilization and oxidation rates and islet NADPH measurements. 

Phrase: "Exposure of islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0274281:Exposure, NOS [Injury or Poisoning]
   790   C0332157:Exposure [Clinical Attribute]

Phrase: "to calpain inhibitors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0054533:calpain inhibitors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "for 4 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "any significant effects on glucose utilization"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C1158774:glucose effect [Genetic Function]
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "oxidation rates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0030011:Oxidation [Molecular Function]
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "islet NADPH measurements."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0242485:measurements [Functional Concept]
Processing 00000000.tx.139: Rates of glucose utilization at basal (2 mmol/l glucose) and stimulatory glucose concentrations (20 mmol/l) in the presence of 100 mol/l ALLM (14.5  3.6 and 89.5  3.0 pmol  islet1  h1, respectively) or 200 mol/l E-64-d (15.5  4 and 79.5  9.5 pmol  islet1  h1, respectively) were not significantly different from those in islets incubated in their absence (14.5  2.1 and 76.5  6.5 pmol  islet1  h1; n = 3 in each case). 

Phrase: "Rates of glucose utilization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0871208:Rate [Activity]
   737   C1521828:Rate [Quantitative Concept]

Phrase: "at basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "(2 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "stimulatory glucose concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   884   C0427743:Glucose concentration [Laboratory Procedure]
   884   C1287281:Glucose concentration [Laboratory or Test Result]
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(20 mmol/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439190:MMOLE [Quantitative Concept]

Phrase: "l) in the presence of 100 mol/l ALLM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   762   C3539687:L/L [Quantitative Concept]

Phrase: "(14.5  3.6"

Phrase: "and"

Phrase: "89.5  3.0 pmol  islet1  h1,"

Phrase: "respectively"

Phrase: ")"

Phrase: "or"

Phrase: "200 mol/l E-64-"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   840   C0347982:mol/L [Quantitative Concept]
   804   C0027960:Mole [Neoplastic Process]
   804   C0324740:Mole [Mammal]
   804   C0439189:Mole [Quantitative Concept]
   804   C1456781:mole [Neoplastic Process]
   804   C1824986:mol [Gene or Genome]
   721 E C0026367:Molar [Body Part, Organ, or Organ Component]
   704 E C0027962:moles [Neoplastic Process]

Phrase: "d ("

Phrase: "15.5  4"

Phrase: "and"

Phrase: "79.5  9.5 pmol  islet1  h1,"

Phrase: "respectively"

Phrase: ")"

Phrase: "were"

Phrase: "not significantly different from those in islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1705242:Different [Qualitative Concept]

Phrase: "incubated in their absence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332197:absence [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "(14.5  2.1"

Phrase: "and"

Phrase: "76.5  6.5 pmol  islet1  h1"

Phrase: "; n = 3 in each case"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441922:N+ [Intellectual Product]
   760   C0868928:Case [Functional Concept]
   760   C1553036:[n] [Quantitative Concept]
   760   C1706255:CASE [Medical Device]
   760   C1706256:Case [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.140: Similarly, there was no significant difference in the glucose oxidation rates at basal or stimulatory glucose concentrations in the presence of ALLM (6.0  0.7 and 39.5  4.1 pmol  islet1  h1) and E-64-d (5.2  0.4 and 40.0  2.4 pmol  islet1  h1) compared with those measured in the absence of inhibitor (4.4  0.8 and 32.5  6.5 pmol  islet1  h1; n = 3 in each case). 

Phrase: "Similarly,"

Phrase: "there"

Phrase: "was"

Phrase: "no significant difference in the glucose oxidation rates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1705241:*Difference [Quantitative Concept]
   744   C1705242:Difference [Qualitative Concept]

Phrase: "at basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "or"

Phrase: "stimulatory glucose concentrations in the presence of ALLM"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   767   C0427743:concentrations glucose [Laboratory Procedure]
   767   C1287281:concentrations glucose [Laboratory or Test Result]
   744   C0086045:Concentrations [Mental Process]
   711 E C1446561:Concentration [Quantitative Concept]

Phrase: "(6.0  0.7"

Phrase: "and"

Phrase: "39.5  4.1 pmol  islet1  h1"

Phrase: ")"

Phrase: "and"

Phrase: "E-64-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0058882:E 64 [Organic Chemical,Pharmacologic Substance]

Phrase: "d ("

Phrase: "5.2  0.4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439084:>5 [Quantitative Concept]
   812   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "40.0  2.4 pmol  islet1  h1"

Phrase: ")"

Phrase: "compared with those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "measured in the absence of inhibitor"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0332197:absence [Quantitative Concept]
   753   C0444706:Measured [Qualitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]
   753   C1999216:Inhibitor [Qualitative Concept]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]

Phrase: "(4.4  0.8"

Phrase: "and"

Phrase: "32.5  6.5 pmol  islet1  h1"

Phrase: "; n = 3 in each case"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441922:N+ [Intellectual Product]
   760   C0868928:Case [Functional Concept]
   760   C1553036:[n] [Quantitative Concept]
   760   C1706255:CASE [Medical Device]
   760   C1706256:Case [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.141: Consistent with a lack of effect of ALLM and E-64-d on -cell glucose metabolism, the NADPH response to an increase in the glucose concentration from 2 to 14 mmol/l in the presence of 100 mol/l ALLM (2.7  0.4-fold increase; n = 4) and E-64-d (2.8  0.3-fold increase; n = 2) was not significantly different from controls (2.6  0.2-fold increase; n = 4). 

Phrase: "Consistent with a lack of effect of ALLM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "and"

Phrase: "E-64-d on -cell glucose metabolism,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   818   C0596620:glucose metabolism [Molecular Function]
   795   C0025519:Metabolism [Organism Function]
   795   C0025520:metabolism [Functional Concept]

Phrase: "the NADPH response to an increase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "in the glucose concentration"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0427743:Glucose concentration [Laboratory Procedure]
  1000   C1287281:Glucose concentration [Laboratory or Test Result]
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "from 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "to 14 mmol/l"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1532563:mmol/L [Quantitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 100 mol/l ALLM"

Phrase: "(2.7  0.4-fold increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0442805:Increase [Functional Concept]

Phrase: "; n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "E-64-d (2.8  0.3-fold increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0442805:Increase [Functional Concept]

Phrase: "; n = 2)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "was"

Phrase: "not significantly different from controls"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]

Phrase: "(2.6  0.2-fold increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0442805:Increase [Functional Concept]

Phrase: "; n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.142: A 4-h exposure to calpain inhibitors does not increase [Ca2+]i or calcium current density. 

Phrase: "A 4-h exposure to calpain inhibitors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0332157:Exposure to [Clinical Attribute]
           Exposure
   748   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "or"

Phrase: "calcium current density."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0178587:density [Quantitative Concept]
   755 E C0439794:Dense [Qualitative Concept]
Processing 00000000.tx.143: The stimulatory effects of ALLM and E-64-d on insulin secretion in response to high glucose were not associated with increases in [Ca2+]i (Figs. 2A and B). 

Phrase: "The stimulatory effects of ALLM"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "E-64-d on insulin secretion"

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to high glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0860803:high glucose [Finding]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "associated with increases in [Ca2+"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0442805:increases [Functional Concept]
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "]i (Figs. 2A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.144: Calcium currents were similar in control and ALLM-treated cells (Fig. 2C); 

Phrase: "Calcium currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0521116:currents [Temporal Concept]
   827 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "were"

Phrase: "similar in control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "ALLM-treated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 2C"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.145: no differences in amplitude or kinetics were apparent. 

Phrase: "no differences in amplitude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "or"

Phrase: "kinetics"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022702:Kinetics [Natural Phenomenon or Process]
  1000   C0220865:kinetics [Functional Concept]
  1000   C2825046:Kinetics [Occupation or Discipline]

Phrase: "were"

Phrase: "apparent."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750489:apparent [Idea or Concept]
Processing 00000000.tx.146: In addition, no shifts in voltage dependence were observed (data not shown), and the average peak calcium current density obtained in control and ALLM-pretreated cells was comparable (Fig. 2D). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "no shifts in voltage dependence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0333051:shifts [Functional Concept]
   726 E C2347509:Shift [Phenomenon or Process]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the average peak calcium current density"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0178587:density [Quantitative Concept]
   733 E C0439794:Dense [Qualitative Concept]

Phrase: "obtained in control"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1301820:Obtained [Functional Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "and"

Phrase: "ALLM-pretreated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "comparable"

Phrase: "(Fig. 2D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1705052:2D [Spatial Concept]
   861   C2986796:2D [Functional Concept]

Phrase: ")."
Processing 00000000.tx.147: View larger version (26K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(26K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.148: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.149: Effect of calpain inhibitors on [Ca2+]i, whole-cell calcium currents, and whole-cell capacitance responses. 

Phrase: "Effect of calpain inhibitors on [Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "]i,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "whole-cell calcium currents,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0521116:currents [Temporal Concept]
   779 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "whole-cell capacitance responses."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0871261:responses [Organism Attribute]
   779 E C1704632:Response [Finding]
   779 E C1706817:Response [Intellectual Product]
   779 E C2911692:Response [Mental Process]
Processing 00000000.tx.150: A and B: [Ca2+]i responses to 14 mmol/l glucose (), washout (2 mmol/l glucose), and stimulation with 30 mmol/l KCl in the continued presence of 2 mmol/l glucose (). 

Phrase: "A"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i responses to 14 mmol/l glucose"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0871261:responses [Organism Attribute]
   714 E C1704632:Response [Finding]
   714 E C1706817:Response [Intellectual Product]
   714 E C2911692:Response [Mental Process]

Phrase: "("

Phrase: ")"

Phrase: ","

Phrase: "washout"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1710661:Washout [Temporal Concept]
  1000   C2986829:Washout [Functional Concept]

Phrase: "(2 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "stimulation with 30 mmol/l KCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   753   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "in the continued presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0392148:Presence [Therapeutic or Preventive Procedure]
   789 E C0150312:Present [Quantitative Concept]
   789 E C0449450:Present [Idea or Concept]

Phrase: "of 2 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "("

Phrase: ")."
Processing 00000000.tx.151: The 340/380 ratio is an indirect measure of [Ca2+]i. 

Phrase: "The 340/380 ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0456603:Ratio [Quantitative Concept]
   827   C1547037:Ratio [Intellectual Product]

Phrase: "is"

Phrase: "an indirect measure of [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.152: Islets were preincubated for 4 h in the absence (A) or presence (B) of 100 mol/l ALLM. 

Phrase: "Islets"

Phrase: "were"

Phrase: "preincubated for 4 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "in the absence (A)"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "(B) of 100 mol/l ALLM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.153: The areas under the [Ca2+]i curve during exposure to glucose and KCl were compared between groups and were not significantly different between islets cultured in the presence or absence of ALLM (n = 4 per group). 

Phrase: "The areas under the [Ca2+"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0205146:areas [Spatial Concept]
   726 E C0017446:Area [Geographic Area]

Phrase: "]i curve during exposure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205134:Curve [Spatial Concept]

Phrase: "to glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "KCl"

Phrase: "were"

Phrase: "compared between groups"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0441833:Group [Idea or Concept]
   790   C0687744:group [Population Group]
   790   C1257890:Group [Population Group]
   790   C1552516:Group [Health Care Related Organization]
   790   C1552839:groups [Idea or Concept]
   790   C1705428:Group [Conceptual Entity]
   790   C1705429:Group [Population Group]
   790   C1707455:Compared [Activity]

Phrase: "and"

Phrase: "were"

Phrase: "not significantly different between islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]

Phrase: "cultured in the presence"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "or"

Phrase: "absence of ALLM"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "(n = 4 per group"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   819   C0441848:Group N [Intellectual Product]
   819   C0441876:Group 4 [Intellectual Product]
   770   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441833:Group [Idea or Concept]
   770   C0441922:N+ [Intellectual Product]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1553036:[n] [Quantitative Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]

Phrase: ")."
Processing 00000000.tx.154: Similar results were obtained with E-64-d (data not shown). 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained with E-64-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "d ("

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.155: C: ALLM pretreatment did not alter whole-cell Ca2+ currents recorded in -cells. 

Phrase: "C"

Phrase: ":"

Phrase: "ALLM pretreatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1550147:Pretreatment [Substance]
   861   C2709094:pre treatment [Temporal Concept]
   861   C3539075:Pretreatment [Temporal Concept]
   861   C3539076:Pretreatment [Activity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "whole-cell Ca2+ currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0521116:currents [Temporal Concept]
   779 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "recorded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0034869:Record [Intellectual Product]

Phrase: "in -cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.156: Representative Ca2+ currents recordings obtained from a control cell (0.1% DMSO, top) and from a cell pretreated with ALLM (100 mol/l, bottom) are shown. 

Phrase: "Representative Ca2+ currents recordings"

Phrase: "obtained from a control cell"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   760   C0007634:Cell [Cell]
   760   C0243148:control [Qualitative Concept]
   760   C1269647:Cell [Cell]
   760   C1301820:Obtained [Functional Concept]
   760   C1550141:Control [Substance]
   760   C1704653:Cell [Medical Device]
   760   C1882979:Control [Conceptual Entity]
   760   C1948049:Cell [Spatial Concept]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "(0.1% DMSO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012403:DMSO [Organic Chemical,Pharmacologic Substance]

Phrase: "top)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "and from a cell"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0007634:Cell [Cell]
   770   C1269647:Cell [Cell]
   770   C1515981:And [Idea or Concept]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]

Phrase: "pretreated with ALLM"

Phrase: "(100 mol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0347982:mol/L [Quantitative Concept]

Phrase: "bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: ")"

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.157: D: The average peak Ca2+ current density for control (, 34.2  2.2 pA/pF, n = 18) and for ALLM-pretreated (100 mol/l) cells (, 36.7  3.9 pA/pF, n = 15; P > 0.05 using nonpaired t test). 

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ":"

Phrase: "The average peak Ca2+ current density for control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0178587:density [Quantitative Concept]

Phrase: "(,"

Phrase: "34.2  2.2 pA/pF,"

Phrase: "n = 18"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and for ALLM-pretreated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515981:And [Idea or Concept]

Phrase: "(100 mol/l) cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   902   C1441340:100 cells [Cell]
   861   C0347982:mol/L [Quantitative Concept]
   827   C0022827:L cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(,"

Phrase: "36.7  3.9 pA/pF,"

Phrase: "n = 15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "; P > 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "nonpaired t test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.158: Current density was obtained by dividing peak current amplitude (pA) by whole-cell membrane capacitance (pF), thereby normalizing the data for cell size. 

Phrase: "Current density"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0178587:density [Quantitative Concept]
   789 E C0439794:Dense [Qualitative Concept]

Phrase: "was"

Phrase: "obtained by dividing peak current amplitude"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0332849:dividing [Functional Concept]
   753   C0444505:Peak [Quantitative Concept]
   753   C0521116:Current [Temporal Concept]
   753   C1301820:Obtained [Functional Concept]
   753   C1705970:Current [Natural Phenomenon or Process]
   753   C2346753:Amplitude [Spatial Concept]
   719 E C1706701:Obtain [Activity]

Phrase: "(pA) by whole-cell membrane capacitance"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C0007603:Cell Membrane [Cell Component]
   790   C3161472:Cell Membrane [Cell Component]
   753   C0007634:Cell [Cell]
   753   C0025255:Membrane [Tissue]
   753   C0242264:capacitance [Quantitative Concept]
   753   C0444667:Whole [Quantitative Concept]
   753   C0596901:Membrane [Cell Component]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1706182:Membrane [Manufactured Object]
   753   C1948049:Cell [Spatial Concept]
   753   C3541314:PA [Idea or Concept]

Phrase: "(pF"

Phrase: ")"

Phrase: ","

Phrase: "thereby"

Phrase: "normalizing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882115:Normalize [Research Activity]

Phrase: "the data for cell size."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]
Processing 00000000.tx.159: E and F: Measurements of membrane capacitance in isolated -cells. 

Phrase: "E"

Phrase: "and"

Phrase: "F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: ":"

Phrase: "Measurements of membrane capacitance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0242485:measurements [Functional Concept]

Phrase: "in isolated -cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.160: Capacitance measurements reveal a large increase in insulin secretion after pretreatment with ALLM (100 mol/l). 

Phrase: "Capacitance measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242485:measurements [Functional Concept]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "a large increase in insulin secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0020459:INSULIN INCREASE [Disease or Syndrome]
   753   C0442805:Increase [Functional Concept]

Phrase: "after pretreatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1550147:Pretreatment [Substance]
  1000   C2709094:pre treatment [Temporal Concept]
  1000   C3539075:Pretreatment [Temporal Concept]
  1000   C3539076:Pretreatment [Activity]

Phrase: "with ALLM"

Phrase: "(100 mol/l)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0347982:mol/L [Quantitative Concept]
Processing 00000000.tx.161: With the use of the perforated whole-cell recording configuration, -cells were stimulated with a train of 10-step depolarizations to +20 mV (holding potential = -80 mV). 

Phrase: "With the use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "of the perforated whole-cell recording configuration, -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0449830:Configuration [Spatial Concept]
   804   C2827597:Configuration [Conceptual Entity]
   717   C0242624:Whole-Cell Recording [Research Activity]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stimulated with a train"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0336809:Train [Manufactured Object]
   770   C1552514:Train [Manufactured Object]
   770   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "of 10-step depolarizations to +20 mV (holding potential"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C3245505:Potential [Qualitative Concept]
   760   C1553387:Hold [Idea or Concept]
   760   C1948035:Hold [Activity]

Phrase: "= -80 mV"

Phrase: ")."
Processing 00000000.tx.162: Each depolarization lasted 150 ms and was separated by a 400-ms interpulse duration. 

Phrase: "Each depolarization"

Phrase: "lasted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1517741:Last [Qualitative Concept]

Phrase: "150 ms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]

Phrase: "and"

Phrase: "was"

Phrase: "separated by a 400-ms interpulse duration."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0086972:Separated [Finding]
   748   C0443299:separated [Spatial Concept]
   748   C0449238:Duration [Temporal Concept]
   748   C0687118:Separated [Functional Concept]
   748   C2349943:Ms. [Conceptual Entity]
   748   C2926735:Duration [Pharmacologic Substance]
   748   C3539704:MS [Gene or Genome]
Processing 00000000.tx.163: E: Representative capacitance traces obtained from a control -cell (top) and from a cell pretreated with ALLM (100 mol/l, bottom) showing the change in membrane capacitance (fF) plotted against time. 

Phrase: "E"

Phrase: ":"

Phrase: "Representative capacitance traces"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0442822:Trace [Quantitative Concept]
   793   C1524031:Trace [Qualitative Concept]
   793   C1883002:Trace [Functional Concept]

Phrase: "obtained from a control -cell"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   760   C0007634:Cell [Cell]
   760   C0243148:control [Qualitative Concept]
   760   C1269647:Cell [Cell]
   760   C1301820:Obtained [Functional Concept]
   760   C1550141:Control [Substance]
   760   C1704653:Cell [Medical Device]
   760   C1882979:Control [Conceptual Entity]
   760   C1948049:Cell [Spatial Concept]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "(top)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "and from a cell"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0007634:Cell [Cell]
   770   C1269647:Cell [Cell]
   770   C1515981:And [Idea or Concept]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]

Phrase: "pretreated with ALLM"

Phrase: "(100 mol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0347982:mol/L [Quantitative Concept]

Phrase: "bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: ")"

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the change in membrane capacitance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0025320:The change [Physiologic Function]
   760   C0392747:Change [Functional Concept]
   760   C0443172:change [Quantitative Concept]
   760   C1705241:Change [Quantitative Concept]

Phrase: "(fF)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539653:FF [Idea or Concept]

Phrase: "plotted against time."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0040223:Time [Temporal Concept]
   790   C3541383:Time [Temporal Concept]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.164: F: Average peak change in membrane capacitance elicited by trains of depolarizations from control (, n = 9) and ALLM-pretreated (100 mol/l) cells (, n = 11). 

Phrase: "F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: ":"

Phrase: "Average peak change in membrane capacitance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0392747:Change [Functional Concept]
   753   C0443172:change [Quantitative Concept]
   753   C1705241:Change [Quantitative Concept]

Phrase: "elicited by trains of depolarizations"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0449265:Elicited by [Qualitative Concept]
           elicited
   726   C0336809:Train [Manufactured Object]
   726   C1552514:Train [Manufactured Object]

Phrase: "from control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "(,"

Phrase: "n = 9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "ALLM-pretreated"

Phrase: "(100 mol/l) cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   902   C1441340:100 cells [Cell]
   861   C0347982:mol/L [Quantitative Concept]
   827   C0022827:L cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(,"

Phrase: "n = 11"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.165: Data are mean  SE, *P < 0.05, using nonpaired t test.  

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "mean  SE,"

Phrase: "*P < 0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "nonpaired t test."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
Processing 00000000.tx.166: A 4-h exposure to calpain inhibitors affects -cell membrane capacitance. 

Phrase: "A 4-h exposure to calpain inhibitors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0332157:Exposure to [Clinical Attribute]
           Exposure
   748   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "affects -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "cell membrane capacitance."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   901   C0007603:Cell Membrane [Cell Component]
   901   C3161472:Cell Membrane [Cell Component]
   827   C0007634:Cell [Cell]
   827   C0025255:Membrane [Tissue]
   827   C0242264:capacitance [Quantitative Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1706182:Membrane [Manufactured Object]
   827   C1948049:Cell [Spatial Concept]
   755 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.167: Membrane capacitance measurements confirmed the large enhancement of insulin secretion observed after ALLM pretreatment (Figs. 2E and F). 

Phrase: "Membrane capacitance measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0242485:measurements [Functional Concept]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the large enhancement of insulin secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   753   C2349975:Enhancement [Activity]

Phrase: "observed after ALLM pretreatment"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1441672:Observed [Functional Concept]
   770   C1550147:Pretreatment [Substance]
   770   C2709094:pre treatment [Temporal Concept]
   770   C3539075:Pretreatment [Temporal Concept]
   770   C3539076:Pretreatment [Activity]

Phrase: "(Figs. 2E"

Phrase: "and"

Phrase: "F)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.168: Representative capacitance changes, from control (top) and ALLM-pretreated cells (bottom) are shown in Fig. 

Phrase: "Representative capacitance changes,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0392747:changes [Functional Concept]
   827   C0443172:changes [Quantitative Concept]
   793 E C1705241:Change [Quantitative Concept]

Phrase: "from control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "(top)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "and"

Phrase: "ALLM-pretreated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: ")"

Phrase: "are"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.169: 2E. 

Phrase: "2E."
Processing 00000000.tx.170: Stimulation induced much larger average changes in peak membrane capacitance in ALLM-pretreated cells in comparison with control cells (Fig. 2F). 

Phrase: "Stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "much larger average changes in peak membrane capacitance"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0392747:changes [Functional Concept]
   744   C0443172:changes [Quantitative Concept]
   711 E C1705241:Change [Quantitative Concept]

Phrase: "in ALLM-pretreated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "in comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "with control cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0007634:Cells [Cell]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 2F"

Phrase: ")."
Processing 00000000.tx.171: A 4-h exposure to calpain inhibitors is associated with a reduction in calpain activity in pancreatic islets. 

Phrase: "A 4-h exposure to calpain inhibitors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0332157:Exposure to [Clinical Attribute]
           Exposure
   748   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "is"

Phrase: "associated with a reduction"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in calpain activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150129:calpain activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "in pancreatic islets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
Processing 00000000.tx.172: To document that ALLM and E-64-d were inhibiting calpains rather than other cysteine proteases, we measured calpain activity in isolated islets using the fluorogenic calpain-specific substrate Boc-Leu-Met-CMAC (Fig. 3) (9). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "document"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1301746:document [Intellectual Product]
  1000   C1547673:Document [Intellectual Product]

Phrase: "that ALLM"

Phrase: "and"

Phrase: "E-64-d"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0058882:E 64 [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "inhibiting calpains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "rather than"

Phrase: "other cysteine proteases,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C2717970:Cysteine Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   983 E C0758959:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   983 E C0769345:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Proteases [Enzyme]

Phrase: "we"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "calpain activity in isolated islets"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1150129:calpain activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the fluorogenic calpain-specific substrate Boc-Leu-Met-CMAC (Fig. 3"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   880   C1413113:CALPAIN 3 [Gene or Genome]
   824   C0016349:Fluorogenic Substrate [Indicator, Reagent, or Diagnostic Aid]
   804   C0639683:Leu-Met [Amino Acid, Peptide, or Protein]
   790   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0023401:Leu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C0205369:Specific [Qualitative Concept]
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1552740:specific [Intellectual Product]
   790   C1710236:Substrate [Manufactured Object]
   790   C1826625:BOC [Gene or Genome]

Phrase: ")"

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.173: Although this compound does not distinguish between different calpain isozymes, it does seem to be specific for calpains and not for other lysosomal proteases under physiological conditions (9). 

Phrase: "Although"

Phrase: "this compound"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205198:Compound [Qualitative Concept]
  1000   C1706082:Compound [Chemical]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "distinguish between different calpain isozymes,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0022173:Isozymes [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1705242:Different [Qualitative Concept]

Phrase: "it"

Phrase: "does"

Phrase: "seem"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "specific for calpains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205369:Specific [Qualitative Concept]
   790   C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "not for other lysosomal proteases"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0521450:Lysosomal [Body Location or Region]
   760   C1518422:Not [Functional Concept]
   760   C1947941:Proteases [Enzyme]

Phrase: "under physiological conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.174: In islets incubated in the presence of 200 mol/l ALLM or 200 mol/l E-64-d, the rate of generation of the fluorescent signal was lower than in islets incubated in the absence of the calpain inhibitors (Fig. 3A). 

Phrase: "In islets"

Phrase: "incubated in the presence of 200 mol/l ALLM"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C0347982:mol/L [Quantitative Concept]
   742   C0027960:Mole [Neoplastic Process]
   742   C0324740:Mole [Mammal]
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
   742   C0439189:Mole [Quantitative Concept]
   742   C1439852:Incubated [Laboratory Procedure]
   742   C1456781:mole [Neoplastic Process]
   742   C1824986:mol [Gene or Genome]

Phrase: "or"

Phrase: "200 mol/l E-64-d,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   876   C0439428:mol/d [Quantitative Concept]

Phrase: "the rate of generation of the fluorescent signal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0871208:Rate [Activity]
   744   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "lower than"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0441994:Lower [Spatial Concept]
   833   C1548802:Lower [Body Location or Region]
   833   C2003888:Lower [Activity]

Phrase: "in islets"

Phrase: "incubated in the absence of the calpain inhibitors"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0054533:calpain inhibitors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0243077:inhibitors [Chemical Viewed Functionally]
   744   C0332197:absence [Quantitative Concept]
   744   C1439852:Incubated [Laboratory Procedure]
   744   C1689985:Absence [Anatomical Abnormality]
   711 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.175: The area under the curve (AUC), which is a measure of the rate of generation of the fluorescent product, was reduced to 35  4% (n = 3, P < 0.01) and 45  5% (n = 4, P < 0.03, using ANOVA and post hoc Duncan test) of control values in the presence of ALLM (200 mol/l) and of E-64-d (200 mol/l), respectively (Fig. 3B). 

Phrase: "The area under the curve (AUC),"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   882   C0376690:Area under the curve [Quantitative Concept]
           Area Under Curve
   760   C0017446:Area [Geographic Area]
   760   C0205146:Area [Spatial Concept]

Phrase: "which"

Phrase: "is"

Phrase: "a measure of the rate of generation of the fluorescent product,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0079809:Measure [Quantitative Concept]
   738   C0242485:Measure [Functional Concept]

Phrase: "was"

Phrase: "reduced to 35  4%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392756:Reduced [Qualitative Concept]

Phrase: "(n = 3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "45  5%"

Phrase: "(n = 4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P < 0.03,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ANOVA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "post hoc Duncan test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0392366:test [Intellectual Product]

Phrase: ")"

Phrase: "of control values"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0042295:Values [Qualitative Concept]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of ALLM"

Phrase: "(200 mol/l)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0347982:mol/L [Quantitative Concept]

Phrase: "and of E-64-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515981:And [Idea or Concept]

Phrase: "d ("

Phrase: "200 mol/l), respectively"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0347982:mol/L [Quantitative Concept]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1824986:mol [Gene or Genome]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.176: View larger version (22K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(22K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.177: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.178: Effects of protease inhibitors on calpain activity in islets. 

Phrase: "Effects of protease inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on calpain activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150129:calpain activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "in islets."
Processing 00000000.tx.179: A: Mouse islets were preincubated for 4 h in the absence or presence of calpain inhibitors. 

Phrase: "A"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: ":"

Phrase: "Mouse islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522528:Mouse Islets [Tissue]

Phrase: "were"

Phrase: "preincubated for 4 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of calpain inhibitors."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.180: Islets then were incubated in KRB containing 10 mol/l Boc-Leu-Met-CMAC from 0 min and fluorescence emitted by the calpain proteolytic product was measured after excitation by light at 340 nm. 

Phrase: "Islets then"

Phrase: "were"

Phrase: "incubated in KRB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C1439852:Incubated [Laboratory Procedure]
   726   C1875730:RINGER'S [Organic Chemical,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10 mol/l Boc-Leu-Met-CMAC from 0 min"

Phrase: "and"

Phrase: "fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "emitted by the calpain proteolytic product"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0597304:Proteolytic [Molecular Function]
   753   C1514468:product [Entity]
   753   C1704444:Product [Quantitative Concept]
   753   C1947941:proteolytic [Enzyme]
   719   C0162676:EMIT [Laboratory Procedure]
   719   C1623049:EMIT [Laboratory Procedure]

Phrase: "was"

Phrase: "measured after excitation"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0444706:Measured [Qualitative Concept]
   790   C0549255:Excitation [Activity]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "by light"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023693:Light [Natural Phenomenon or Process]
  1000   C1306462:Light [Functional Concept]
  1000   C1881376:Light [Qualitative Concept]

Phrase: "at 340 nm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]
Processing 00000000.tx.181: Data represent mean  SE of three to four separate experiments. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "mean  SE of three to four separate experiments."
Processing 00000000.tx.182: B: The AUC of fluorescence generation in the absence and presence of calpain inhibitors (n = 34). 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "The AUC of fluorescence generation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   815   C0376690:Area under the curve [Quantitative Concept]
           Area Under Curve
   744   C0017446:Area [Geographic Area]
   744   C0205146:Area [Spatial Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "and"

Phrase: "presence of calpain inhibitors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(n = 34"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.183: *P < 0.03 compared with islets incubated in the absence of inhibitor (using ANOVA and post hoc Duncan test).  

Phrase: "*P < 0.03"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared with islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "incubated in the absence of inhibitor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0332197:absence [Quantitative Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1689985:Absence [Anatomical Abnormality]
   753   C1999216:Inhibitor [Qualitative Concept]

Phrase: "("

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ANOVA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "post hoc Duncan test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0392366:test [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.184: Calpain inhibitors affect insulin action in skeletal muscle and adipocytes. 

Phrase: "Calpain inhibitors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0054533:calpain inhibitors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "insulin action in skeletal muscle"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   797   C0920875:Muscle action [Organ or Tissue Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0441472:Action [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C3266814:Action [Activity]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "adipocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206131:Adipocytes [Cell]
Processing 00000000.tx.185: We measured insulin-stimulated 2-DOG uptake in adipocytes and muscle strips in the presence of 100 mol/l ALLM and 200 mol/l E-64-d. 

Phrase: "We"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "insulin-"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "2-DOG uptake in adipocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243144:Uptake [Physiologic Function]
   760   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "muscle"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026845:Muscle [Tissue]
   928 E C0442025:Muscular [Spatial Concept]

Phrase: "strips in the presence of 100 mol/l ALLM"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C0347982:mol/L [Quantitative Concept]
   742   C0027960:Mole [Neoplastic Process]
   742   C0324740:Mole [Mammal]
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
   742   C0439189:Mole [Quantitative Concept]
   742   C1321564:Strip [Medical Device]
   742   C1456781:mole [Neoplastic Process]
   742   C1824986:mol [Gene or Genome]

Phrase: "and"

Phrase: "200 mol/l E-64-d."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   876   C0439428:mol/d [Quantitative Concept]
Processing 00000000.tx.186: In adipocytes, insulin (12 nmol/l) increased uptake of 2-DOG from 457  59 pmol  2 x 105 cells1  5 min1 to 1,384  178 pmol  2 x 105 cells1  5 min1 (P < 0.01, n = 4, paired t test; Fig. 4A). 

Phrase: "In adipocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206131:Adipocytes [Cell]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(12 nmol/l) increased uptake of 2-DOG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0243144:Uptake [Physiologic Function]
   744   C0347980:% uptake [Quantitative Concept]

Phrase: "from 457  59 pmol  2 x 105 cells1  5 min1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C3272448:MIN1 [Gene or Genome]

Phrase: "to 1,384  178 pmol  2 x 105 cells1  5 min1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C3272448:MIN1 [Gene or Genome]
   713   C0450316:1/5 [Quantitative Concept]

Phrase: "(P < 0.01,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "n = 4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "paired t test"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1709451:Paired t-Test [Intellectual Product]
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]

Phrase: "; Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.187: In the presence of 100 mol/l ALLM, insulin increased 2-DOG uptake from 598  102 pmol  2 x 105 cells1  5 min1 to 751  71 pmol  2 x 105 cells1  5 min1. 

Phrase: "In the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 100 mol/l ALLM,"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "2-DOG uptake from 598  102 pmol  2 x 105 cells1  5 min1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   735   C0243144:Uptake [Physiologic Function]
   735   C0347980:% uptake [Quantitative Concept]

Phrase: "to 751  71 pmol  2 x 105 cells1  5 min1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C3272448:MIN1 [Gene or Genome]
Processing 00000000.tx.188: This change represented an 84% reduction in the increase in 2-DOG uptake in response to insulin (P < 0.01) compared with experiments performed in the absence of calpain inhibitors. 

Phrase: "This change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "represented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "an 84% reduction in the increase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "in 2-DOG uptake"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0243144:Uptake [Physiologic Function]
   827   C0347980:% uptake [Quantitative Concept]
   734   C0011501:2-Deoxyglucose [Carbohydrate,Pharmacologic Substance]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "compared with experiments"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0681814:Experiments [Research Activity]
   790   C1707455:Compared [Activity]
   756 E C1706386:Experiment [Conceptual Entity]
   706 E C1517586:Experimental [Qualitative Concept]

Phrase: "performed in the absence of calpain inhibitors."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   778   C0054533:calpain inhibitors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0243077:inhibitors [Chemical Viewed Functionally]
   748   C0332197:absence [Quantitative Concept]
   748   C0884358:Performed [Functional Concept]
   748   C1689985:Absence [Anatomical Abnormality]
   714 E C1999216:Inhibitor [Qualitative Concept]
   714 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.189: In the presence of E-64-d, 2-DOG uptake was 361  29 and 749  129 pmol  2 x 105 cells1  5 min1 in the absence and presence of insulin, respectively (n = 4), a 58% reduction in insulin-stimulated 2-DOG uptake (P < 0.03). 

Phrase: "In the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of E-64-d,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0058882:E 64 [Organic Chemical,Pharmacologic Substance]

Phrase: "2-DOG uptake"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0243144:Uptake [Physiologic Function]
   827   C0347980:% uptake [Quantitative Concept]
   734   C0011501:2-Deoxyglucose [Carbohydrate,Pharmacologic Substance]

Phrase: "was"

Phrase: "361  29"

Phrase: "and"

Phrase: "749  129 pmol  2 x 105 cells1  5 min1 in the absence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C3272448:MIN1 [Gene or Genome]

Phrase: "and"

Phrase: "presence of insulin,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0392148:Presence [Therapeutic or Preventive Procedure]
   718 E C0150312:Present [Quantitative Concept]
   718 E C0449450:Present [Idea or Concept]

Phrase: "respectively"

Phrase: "(n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "a 58% reduction in insulin-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "2-DOG uptake"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0243144:Uptake [Physiologic Function]
   827   C0347980:% uptake [Quantitative Concept]
   734   C0011501:2-Deoxyglucose [Carbohydrate,Pharmacologic Substance]

Phrase: "(P < 0.03"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.190: View larger version (30K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(30K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413114:30K [Gene or Genome]

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.191: 4. 

Phrase: "4."
Processing 00000000.tx.192: Effects of protease inhibitors on insulin action in adipocytes and skeletal muscle. 

Phrase: "Effects of protease inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on insulin action"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0441472:Action [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C3266814:Action [Activity]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206131:Adipocytes [Cell]

Phrase: "and"

Phrase: "skeletal muscle."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.193: A: Effects of insulin alone or insulin in the presence of cysteine protease inhibitors on 2-DOG uptake into rat adipocytes. 

Phrase: "A"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: ":"

Phrase: "Effects of insulin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or"

Phrase: "insulin in the presence of cysteine protease inhibitors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0021643:inhibitors insulin [Pharmacologic Substance]
   767   C0021669:Insulin Protease [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]

Phrase: "on 2-DOG uptake"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0243144:Uptake [Physiologic Function]
   827   C0347980:% uptake [Quantitative Concept]
   734   C0011501:2-Deoxyglucose [Carbohydrate,Pharmacologic Substance]

Phrase: "into rat adipocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206131:Adipocytes [Cell]
Processing 00000000.tx.194: *P < 0.05 compared with cells incubated in the absence of inhibitor. 

Phrase: "*P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared with cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C1707455:Compared [Activity]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "incubated in the absence of inhibitor."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0332197:absence [Quantitative Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1689985:Absence [Anatomical Abnormality]
   753   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.195: B: Effect of ALLM (100 mol/l) and E-64-d (200 mol/l) on 2-DOG uptake by skeletal muscle. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "Effect of ALLM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "(100 mol/l)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0347982:mol/L [Quantitative Concept]

Phrase: "and"

Phrase: "E-64-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0058882:E 64 [Organic Chemical,Pharmacologic Substance]

Phrase: "d ("

Phrase: "200 mol/l) on 2-DOG uptake"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   778   C0347982:mol/L [Quantitative Concept]

Phrase: "by skeletal muscle."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.196: Soleus muscle strips from normal adult male rats were incubated in the absence or presence of insulin and in the absence and presence of protease inhibitors as shown. 

Phrase: "Soleus muscle"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0242694:Soleus Muscle [Body Part, Organ, or Organ Component]
           Soleus
   861   C0026845:Muscle [Tissue]
   861   C1305356:Soleus [Body Part, Organ, or Organ Component]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "strips from normal adult male rats"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   753   C0001675:Adult [Age Group]
   753   C0024554:Male [Finding]
   753   C0034693:rats [Mammal]
   753   C0034721:Rats [Mammal]
   753   C0086582:male [Population Group]
   753   C0205307:Normal [Qualitative Concept]
   753   C0439166:% normal [Quantitative Concept]
   753   C1321564:Strip [Medical Device]
   753   C1706180:Male [Qualitative Concept]
   753   C1706428:Male [Qualitative Concept]
   753   C1706429:Male [Organism Attribute]
   753   C1706450:Adult [Human]
   753   C2347086:% Normal [Quantitative Concept]

Phrase: "were"

Phrase: "incubated in the absence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332197:absence [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "or"

Phrase: "presence of insulin"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0392148:Presence [Therapeutic or Preventive Procedure]
   718 E C0150312:Present [Quantitative Concept]
   718 E C0449450:Present [Idea or Concept]

Phrase: "and in the absence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332197:absence [Quantitative Concept]
   770   C1515981:And [Idea or Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "and"

Phrase: "presence of protease inhibitors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "as"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.197: Results are mean  SE of five separate experiments. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "mean  SE of five separate experiments."
Processing 00000000.tx.198: #P < 0.05 compared with muscles incubated in the absence of insulin (using ANOVA and post hoc Duncan test). 

Phrase: "#P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared with muscles"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0026845:Muscles [Tissue]
   790   C1707455:Compared [Activity]
   790   C1995013:Muscles [Body Part, Organ, or Organ Component]
   706 E C0442025:Muscular [Spatial Concept]

Phrase: "incubated in the absence of insulin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0332197:absence [Quantitative Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "("

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ANOVA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "post hoc Duncan test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0392366:test [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.199: C: Effect of ALLM (100 mol/l) on insulin-stimulated 3- MG uptake in muscle. 

Phrase: "C"

Phrase: ":"

Phrase: "Effect of ALLM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "(100 mol/l) on insulin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   806   C0347982:mol/L [Quantitative Concept]

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "3- MG uptake in muscle."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243144:Uptake [Physiologic Function]
   760   C0347980:% uptake [Quantitative Concept]
Processing 00000000.tx.200: Epitrochlearis muscles were incubated for 60 min in medium containing 100 mol/l ALLM and then stimulated by 12 nmol/l insulin for 30 min before measuring 3-MG uptake. 

Phrase: "Epitrochlearis muscles"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0026845:Muscles [Tissue]
   861   C1995013:Muscles [Body Part, Organ, or Organ Component]
   777 E C0442025:Muscular [Spatial Concept]

Phrase: "were"

Phrase: "incubated for 60 min in medium containing 100 mol/l ALLM"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   772   C2827898:min*mol/L [Quantitative Concept]
   756   C0347982:mol/L [Quantitative Concept]
   754   C0560025:mol/min [Quantitative Concept]
   738   C0009458:Medium [Intellectual Product]
   738   C0027960:Mole [Neoplastic Process]
   738   C0324740:Mole [Mammal]
   738   C0332256:Containing [Functional Concept]
   738   C0439189:Mole [Quantitative Concept]
   738   C0439536:Medium [Quantitative Concept]
   738   C0702093:/min [Temporal Concept]
   738   C1439852:Incubated [Laboratory Procedure]
   738   C1456781:mole [Neoplastic Process]
   738   C1705217:Medium [Substance]
   738   C1824986:mol [Gene or Genome]
   738   C2700400:Containing [Activity]
   738   C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "stimulated by 12 nmol/l insulin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0439282:nmol/L [Quantitative Concept]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0439191:NMOLE [Quantitative Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "before"

Phrase: "measuring"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:measuring [Qualitative Concept]
  1000   C0449770:measuring [Quantitative Concept]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "3-MG uptake."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0243144:Uptake [Physiologic Function]
   827   C0347980:% uptake [Quantitative Concept]
Processing 00000000.tx.201: Data are mean  SE of five muscles/treatment group. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "mean  SE of five muscles/treatment group."
Processing 00000000.tx.202: *P < 0.01 compared with insulin alone. 

Phrase: "*P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared with insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   790   C1707455:Compared [Activity]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.203: D: Effect of ALLM (100 mol/l) on hypoxia-stimulated 3-MG uptake in epitrochlearis muscle. 

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ":"

Phrase: "Effect of ALLM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "(100 mol/l) on hypoxia-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   806   C0347982:mol/L [Quantitative Concept]

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "3-MG uptake in epitrochlearis muscle."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243144:Uptake [Physiologic Function]
   753   C0347980:% uptake [Quantitative Concept]
Processing 00000000.tx.204: Isolated muscle strips were incubated for 60 min in medium containing 100 mol/l ALLM and then incubated further in similar medium gassed with 95% N2/5% CO2 for 80 min before measuring 3-MG uptake. 

Phrase: "Isolated muscle strips"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1321564:strips [Medical Device]

Phrase: "were"

Phrase: "incubated for 60 min in medium containing 100 mol/l ALLM"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   772   C2827898:min*mol/L [Quantitative Concept]
   756   C0347982:mol/L [Quantitative Concept]
   754   C0560025:mol/min [Quantitative Concept]
   738   C0009458:Medium [Intellectual Product]
   738   C0027960:Mole [Neoplastic Process]
   738   C0324740:Mole [Mammal]
   738   C0332256:Containing [Functional Concept]
   738   C0439189:Mole [Quantitative Concept]
   738   C0439536:Medium [Quantitative Concept]
   738   C0702093:/min [Temporal Concept]
   738   C1439852:Incubated [Laboratory Procedure]
   738   C1456781:mole [Neoplastic Process]
   738   C1705217:Medium [Substance]
   738   C1824986:mol [Gene or Genome]
   738   C2700400:Containing [Activity]
   738   C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "further in similar medium"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0009458:Medium [Intellectual Product]
   770   C0439536:Medium [Quantitative Concept]
   770   C1517331:Further [Spatial Concept]
   770   C1705217:Medium [Substance]
   770   C2348205:Similar [Qualitative Concept]
   770   C3244283:medium [Intellectual Product]
   737 E C0205108:far [Spatial Concept]

Phrase: "gassed with 95% N2/5% CO2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0441960:N2 [Finding]
   753   C2347816:Co2+ [Element, Ion, or Isotope]
   719   C0017110:Gas [Chemical Viewed Structurally]
   719   C0596601:Gas [Sign or Symptom]

Phrase: "for 80 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "before"

Phrase: "measuring"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:measuring [Qualitative Concept]
  1000   C0449770:measuring [Quantitative Concept]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "3-MG uptake."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0243144:Uptake [Physiologic Function]
   827   C0347980:% uptake [Quantitative Concept]
Processing 00000000.tx.205: Data are mean  SE of five muscles/treatment group. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "mean  SE of five muscles/treatment group."
Processing 00000000.tx.206: *P < 0.05 compared with no ALLM.  

Phrase: "*P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared with no ALLM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Compared [Activity]
Processing 00000000.tx.207: Insulin-mediated 2-DOG transport into strips of soleus muscle also was reduced by 100 mol/l ALLM or 200 mol/l E-64-d (Fig. 4B). 

Phrase: "Insulin-"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "2-DOG transport into strips of soleus muscle also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0005528:Transport, NOS [Cell Function]
   742   C1317949:Transport [Manufactured Object]
   742   C3495449:transport [Medical Device]

Phrase: "was"

Phrase: "reduced by 100 mol/l ALLM"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0347982:mol/L [Quantitative Concept]
   753   C0027960:Mole [Neoplastic Process]
   753   C0324740:Mole [Mammal]
   753   C0392756:Reduced [Qualitative Concept]
   753   C0439189:Mole [Quantitative Concept]
   753   C1456781:mole [Neoplastic Process]
   753   C1824986:mol [Gene or Genome]

Phrase: "or"

Phrase: "200 mol/l E-64-"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   840   C0347982:mol/L [Quantitative Concept]
   804   C0027960:Mole [Neoplastic Process]
   804   C0324740:Mole [Mammal]
   804   C0439189:Mole [Quantitative Concept]
   804   C1456781:mole [Neoplastic Process]
   804   C1824986:mol [Gene or Genome]
   721 E C0026367:Molar [Body Part, Organ, or Organ Component]
   704 E C0027962:moles [Neoplastic Process]

Phrase: "d ("

Phrase: "Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.208: Insulin (12 nmol/l) increased 2-DOG uptake into soleus muscle strips from 0.26  0.01 to 0.47  0.03 mol  ml H2O1  30 min1 (P < 0.001, n = 5, paired t test). 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(12 nmol/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439191:NMOLE [Quantitative Concept]

Phrase: "l)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "2-DOG uptake into soleus muscle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243144:Uptake [Physiologic Function]
   753   C0347980:% uptake [Quantitative Concept]

Phrase: "strips from 0.26  0.01"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1321564:Strip [Medical Device]

Phrase: "to 0.47  0.03 mol  ml H2O1  30 min1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C3272448:MIN1 [Gene or Genome]

Phrase: "(P < 0.001,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "n = 5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "paired t test"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1709451:Paired t-Test [Intellectual Product]
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.209: In the presence of ALLM, 2-DOG uptake was 0.28  0.04 and 0.34  0.05 mol  ml H2O1  30 min1 in the absence and presence of insulin, respectively (n = 5), whereas in the presence of E-64-d, 2-DOG uptake was 0.31  0.02 and 0.36  0.02 mol  ml H2O1  30 min1 in the absence and presence of insulin, respectively (n = 5). 

Phrase: "In the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of ALLM,"

Phrase: "2-DOG uptake"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0243144:Uptake [Physiologic Function]
   827   C0347980:% uptake [Quantitative Concept]
   734   C0011501:2-Deoxyglucose [Carbohydrate,Pharmacologic Substance]

Phrase: "was"

Phrase: "0.28  0.04"

Phrase: "and"

Phrase: "0.34  0.05 mol  ml H2O1  30 min1 in the absence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C3272448:MIN1 [Gene or Genome]

Phrase: "and"

Phrase: "presence of insulin,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0392148:Presence [Therapeutic or Preventive Procedure]
   718 E C0150312:Present [Quantitative Concept]
   718 E C0449450:Present [Idea or Concept]

Phrase: "respectively"

Phrase: "(n = 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "whereas in the presence of E-64-d,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "2-DOG uptake"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0243144:Uptake [Physiologic Function]
   827   C0347980:% uptake [Quantitative Concept]
   734   C0011501:2-Deoxyglucose [Carbohydrate,Pharmacologic Substance]

Phrase: "was"

Phrase: "0.31  0.02"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0450355:31 [Intellectual Product]

Phrase: "and"

Phrase: "0.36  0.02 mol  ml H2O1  30 min1 in the absence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C3272448:MIN1 [Gene or Genome]

Phrase: "and"

Phrase: "presence of insulin,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0392148:Presence [Therapeutic or Preventive Procedure]
   718 E C0150312:Present [Quantitative Concept]
   718 E C0449450:Present [Idea or Concept]

Phrase: "respectively"

Phrase: "(n = 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.210: The magnitude of the increase in 2-DOG uptake in response to insulin was reduced by 71 and 75% in the presence of ALLM and E-64-d, respectively (P < 0.001 in each case using ANOVA and post hoc Duncan test). 

Phrase: "The magnitude of the increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449286:magnitude [Quantitative Concept]
   760   C1704240:Magnitude [Quantitative Concept]

Phrase: "in 2-DOG uptake"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0243144:Uptake [Physiologic Function]
   827   C0347980:% uptake [Quantitative Concept]
   734   C0011501:2-Deoxyglucose [Carbohydrate,Pharmacologic Substance]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "reduced by 71"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0392756:Reduced [Qualitative Concept]
   790   C0450389:71 [Intellectual Product]

Phrase: "and"

Phrase: "75% in the presence of ALLM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "E-64-d,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0058882:E 64 [Organic Chemical,Pharmacologic Substance]

Phrase: "respectively"

Phrase: "(P < 0.001 in each case"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0868928:Case [Functional Concept]
   753   C1706255:CASE [Medical Device]
   753   C1706256:Case [Conceptual Entity]
   753   C2603361:P' [Clinical Attribute]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ANOVA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "post hoc Duncan test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0392366:test [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.211: Similar results were observed with the measurement of 3-MG uptake in epitrochlearis muscles (Fig. 4C). 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "observed with the measurement of 3-MG uptake"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   767   C0201807:Uptake measurement [Laboratory Procedure]
   744   C0242485:Measurement [Functional Concept]
   744   C0243144:Uptake [Physiologic Function]
   744   C0347980:% uptake [Quantitative Concept]
   744   C0439269:mg% [Quantitative Concept]
   744   C1441672:Observed [Functional Concept]
   744   C1960952:mg % [Quantitative Concept]
   744   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "in epitrochlearis muscles"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0026845:Muscles [Tissue]
   861   C1995013:Muscles [Body Part, Organ, or Organ Component]
   777 E C0442025:Muscular [Spatial Concept]

Phrase: "(Fig. 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.212: Thus, after a 1-h treatment with 100 mol/l ALLM, the rate of 3-MG uptake in epitrochlearis stimulated by 12 nmol/l insulin was reduced by 61% (0.44  0.06 vs. 1.13  0.07 mol  ml1  10 min1, for n = 5 muscles/group; P < 0.01). 

Phrase: "Thus,"

Phrase: "after"

Phrase: "a 1-h treatment with 100 mol/l ALLM,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0039798:treatment [Functional Concept]
   742   C0087111:Treatment [Therapeutic or Preventive Procedure]
   742   C1522326:Treatment [Functional Concept]
   742   C1533734:Treatment [Therapeutic or Preventive Procedure]
   742   C1705169:Treatment [Conceptual Entity]
   742   C3538994:TREATMENT [Research Activity]

Phrase: "the rate of 3-MG uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]

Phrase: "in epitrochlearis"

Phrase: "stimulated by 12 nmol/l insulin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0439282:nmol/L [Quantitative Concept]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0439191:NMOLE [Quantitative Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "reduced by 61%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0392756:Reduced [Qualitative Concept]

Phrase: "(0.44  0.06"

Phrase: "vs. 1.13  0.07 mol  ml1  10 min1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C3272448:MIN1 [Gene or Genome]

Phrase: "for n = 5 muscles/group"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   844   C1995013:Muscle group [Body Part, Organ, or Organ Component]
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]

Phrase: "; P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.213: To determine whether the observed effects were specific for calpain inhibitors, we used the cathepsin inhibitor compound CA074ME (a cell permeable peptide inhibitor of cathepsin B [19]) in similar experiments. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the observed effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "specific for calpain inhibitors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205369:Specific [Qualitative Concept]
   770   C1552740:specific [Intellectual Product]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the cathepsin inhibitor compound CA074ME"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0910208:CA074Me [Organic Chemical]

Phrase: "(a cell permeable peptide inhibitor of cathepsin B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1999216:Inhibitor [Qualitative Concept]

Phrase: "[19"

Phrase: "]"

Phrase: ")"

Phrase: "in similar experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.214: Maximal insulin-stimulated glucose uptake (12 nmol/l insulin) in epitrochlearis muscle strips was 1.1  0.14 mol  ml H2O1  10 min1 (n = 8) in the absence and 1.1  0.14 mol  ml H2O1  10 min1 (n = 6) in the presence of 1 mol/l CA074ME. 

Phrase: "Maximal insulin-stimulated glucose uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C1159527:glucose uptake [Cell Function]
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   804   C0243144:Uptake [Physiologic Function]
   804   C0347980:% uptake [Quantitative Concept]

Phrase: "(12 nmol/l insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "in epitrochlearis muscle strips"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1321564:strips [Medical Device]

Phrase: "was"

Phrase: "1.1  0.14 mol  ml H2O1  10 min1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C3272448:MIN1 [Gene or Genome]

Phrase: "(n = 8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "and"

Phrase: "1.1  0.14 mol  ml H2O1  10 min1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C3272448:MIN1 [Gene or Genome]

Phrase: "(n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 1 mol/l CA074ME."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0910208:CA074Me [Organic Chemical]
Processing 00000000.tx.215: ALLM also inhibited hypoxia-induced 3-MG uptake in skeletal muscle (Fig. 4D). 

Phrase: "ALLM also"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "hypoxia-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242184:Hypoxia [Pathologic Function]
  1000   C1963140:HYPOXIA [Finding]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "3-MG uptake in skeletal muscle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243144:Uptake [Physiologic Function]
   753   C0347980:% uptake [Quantitative Concept]

Phrase: "(Fig. 4D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450377:4d [Intellectual Product]
   861   C2986754:4D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.216: An 80-min incubation of epitrochlearis muscle in hypoxic conditions caused an increase in 3-MG uptake in the absence of ALLM (0.26  0.05 vs. 1.21  0.2 mol  ml1  10 min1), and a 1-h preexposure to 100 mol/l ALLM suppressed the hypoxia-induced 3-MG uptake by 58% (0.50  0.09 vs. 1.21  0.2 mol  ml1  10 min1 for n = 4 muscles/group; P < 0.05). 

Phrase: "An 80-min incubation of epitrochlearis muscle"

Phrase: "in hypoxic conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "an increase in 3-MG uptake"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of ALLM"

Phrase: "(0.26  0.05"

Phrase: "vs. 1.21  0.2 mol  ml1  10 min1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C3272448:MIN1 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "a 1-h preexposure to 100 mol/l ALLM"

Phrase: "suppressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:Suppressed [Functional Concept]

Phrase: "the hypoxia-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242184:Hypoxia [Pathologic Function]
  1000   C1963140:HYPOXIA [Finding]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "3-MG uptake by 58%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243144:Uptake [Physiologic Function]
   760   C0347980:% uptake [Quantitative Concept]

Phrase: "(0.50  0.09"

Phrase: "vs. 1.21  0.2 mol  ml1  10 min1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C3272448:MIN1 [Gene or Genome]

Phrase: "for n = 4 muscles/group"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   844   C1995013:Muscle group [Body Part, Organ, or Organ Component]
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]

Phrase: "; P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.217: The basal 3-MG uptake rate also was significantly inhibited by ALLM (0.26  0.05 vs. 0.07  0.02 mol  ml1  10 min1 for n = 4 muscles/group; P < 0.05). 

Phrase: "The basal 3-MG uptake rate also"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   876   C1648294:Basal rate [Clinical Attribute]
   799   C0243144:Uptake [Physiologic Function]
   799   C0347980:% uptake [Quantitative Concept]
   799   C0871208:Rate [Activity]
   799   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "significantly"

Phrase: "inhibited by ALLM"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   790   C0311403:Inhibited [Qualitative Concept]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "(0.26  0.05"

Phrase: "vs. 0.07  0.02 mol  ml1  10 min1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C3272448:MIN1 [Gene or Genome]

Phrase: "for n = 4 muscles/group"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   844   C1995013:Muscle group [Body Part, Organ, or Organ Component]
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]

Phrase: "; P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.218: Insulin (6 nmol/l) increased the rate of muscle glycogen synthesis in soleus muscle strips from 0.58  0.08 to 1.55  0.20 nmol glucose  mg1  h1 (n = 6, P < 0.005, using paired t test; Fig. 5). 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(6 nmol/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439191:NMOLE [Quantitative Concept]

Phrase: "l)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the rate of muscle glycogen synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]

Phrase: "in soleus muscle"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0242694:Soleus Muscle [Body Part, Organ, or Organ Component]
           Soleus
   861   C0026845:Muscle [Tissue]
   861   C1305356:Soleus [Body Part, Organ, or Organ Component]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "strips from 0.58  0.08"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1321564:Strip [Medical Device]

Phrase: "to 1.55  0.20 nmol glucose  mg1  h1"

Phrase: "(n = 6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P < 0.005,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "paired t test"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1709451:Paired t-Test [Intellectual Product]
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]

Phrase: "; Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.219: In the presence of 100 mol/l ALLM, the glycogen synthesis rates were 0.27  0.03 and 0.40  0.05 nmol glucose  mg1  h1 in the absence and presence of insulin, respectively (n = 6), whereas in the presence of 200 mol/l E-64-d, the glycogen synthesis rates were 0.49  0.08 and 0.80  0.14 nmol glucose  mg1  h1 in the absence and presence of insulin, respectively (n = 6). 

Phrase: "In the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 100 mol/l ALLM,"

Phrase: "the glycogen synthesis rates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0871208:Rate [Activity]
   793   C1521828:Rate [Quantitative Concept]
   734   C1157202:glycogen synthesis [Molecular Function]

Phrase: "were"

Phrase: "0.27  0.03"

Phrase: "and"

Phrase: "0.40  0.05 nmol glucose  mg1  h1 in the absence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   754   C1415384:H1.0 [Gene or Genome]

Phrase: "and"

Phrase: "presence of insulin,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0392148:Presence [Therapeutic or Preventive Procedure]
   718 E C0150312:Present [Quantitative Concept]
   718 E C0449450:Present [Idea or Concept]

Phrase: "respectively"

Phrase: "(n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "whereas in the presence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "of 200 mol/l E-64-d,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   876   C0439428:mol/d [Quantitative Concept]

Phrase: "the glycogen synthesis rates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0871208:Rate [Activity]
   793   C1521828:Rate [Quantitative Concept]
   734   C1157202:glycogen synthesis [Molecular Function]

Phrase: "were"

Phrase: "0.49  0.08"

Phrase: "and"

Phrase: "0.80  0.14 nmol glucose  mg1  h1 in the absence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   754   C1415384:H1.0 [Gene or Genome]

Phrase: "and"

Phrase: "presence of insulin,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0392148:Presence [Therapeutic or Preventive Procedure]
   718 E C0150312:Present [Quantitative Concept]
   718 E C0449450:Present [Idea or Concept]

Phrase: "respectively"

Phrase: "(n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.220: The magnitude of the increase in glycogen synthesis in response to insulin was 87 and 68% lower in the presence of ALLM and E-64-d, respectively (P < 0.01 in each case using ANOVA and post hoc Duncan test). 

Phrase: "The magnitude of the increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449286:magnitude [Quantitative Concept]
   760   C1704240:Magnitude [Quantitative Concept]

Phrase: "in glycogen synthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1157202:glycogen synthesis [Molecular Function]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "87"

Phrase: "and"

Phrase: "68% lower in the presence of ALLM"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0441994:Lower [Spatial Concept]
   748   C1548802:Lower [Body Location or Region]
   748   C2003888:Lower [Activity]

Phrase: "and"

Phrase: "E-64-d,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0058882:E 64 [Organic Chemical,Pharmacologic Substance]

Phrase: "respectively"

Phrase: "(P < 0.01 in each case"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0868928:Case [Functional Concept]
   753   C1706255:CASE [Medical Device]
   753   C1706256:Case [Conceptual Entity]
   753   C2603361:P' [Clinical Attribute]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ANOVA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "post hoc Duncan test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0392366:test [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.221: View larger version (18K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(18K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.222: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.223: Effect of ALLM and E-64-d on glycogen synthesis rates in skeletal muscle. 

Phrase: "Effect of ALLM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "E-64-d on glycogen synthesis rates"

Phrase: "in skeletal muscle."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.224: Muscle strips were incubated in the absence or presence of insulin and in the absence and presence of inhibitors as shown. 

Phrase: "Muscle strips"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1321564:strips [Medical Device]

Phrase: "were"

Phrase: "incubated in the absence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332197:absence [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "or"

Phrase: "presence of insulin"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0392148:Presence [Therapeutic or Preventive Procedure]
   718 E C0150312:Present [Quantitative Concept]
   718 E C0449450:Present [Idea or Concept]

Phrase: "and in the absence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332197:absence [Quantitative Concept]
   770   C1515981:And [Idea or Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "and"

Phrase: "presence of inhibitors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0392148:Presence [Therapeutic or Preventive Procedure]
   718 E C0150312:Present [Quantitative Concept]
   718 E C0449450:Present [Idea or Concept]

Phrase: "as"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.225: Results are mean  SE of six separate experiments. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "mean  SE of six separate experiments."
Processing 00000000.tx.226: *P < 0.05 compared with muscles incubated in the absence of insulin; 

Phrase: "*P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared with muscles"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0026845:Muscles [Tissue]
   790   C1707455:Compared [Activity]
   790   C1995013:Muscles [Body Part, Organ, or Organ Component]
   706 E C0442025:Muscular [Spatial Concept]

Phrase: "incubated in the absence of insulin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0332197:absence [Quantitative Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: ";"
Processing 00000000.tx.227: #P < 0.05 compared with muscles incubated in the absence of inhibitor (using ANOVA and post hoc Duncan test in each case).   

Phrase: "#P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared with muscles"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0026845:Muscles [Tissue]
   790   C1707455:Compared [Activity]
   790   C1995013:Muscles [Body Part, Organ, or Organ Component]
   706 E C0442025:Muscular [Spatial Concept]

Phrase: "incubated in the absence of inhibitor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0332197:absence [Quantitative Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1689985:Absence [Anatomical Abnormality]
   753   C1999216:Inhibitor [Qualitative Concept]

Phrase: "("

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ANOVA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "post hoc Duncan test in each case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0022885:Test [Laboratory Procedure]
   748   C0039593:Test [Functional Concept]
   748   C0392366:test [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.228: DISCUSSION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Genetic studies have shown that variation in the gene encoding calpain-10 is associated with type 2 diabetes (2). 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Genetic studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   983   C2827447:Genetic Study [Research Activity]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that variation in the gene encoding calpain-10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205419:Variation [Qualitative Concept]

Phrase: "is"

Phrase: "associated with type 2 diabetes"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.229: Low levels of calpain-10 mRNA in skeletal muscle also are associated with insulin resistance, suggesting that calpain-10 may have a role in determining the normal response of skeletal muscle to the effects of insulin (3). 

Phrase: "Low levels of calpain-10 mRNA"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "in skeletal muscle also"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0242692:Muscle, Skeletal [Tissue]
   901   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   827   C0026845:Muscle [Tissue]
   827   C0037253:skeletal [Body System]
   827   C0521324:Skeletal [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: "are"

Phrase: "associated with insulin resistance,"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that calpain-10"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0961737:calpain 10 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413110:CALPAIN 10 [Gene or Genome]
   861   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "may"

Phrase: "have"

Phrase: "a role in determining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "the normal response of skeletal muscle"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "to the effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "of insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.230: The presence of calpain-10 mRNA in pancreatic islets, muscle, and liver, the three most important tissues that control blood glucose levels, suggests that calpain-10 may regulate pathways that affect insulin secretion, insulin action, and hepatic glucose production, each of which is altered in patients with type 2 diabetes. 

Phrase: "The presence of calpain-10 mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in pancreatic islets,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "muscle,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026845:Muscle [Tissue]
   928 E C0442025:Muscular [Spatial Concept]

Phrase: "and"

Phrase: "liver,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "the three most important tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0040300:Tissues [Tissue]
   779 E C1547928:Tissue [Intellectual Product]

Phrase: "that"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "blood glucose levels,"
Meta Candidates (Total=19; Excluded=11; Pruned=0; Remaining=8)
  1000   C0428554:blood glucose levels [Laboratory or Test Result]
   901   C0005802:Blood Glucose [Carbohydrate]
   901   C0428548:glucose levels [Laboratory or Test Result]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0229664:Blood [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that calpain-10"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0961737:calpain 10 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413110:CALPAIN 10 [Gene or Genome]
   861   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "may"

Phrase: "regulate"

Phrase: "pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathways [Molecular Function]
  1000   C1705987:Pathways [Conceptual Entity]

Phrase: "that"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "insulin secretion,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "insulin action,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0441472:Action [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C3266814:Action [Activity]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "hepatic glucose production,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0033268:production [Occupational Activity]
   827   C0205054:Hepatic [Body Location or Region]

Phrase: "each of which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1457900:Each [Quantitative Concept]

Phrase: "is"

Phrase: "altered in patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C0392747:Altered [Functional Concept]

Phrase: "with type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.231: As a first step in identifying the biochemical pathways that may be regulated by calpain-10 and/or other calpains, we studied the effects of calpain inhibitors on insulin secretory responses to glucose in islets and insulin action in muscle and adipocytes. 

Phrase: "As a first step in identifying"

Phrase: "the biochemical pathways"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0243123:biochemical pathways [Qualitative Concept]
   966 E C1704259:Biochemical Pathway [Molecular Function]
           Pathways
   861   C0205474:Biochemical [Functional Concept]
   861   C1705987:Pathways [Conceptual Entity]

Phrase: "that"

Phrase: "may"

Phrase: "be"

Phrase: "regulated by calpain-10"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0961737:calpain 10 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1413110:CALPAIN 10 [Gene or Genome]
   770   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "and/or"

Phrase: "other calpains,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "we"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the effects of calpain inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on insulin secretory responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0871261:responses [Organism Attribute]
   793 E C1704632:Response [Finding]
   793 E C1706817:Response [Intellectual Product]
   793 E C2911692:Response [Mental Process]

Phrase: "to glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "in islets"

Phrase: "and"

Phrase: "insulin action in muscle"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   819   C0920875:Muscle action [Organ or Tissue Function]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0441472:Action [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C3266814:Action [Activity]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "adipocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206131:Adipocytes [Cell]
Processing 00000000.tx.232: The present studies provide some insight into the mechanism by which ALLM and E-64-d alter the insulin secretory responses to glucose. 

Phrase: "The present studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "some insight into the mechanism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0233820:Insight [Mental Process]

Phrase: "by which ALLM"

Phrase: "and"

Phrase: "E-64-d"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0058882:E 64 [Organic Chemical,Pharmacologic Substance]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the insulin secretory responses to glucose."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0871261:responses [Organism Attribute]
   719 E C1704632:Response [Finding]
   719 E C1706817:Response [Intellectual Product]
   719 E C2911692:Response [Mental Process]
Processing 00000000.tx.233: After a 4-h exposure to calpain inhibitors, the increase in glucose-induced insulin secretion was not associated with increased [Ca2+]i, rates of glucose oxidation and utilization, or NADPH generation. 

Phrase: "After a 4-h exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0274281:Exposure, NOS [Injury or Poisoning]
   827   C0332157:Exposure [Clinical Attribute]

Phrase: "to calpain inhibitors,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0054533:calpain inhibitors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "the increase in glucose-induced insulin secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0020459:INSULIN INCREASE [Disease or Syndrome]
   748   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "associated with increased"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "rates of glucose oxidation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0871208:Rate [Activity]
   737   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "utilization,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042153:utilization [Functional Concept]

Phrase: "or"

Phrase: "NADPH generation."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0079411:Generation [Temporal Concept]
   861   C3146294:Generation [Activity]
   768 E C1414672:Genesis [Gene or Genome]
   768 E C2984892:Genesis [Gene or Genome]
Processing 00000000.tx.234: Thus, pathways in the -cell that are responsible for the uptake and metabolism of glucose were unaffected. 

Phrase: "Thus,"

Phrase: "pathways in the -cell"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1704259:Pathways [Molecular Function]
   770   C1705987:Pathways [Conceptual Entity]

Phrase: "that"

Phrase: "are"

Phrase: "responsible for the uptake"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "and"

Phrase: "metabolism of glucose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C0596620:glucose metabolism [Molecular Function]
   790   C0025519:Metabolism [Organism Function]
   790   C0025520:metabolism [Functional Concept]

Phrase: "were"

Phrase: "unaffected."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986417:Unaffected [Conceptual Entity]
Processing 00000000.tx.235: We believe that the primary site(s) of calpain action in the regulation of insulin secretion may be in the pathways that regulate the movement or fusion of insulin secretory granules with the plasma membrane. 

Phrase: "We"

Phrase: "believe"

Phrase: "that"

Phrase: "the primary site"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0449695:Primary site [Spatial Concept]
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "("

Phrase: "s) of calpain action"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0441472:Action [Functional Concept]
   770   C2603362:S' [Clinical Attribute]
   770   C3266814:Action [Activity]

Phrase: "in the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "may"

Phrase: "be in the pathways"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1704259:Pathways [Molecular Function]
   770   C1705987:Pathways [Conceptual Entity]
   770   C2987476:Be [Conceptual Entity]

Phrase: "that"

Phrase: "regulate"

Phrase: "the movement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026649:Movement [Organism Function]

Phrase: "or"

Phrase: "fusion of insulin secretory granules"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332466:Fusion [Functional Concept]
   760   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "with the plasma membrane."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.236: This hypothesis is supported by the observation that membrane capacitance is increased in islets after short-term exposure to ALLM, in the absence of effects on glucose metabolism and mitochondrial function. 

Phrase: "This hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "is"

Phrase: "supported by the observation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0302523:Observation [Research Activity]
   770   C0700325:observation [Health Care Activity]
   770   C1521721:Supported [Conceptual Entity]
   770   C1964257:Observation [Diagnostic Procedure]
   737 E C0183683:Support [Medical Device]

Phrase: "that membrane capacitance"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0025255:Membrane [Tissue]
   861   C0242264:capacitance [Quantitative Concept]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "is"

Phrase: "increased in islets"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "after short-term exposure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0274281:Exposure, NOS [Injury or Poisoning]
   827   C0332157:Exposure [Clinical Attribute]
   734   C0443303:Short-term [Temporal Concept]

Phrase: "to ALLM,"

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "on glucose metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596620:glucose metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "mitochondrial function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.237: Glucose transport is the major rate-limiting step in the metabolism of glucose in muscle and fat tissue, and impaired glucose uptake by theses tissues is an important feature of insulin resistance (20). 

Phrase: "Glucose transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178666:glucose transport [Cell Function]
   861   C0005528:Transport, NOS [Cell Function]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]

Phrase: "is"

Phrase: "the major rate-limiting step in"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1261552:Step [Conceptual Entity]
   804   C1704379:Step [Functional Concept]
   804   C1705117:Step [Quantitative Concept]
   804   C2825408:Step [Manufactured Object]

Phrase: "the metabolism of glucose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0596620:glucose metabolism [Molecular Function]
   770   C0025519:Metabolism [Organism Function]
   770   C0025520:metabolism [Functional Concept]

Phrase: "in muscle"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026845:Muscle [Tissue]
   928 E C0442025:Muscular [Spatial Concept]

Phrase: "and"

Phrase: "fat tissue,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001527:Fat Tissue [Tissue]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "and"

Phrase: "impaired glucose uptake by theses tissues"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1159527:glucose uptake [Cell Function]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0243144:Uptake [Physiologic Function]
   753   C0347980:% uptake [Quantitative Concept]

Phrase: "is"

Phrase: "an important feature of insulin resistance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1521970:Feature [Qualitative Concept]
   753   C1706388:Feature [Conceptual Entity]
   753   C2346469:Feature [Qualitative Concept]
   753   C2348519:Feature [Qualitative Concept]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.238: Treatment of muscle strips with ALLM and E-64-d resulted in a significant reduction in the rate of insulin-stimulated glucose uptake, as measured by two different assays (2-DOG and 3-MG uptake) and the incorporation of glucose into glycogen. 

Phrase: "Treatment of muscle"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "strips with ALLM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1321564:Strip [Medical Device]

Phrase: "and"

Phrase: "E-64-d"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0058882:E 64 [Organic Chemical,Pharmacologic Substance]

Phrase: "resulted in a significant reduction"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0237881:significant [Quantitative Concept]
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]
   760   C0750502:Significant [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "in the rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0871208:Rate [Activity]
  1000   C1521828:Rate [Quantitative Concept]

Phrase: "of insulin-stimulated glucose uptake,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1159527:glucose uptake [Cell Function]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0243144:Uptake [Physiologic Function]
   812   C0347980:% uptake [Quantitative Concept]

Phrase: "as"

Phrase: "measured by two different assays"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0205448:Two [Quantitative Concept]
   760   C0444706:Measured [Qualitative Concept]
   760   C1705242:Different [Qualitative Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726   C0005507:Assay [Laboratory Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]

Phrase: "(2-DOG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011501:2-Deoxyglucose [Carbohydrate,Pharmacologic Substance]
           Deoxyglucose

Phrase: "and"

Phrase: "3-MG uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0243144:Uptake [Physiologic Function]
   827   C0347980:% uptake [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the incorporation of glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0243126:incorporation [Functional Concept]

Phrase: "into glycogen."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
Processing 00000000.tx.239: The two calpain inhibitors also inhibited 2-DOG uptake, into adipocytes. 

Phrase: "The two calpain inhibitors also"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0054533:calpain inhibitors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243077:inhibitors [Chemical Viewed Functionally]
   779 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "2-DOG uptake,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0243144:Uptake [Physiologic Function]
   827   C0347980:% uptake [Quantitative Concept]
   734   C0011501:2-Deoxyglucose [Carbohydrate,Pharmacologic Substance]

Phrase: "into adipocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206131:Adipocytes [Cell]
Processing 00000000.tx.240: Although the exact site where calpains act in the signaling pathways of insulin action needs further study, the results of the effects of calpain inhibitors on hypoxia-induced 3-MG uptake may shed light on this issue. 

Phrase: "Although"

Phrase: "the exact site where calpains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "act in the signaling pathways of insulin action"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   782   C1512804:Insulin Signaling Pathway [Molecular Function]
   782   C2984300:Insulin signaling pathway [Molecular Function]
   767   C0037080:pathways signaling [Molecular Function]
   754 E C0037083:signaling pathway [Cell Function]
           Signaling
   754 E C0086982:Signaling Pathway [Molecular Function]
   750   C2984427:Insulin Pathway [Functional Concept]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0079613:ACT [Therapeutic or Preventive Procedure]
   744   C0441472:Action [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1704259:Pathways [Molecular Function]
   744   C1705987:Pathways [Conceptual Entity]
   744   C3266814:Action [Activity]
   744   C3537152:signaling [Biologic Function]
   711 E C1710082:Signal [Phenomenon or Process]

Phrase: "needs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "further study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "the results of the effects of calpain inhibitors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711   C2825142:Result [Finding]

Phrase: "on hypoxia-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242184:Hypoxia [Pathologic Function]
  1000   C1963140:HYPOXIA [Finding]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "3-MG uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0243144:Uptake [Physiologic Function]
   827   C0347980:% uptake [Quantitative Concept]

Phrase: "may"

Phrase: "shed"

Phrase: "light on this issue."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0023693:Light [Natural Phenomenon or Process]
   770   C1306462:Light [Functional Concept]
   770   C1881376:Light [Qualitative Concept]
Processing 00000000.tx.241: The hypoxia-associated increase in glucose uptake is not mediated by the insulin receptor-IRS-phosphatidylinositol 3-kinase system (21,22). 

Phrase: "The hypoxia-associated increase in glucose uptake"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "mediated by the insulin receptor-IRS-phosphatidylinositol 3-kinase system"
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   782   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   760   C1334133:INSULIN RECEPTOR [Gene or Genome]
   757   C0070807:receptor, phosphatidylinositol [Amino Acid, Peptide, or Protein,Receptor]
   757   C0217461:IRS kinase [Amino Acid, Peptide, or Protein,Enzyme]
   754 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0086597:mediated [Social Behavior]
   739   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   739   C0449913:System [Functional Concept]
   739   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1553451:System [Manufactured Object]
   739   C1579433:Insulin [Pharmacologic Substance]
   739   C1704459:System [Medical Device]
   739   C2348046:Phosphatidylinositol [Lipid]

Phrase: "(21,"

Phrase: "22"

Phrase: ")."
Processing 00000000.tx.242: The inhibition of hypoxia-stimulated glucose uptake by ALLM suggests that the calpain-regulated step is distal to this system. 

Phrase: "The inhibition of hypoxia-stimulated glucose uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "by ALLM"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the calpain-regulated step"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1261552:Step [Conceptual Entity]
   827   C1704379:Step [Functional Concept]
   827   C1705117:Step [Quantitative Concept]
   827   C2825408:Step [Manufactured Object]

Phrase: "is"

Phrase: "distal to this system."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205108:Distal [Spatial Concept]
Processing 00000000.tx.243: The specific calpain isozyme(s) or cysteine protease(s) implicated in the control of insulin secretion and insulin action in the studies described above is unknown. 

Phrase: "The specific calpain isozyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0022173:Isozyme [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "("

Phrase: "s)"

Phrase: "or"

Phrase: "cysteine protease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0758959:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0769345:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2717970:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Protease [Enzyme]

Phrase: "("

Phrase: "s)"

Phrase: "implicated in the control of insulin secretion"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C1256369:insulin secretion [Cell Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]
   748   C0243148:control [Qualitative Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1550141:Control [Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "insulin action in the studies"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   781   C2986485:Action Study [Research Activity]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0441472:Action [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C3266814:Action [Activity]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: "is"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.244: Because isozyme-specific calpain inhibitors are not available, it is not possible to alter selectively the activity of calpain-10 using inhibitors. 

Phrase: "Because"

Phrase: "isozyme-specific calpain inhibitors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0054533:calpain inhibitors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243077:inhibitors [Chemical Viewed Functionally]
   779 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "are"

Phrase: "not available,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548671:Not available [Idea or Concept]
   861   C0470187:Available [Functional Concept]

Phrase: "it"

Phrase: "is"

Phrase: "not possible to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0332149:Possible [Qualitative Concept]
   827   C1518422:Not [Functional Concept]
   827   C1705910:Possible [Qualitative Concept]
   827   C2362652:Possible [Qualitative Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "selectively"

Phrase: "the activity of calpain-10"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C1150129:calpain activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "inhibitors."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0243077:inhibitors [Chemical Viewed Functionally]
   966 E C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.245: ALLM and E-64-d are not specific inhibitors of calpains; 

Phrase: "ALLM"

Phrase: "and"

Phrase: "E-64-d"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0058882:E 64 [Organic Chemical,Pharmacologic Substance]

Phrase: "are"

Phrase: "not specific inhibitors of calpains"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   781   C0054533:calpain inhibitors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0243077:inhibitors [Chemical Viewed Functionally]
   726 E C1999216:Inhibitor [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.246: they also inhibit cathepsins, and for that reason we cannot be certain that the effects that we are attributing to calpain inhibition are due to inhibition of these proteases. 

Phrase: "they also"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "cathepsins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007428:Cathepsins [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and for that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "reason"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392360:Reason [Idea or Concept]

Phrase: "we"

Phrase: "cannot"

Phrase: "be"

Phrase: "certain"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0205423:Certain [Qualitative Concept]
  1000   C1704787:Certain [Qualitative Concept]
   928 E C0439543:Certainties [Qualitative Concept]

Phrase: "that"

Phrase: "the effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "that"

Phrase: "we"

Phrase: "are"

Phrase: "attributing to calpain inhibition"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]
   737   C0449234:Attribute [Idea or Concept]
   737   C1704772:Attribute [Conceptual Entity]
   737   C1882133:Attribute [Qualitative Concept]

Phrase: "are due to inhibition of these proteases."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C0678226:Due to [Functional Concept]
           due
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C1551058:Are [Quantitative Concept]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C1947941:Proteases [Enzyme]
   748   C3146286:Due [Idea or Concept]
   748   C3463820:Inhibition [Activity]
Processing 00000000.tx.247: However, a number of factors point strongly to calpain inhibition as the mechanism underlying the effects observed. 

Phrase: "However,"

Phrase: "a number of factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "point"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552961:Point [Quantitative Concept]
  1000   C2347617:point [Quantitative Concept]

Phrase: "strongly to calpain inhibition"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "as the mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "underlying"

Phrase: "the effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.248: First, the inhibition of hydrolysis of the calpain-specific substrate Boc-Leu-Met-CMAC by ALLM and E-64-d in pancreatic islets is consistent with the hypothesis that ALLM and E-64-d affect insulin secretion by inhibiting calpain activity rather than lysosomal cysteine proteases such as the cathepsins. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "the inhibition of hydrolysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "of the calpain-specific substrate Boc-Leu-Met-CMAC"

Phrase: "by ALLM"

Phrase: "and"

Phrase: "E-64-d in pancreatic islets"

Phrase: "is"

Phrase: "consistent with the hypothesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that ALLM"

Phrase: "and"

Phrase: "E-64-d"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0058882:E 64 [Organic Chemical,Pharmacologic Substance]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "insulin secretion by inhibiting calpain activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1256369:insulin secretion [Cell Function]
   783   C1145751:insulin activity [Molecular Function]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "rather than"

Phrase: "lysosomal cysteine proteases such as the cathepsins."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   778   C2717970:Cysteine Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   762 E C0758959:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   762 E C0769345:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C1947941:Proteases [Enzyme]
Processing 00000000.tx.249: Second, different calpain inhibitors that work by different mechanism, such as ALLN and the specific calpain inhibitor PD 147631, have similar effects on glucose-induced insulin secretion as ALLM and E-64-d. 

Phrase: "Second, different calpain inhibitors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0054533:calpain inhibitors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243077:inhibitors [Chemical Viewed Functionally]
   779 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "that"

Phrase: "work by different mechanism,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0043227:Work [Occupational Activity]
   770   C0441712:Mechanism [Functional Concept]
   770   C1705242:Different [Qualitative Concept]
   770   C1706376:Mechanism [Manufactured Object]

Phrase: "such as ALLN"

Phrase: "and"

Phrase: "the specific calpain inhibitor PD 147631,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0054533:calpain inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0205369:Specific [Qualitative Concept]
   804   C1552740:specific [Intellectual Product]
   804   C1999216:Inhibitor [Qualitative Concept]

Phrase: "have"

Phrase: "similar effects on glucose-induced insulin secretion"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   757   C1158774:glucose effect [Genetic Function]
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "as ALLM"

Phrase: "and"

Phrase: "E-64-d."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0058882:E 64 [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.250: Third, cathepsin inhibitors and the aspartyl protease inhibitor pepstatin A showed no effect on insulin secretion. 

Phrase: "Third,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Third [Quantitative Concept]

Phrase: "cathepsin inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "the aspartyl protease inhibitor pepstatin A"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0332197:absence [Quantitative Concept]
   804   C1689985:Absence [Anatomical Abnormality]
   733 E C2699517:ABSENT [Finding]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no effect on insulin secretion."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.251: The identification of the specific calpain(s) involved must await the development of specific inhibitors or animal models of either increased or decreased expression of various forms of calpains in different tissues, including the pancreatic -cell and muscle and adipocyte tissue, to determine which calpains are involved in the regulation of insulin action and insulin secretion. 

Phrase: "The identification of the specific calpain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0020792:Identification [Mental Process]
   753   C0205396:Identification [Qualitative Concept]

Phrase: "("

Phrase: "s)"

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "must"

Phrase: "await"

Phrase: "the development of specific inhibitors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]

Phrase: "or"

Phrase: "animal models of either"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0599779:Models, Animal [Animal]
   770   C0003062:Animal [Animal]
   770   C3161035:Models [Intellectual Product]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "or"

Phrase: "decreased expression of various forms of calpains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   732   C1554102:Formal Expression [Idea or Concept]

Phrase: "in different tissues,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the pancreatic -cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "muscle"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026845:Muscle [Tissue]
   928 E C0442025:Muscular [Spatial Concept]

Phrase: "and"

Phrase: "adipocyte tissue,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "which calpains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "involved in the regulation of insulin action"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0441472:Action [Functional Concept]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1314939:Involved [Functional Concept]
   748   C1327622:Regulation [Biologic Function]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C3266814:Action [Activity]

Phrase: "and"

Phrase: "insulin secretion."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.252: The possibility that the enhancement in insulin secretion, observed in islets exposed to calpain inhibitors, results from nonspecific toxic effects of the calpain inhibitors on the islets was considered. 

Phrase: "The possibility"

Phrase: "that"

Phrase: "the enhancement in insulin secretion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   760   C2349975:Enhancement [Activity]

Phrase: "observed in islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "exposed to calpain inhibitors,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0054533:calpain inhibitors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0243077:inhibitors [Chemical Viewed Functionally]
   737 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "results from nonspecific toxic effects of the calpain inhibitors"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   764   C0054533:calpain inhibitors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0205370:Non-specific [Qualitative Concept]
   742   C0243077:inhibitors [Chemical Viewed Functionally]
   742   C0600688:toxic [Injury or Poisoning]
           Toxic effect
   742   C0750540:Nonspecific [Idea or Concept]
   742   C1274040:Result [Functional Concept]
   742   C1280500:effects [Qualitative Concept]
   742   C1407029:Toxic [Qualitative Concept]
   742   C1546471:Result [Idea or Concept]
   742   C2825142:Result [Finding]
   708 E C1999216:Inhibitor [Qualitative Concept]
   708 E C2348382:Effect [Qualitative Concept]

Phrase: "on the islets"

Phrase: "was"

Phrase: "considered."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]
Processing 00000000.tx.253: We do not believe that this is the mechanism for the following reasons. 

Phrase: "We"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "believe"

Phrase: "that"

Phrase: "this"

Phrase: "is"

Phrase: "the mechanism for the following reasons."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.254: First, the effects are seen with calpain inhibitors of different structures that act by different mechanisms. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "the effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "are"

Phrase: "seen with calpain inhibitors of different structures"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   778   C0054533:calpain inhibitors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0205397:Seen [Qualitative Concept]
   748   C0243077:inhibitors [Chemical Viewed Functionally]
   748   C0678594:structures [Spatial Concept]
   748   C1705242:Different [Qualitative Concept]
   714 E C0042789:see [Organism Function]
   714 E C1947903:See [Activity]
   714 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "that"

Phrase: "act by different mechanisms."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0079613:ACT [Therapeutic or Preventive Procedure]
   770   C0441712:Mechanisms [Functional Concept]
   770   C1705242:Different [Qualitative Concept]
   737 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.255: Second, toxic effects on islets would be expected to result in nonspecific release of insulin from islets, but both basal insulin secretion and islet insulin content were unaffected by exposure to calpain inhibitors. 

Phrase: "Second, toxic effects on islets"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   773   C0600688:Toxic effect [Injury or Poisoning]
           toxic
   760   C1280500:effects [Qualitative Concept]
   760   C1407029:Toxic [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "would"

Phrase: "be"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "result in nonspecific release of insulin"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0030685:Release [Health Care Activity]
   753   C0205370:Non-specific [Qualitative Concept]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C0750540:Nonspecific [Idea or Concept]
   753   C1274040:Result [Functional Concept]
   753   C1283071:Release [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1546471:Result [Idea or Concept]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1963578:Release [Therapeutic or Preventive Procedure]
   753   C2825142:Result [Finding]

Phrase: "from islets,"

Phrase: "but"

Phrase: "both basal insulin secretion"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0650607:Basal insulin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1256369:insulin secretion [Cell Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "islet insulin content"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "unaffected by exposure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2986417:Unaffected [Conceptual Entity]

Phrase: "to calpain inhibitors."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0054533:calpain inhibitors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.256: The present studies demonstrate enhancement of glucose-induced insulin secretion in pancreatic islets exposed to calpain inhibitors for 4 h. 

Phrase: "The present studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "demonstrate"

Phrase: "enhancement of glucose-induced insulin secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   753   C2349975:Enhancement [Activity]

Phrase: "in pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "exposed to calpain inhibitors"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0054533:calpain inhibitors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0243077:inhibitors [Chemical Viewed Functionally]
   737 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "for 4 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.257: The mechanism(s) responsible for this change seems to include effects on the insulin secretory machinery responsible for movement of insulin secretory granules to and fusion with the -cell membrane. 

Phrase: "The mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "("

Phrase: "s)"

Phrase: "responsible for this change"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "effects on the insulin secretory machinery"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "responsible for movement of insulin secretory granules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1273518:Responsible [Finding]

Phrase: "to"

Phrase: "and"

Phrase: "fusion with the -cell membrane."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0007594:Cell Fusion [Laboratory Procedure]
   797   C0025246:Membrane Fusion [Molecular Function]
   797   C1261468:Cell fusion [Cell Function]
   760   C0332466:Fusion [Functional Concept]
   760   C1293131:Fusion [Therapeutic or Preventive Procedure]
Processing 00000000.tx.258: Calpain inhibition also results in reduced insulin-stimulated glucose uptake into adipocytes and muscle and reduced glycogen synthesis rates in muscle. 

Phrase: "Calpain inhibition also"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0021467:Inhibition [Mental Process]
   827   C0021469:Inhibition [Molecular Function]
   827   C1628982:% inhibition [Quantitative Concept]
   827   C3463820:Inhibition [Activity]
   755 E C0311403:Inhibited [Qualitative Concept]

Phrase: "results in reduced insulin-stimulated glucose uptake"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   778   C1159527:glucose uptake [Cell Function]
   774   C1719133:Glucose/Insulin [Quantitative Concept]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0243144:Uptake [Physiologic Function]
   748   C0347980:% uptake [Quantitative Concept]
   748   C0392756:Reduced [Qualitative Concept]
   748   C1274040:Result [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1546471:Result [Idea or Concept]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1948023:Stimulated [Natural Phenomenon or Process]
   748   C2825142:Result [Finding]

Phrase: "into adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206131:Adipocytes [Cell]

Phrase: "and"

Phrase: "muscle"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026845:Muscle [Tissue]
   928 E C0442025:Muscular [Spatial Concept]

Phrase: "and"

Phrase: "reduced glycogen synthesis rates in muscle."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0871208:Rate [Activity]
   719   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.259: These latter results are consistent with physiological studies in nondiabetic subjects in which low levels of calpain-10 mRNA were associated with insulin resistance (3). 

Phrase: "These latter results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "are"

Phrase: "consistent with physiological studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "in nondiabetic subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "in which low levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "of calpain-10 mRNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0961737:calpain 10 [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1413110:CALPAIN 10 [Gene or Genome]

Phrase: "were"

Phrase: "associated with insulin resistance"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.260: Taken together, the in vitro studies presented here and in vivo studies in human subjects (3) support the hypothesis that calpains are involved in the regulation of insulin secretion and insulin action.  

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "the in vitro studies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   983   C0681828:in vitro study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "here"

Phrase: "and"

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "studies in human subjects"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   856   C2349001:Human Study Subject [Human]
           Subject
   833   C0178693:human subjects [Research Activity]
           human studies
   802   C0681850:Study Subject [Group]
           Subject
   770   C0086418:Human [Human]
   770   C0557651:Study [Manufactured Object]
   770   C0947630:studies [Laboratory Procedure]
   770   C2603343:Study [Research Activity]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2697811:Subject [Functional Concept]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that calpains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "involved in the regulation of insulin secretion"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   853   C1325895:regulation of insulin secretion [Cell Function]
   804   C1523071:regulation of secretion [Cell Function]
   778   C1256369:insulin secretion [Cell Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1314939:Involved [Functional Concept]
   748   C1327622:Regulation [Biologic Function]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin action."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0441472:Action [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C3266814:Action [Activity]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.261: ACKNOWLEDGMENTS  This work was supported by grants from the U.S. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by grants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from the U.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:U S [Geographic Area]
Processing 00000000.tx.262: Public Health Service (DK-31842, DK-20595, DK-44840, DK-47486, and DK-55889), a gift from the Blum-Kovler Foundation, and by the Howard Hughes Medical Institute. 

Phrase: "Public Health Service"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0041734:Public Health Service [Health Care Related Organization]
  1000   C0699943:Public health service [Health Care Activity]
           public health
   901   C0018747:Service, Health [Health Care Activity]
   901   C0034019:Public Health [Biomedical Occupation or Discipline]
   901   C3244304:public health [Intellectual Product]
   827   C0018684:Health [Idea or Concept]
   827   C0557854:Service [Occupational Activity]
   827   C2825316:Service [Manufactured Object]
   827   C3245478:service [Idea or Concept]
   727 E C0031206:healthiness [Finding]

Phrase: "(DK-31842,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011318:DK [Geographic Area]

Phrase: "DK-20595,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011318:DK [Geographic Area]

Phrase: "DK-44840,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011318:DK [Geographic Area]

Phrase: "DK-47486,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011318:DK [Geographic Area]

Phrase: "and"

Phrase: "DK-55889"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011318:DK [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "a gift from the Blum-Kovler Foundation,"

Phrase: "and by the Howard Hughes Medical Institute."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0021622:institute [Organization]
   748   C0205476:Medical [Functional Concept]
   748   C1272753:Institute [Idea or Concept]
   748   C1515981:And [Idea or Concept]
   748   C1551730:Hughes [Population Group]
Processing 00000000.tx.263: S.K.S., Y.-P.Z., and K.O. contributed equally to the conduct of this study. 

Phrase: "S."

Phrase: "K.S.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Y.-P.Z.,"

Phrase: "and"

Phrase: "K.O."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "contributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880177:Contribute [Activity]

Phrase: "equally to the conduct of this study."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0004927:Conduct [Individual Behavior]
   748   C0557651:Study [Manufactured Object]
   748   C2603343:Study [Research Activity]
Processing 00000000.tx.264: We thank K. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.265: Fox for expert technical assistance.  

Phrase: "Fox for expert technical assistance."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0016633:Fox [Mammal]
Processing 00000000.tx.266: FOOTNOTES  Address correspondence and reprint requests to Kenneth S. 

Phrase: "FOOTNOTES  Address correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "reprint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3273171:Reprint [Intellectual Product]

Phrase: "requests to Kenneth S."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0686900:request [Functional Concept]
   770   C1272683:Request [Functional Concept]
   770   C1522634:Request [Intellectual Product]
Processing 00000000.tx.267: Polonsky, Department of Medicine, Washington University, 660 S. 

Phrase: "Polonsky,"

Phrase: "Department of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "Washington University,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041740:University [Manufactured Object,Organization]
   861   C0043038:Washington [Geographic Area]

Phrase: "660 S."
Processing 00000000.tx.268: Euclid, Campus Box 8066, St. 

Phrase: "Euclid,"

Phrase: "Campus Box 8066,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0179400:Box [Manufactured Object]
   827   C1533124:Box [Medical Device]

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.269: Louis, MO 63110. 

Phrase: "Louis,"

Phrase: "MO 63110."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538743:MO [Idea or Concept]
Processing 00000000.tx.270: E-mail: polonsky{at}im.wustl.edu . Received for publication 21 June 2000 and accepted in revised form 24 May 2001. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "polonsky{at}im.wustl.edu ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: "Received for publication 21 June 2000"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0034036:Publication [Intellectual Product,Manufactured Object]
   753   C0034037:Publication [Occupational Activity]
   753   C1514756:Received [Qualitative Concept]
   753   C1704324:Publication [Intellectual Product]

Phrase: "and"

Phrase: "accepted in revised form 24 May 2001."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1272684:Accepted [Qualitative Concept]
   748   C1522492:Form [Functional Concept]
   748   C1527075:Revised [Therapeutic or Preventive Procedure]
   748   C1548435:Accepted [Idea or Concept]
   714 E C1548601:Accept [Idea or Concept]
Processing 00000000.tx.271: S.K.S. is currently affiliated with the Department of Endocrinology, Royal College of Surgeons, James Connolly Memorial Hospital, Blanchardstown, Dublin, Ireland. 

Phrase: "S."

Phrase: "K.S."

Phrase: "is"

Phrase: "currently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521116:Currently [Temporal Concept]

Phrase: "affiliated with the Department of Endocrinology,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   783   C0587463:Endocrinology department [Health Care Related Organization]
   753   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   753   C1510825:Affiliated [Qualitative Concept]
   753   C1510826:Affiliated [Qualitative Concept]
   753   C1704729:Department [Organization]
   719 E C1696107:affiliate [Idea or Concept]

Phrase: "Royal College of Surgeons,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0557806:College [Manufactured Object]
   812   C0582175:surgeons [Professional or Occupational Group]

Phrase: "James Connolly Memorial Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   812   C1510665:Hospital [Qualitative Concept]
   729 E C1609061:Hospitals [Intellectual Product]

Phrase: "Blanchardstown,"

Phrase: "Dublin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454777:Dublin [Geographic Area]

Phrase: "Ireland."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022067:Ireland [Geographic Area]
Processing 00000000.tx.272: Y.H. is currently affiliated with the Laboratory of Molecular Genetics, Institute for Molecular and Cellular Regulation, Gunma University, Gunma, Japan. 

Phrase: "Y.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "is"

Phrase: "currently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521116:Currently [Temporal Concept]

Phrase: "affiliated with the Laboratory of Molecular Genetics,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   778   C0086345:Genetics, Molecular [Biomedical Occupation or Discipline]
   748   C0017398:Genetics [Biomedical Occupation or Discipline]
   748   C0017399:genetics [Biologic Function]
   748   C0022877:Laboratory [Manufactured Object,Organization]
   748   C1510825:Affiliated [Qualitative Concept]
   748   C1510826:Affiliated [Qualitative Concept]
   748   C1521991:Molecular [Qualitative Concept]
   748   C3244292:laboratory [Functional Concept]
   714 E C1696107:affiliate [Idea or Concept]

Phrase: "Institute for Molecular"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0021622:institute [Organization]
   790   C1272753:Institute [Idea or Concept]

Phrase: "and"

Phrase: "Cellular Regulation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596286:Cellular Regulation [Cell Function]
   861   C0851285:Regulation [Governmental or Regulatory Activity]
   861   C1327622:Regulation [Biologic Function]

Phrase: "Gunma University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Gunma,"

Phrase: "Japan."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]
Processing 00000000.tx.273: ANOVA, analysis of varience; 

Phrase: "ANOVA,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "analysis of varience"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: ";"
Processing 00000000.tx.274: AUC, area under the curve; 

Phrase: "AUC,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0376690:Area under the curve [Quantitative Concept]
           Area Under Curve
   770   C0017446:Area [Geographic Area]
   770   C0205146:Area [Spatial Concept]

Phrase: "area under the curve"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0376690:Area under the curve [Quantitative Concept]
           Area Under Curve
   770   C0017446:Area [Geographic Area]
   770   C0205146:Area [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.275: 2-DOG, 2-deoxyglucose; 

Phrase: "2-DOG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011501:2-Deoxyglucose [Carbohydrate,Pharmacologic Substance]
           Deoxyglucose

Phrase: "2-deoxyglucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011501:2-Deoxyglucose [Carbohydrate,Pharmacologic Substance]
           Deoxyglucose

Phrase: ";"
Processing 00000000.tx.276: KHB, Krebs-Henseleit buffer; 

Phrase: "KHB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0167250:Krebs-Henseleit buffer [Biomedical or Dental Material,Organic Chemical]
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "Krebs-Henseleit buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0167250:Krebs-Henseleit buffer [Biomedical or Dental Material,Organic Chemical]
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.277: KRB, Krebs-Ringers buffer; 

Phrase: "KRB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "Krebs-Ringers buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.278: 3-MG, 3-O-[3H]methyl-D-glucose; 

Phrase: "3-MG,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "3-O-[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1442460:3H [Temporal Concept]

Phrase: "]methyl-"

Phrase: "D-"

Phrase: "glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.279: TEA, tetraethylammonium.  

Phrase: "TEA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076252:Tetraethylammonium [Organic Chemical,Pharmacologic Substance]

Phrase: "tetraethylammonium."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076252:Tetraethylammonium [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.280: REFERENCES TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  DeFronzo RA: Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "DeFronzo RA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: ":"

Phrase: "Pathogenesis of type 2 diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0543483:pathogenesis [Functional Concept]
   760   C0699748:Pathogenesis [Pathologic Function]

Phrase: ":"

Phrase: "metabolic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0311400:Metabolic [Functional Concept]
  1000   C1524026:Metabolic [Cell Function]
  1000   C2707259:Metabolic [Clinical Attribute]

Phrase: "and"

Phrase: "molecular implications for identifying diabetes genes."
Processing 00000000.tx.281: Diabetes Rev 5:177269, 1997 Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, Hinokio Y, Lindner TH, Mashima H, Schwarz PEH, del Bosque-Plata L, Horikawa Y, Oda Y, Yoshiuchi I, Colilla S, Polonsky KS, Wei S, Concannon P, Iwasaki N, Schulze J, Baier LJ, Bogardus C, Groop L, Boerwinkle E, Hanis CL, Bell GI: Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes. 

Phrase: "Diabetes Rev 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "177269,"

Phrase: "1997 Horikawa Y,"

Phrase: "Oda N,"

Phrase: "Cox NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Li X,"

Phrase: "Orho-Melander M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Hara M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hinokio Y,"

Phrase: "Lindner TH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039725:TH [Geographic Area]
   861   C0039738:Th [Element, Ion, or Isotope]
   861   C1420718:TH [Gene or Genome]

Phrase: "Mashima H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Schwarz PEH,"

Phrase: "del Bosque-Plata L,"

Phrase: "Horikawa Y,"

Phrase: "Oda Y,"

Phrase: "Yoshiuchi I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Colilla S,"

Phrase: "Polonsky KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: "Wei S,"

Phrase: "Concannon P,"

Phrase: "Iwasaki N,"

Phrase: "Schulze J,"

Phrase: "Baier LJ,"

Phrase: "Bogardus C,"

Phrase: "Groop L,"

Phrase: "Boerwinkle E,"

Phrase: "Hanis CL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "Bell GI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]

Phrase: ":"

Phrase: "Genetic variation in the gene encoding calpain-10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0042333:Genetic Variation [Natural Phenomenon or Process]
   744   C0205419:Variation [Qualitative Concept]

Phrase: "is"

Phrase: "associated with type 2 diabetes."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.282: Nat Genet 26:16375, 2000[Medline] Baier LJ, Permana P, Yang X, Pratley RE, Hanson RL, Shen G-Q, Mott D, Knowler WC, Cox NJ, Horikawa Y, Oda N, Bell GI, Bogardus C: A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. 

Phrase: "Nat Genet 26"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ":"

Phrase: "16375,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Baier LJ,"

Phrase: "Permana P,"

Phrase: "Yang X,"

Phrase: "Pratley RE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]

Phrase: "Hanson RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: "Shen G-Q,"

Phrase: "Mott D,"

Phrase: "Knowler WC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: "Cox NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Horikawa Y,"

Phrase: "Oda N,"

Phrase: "Bell GI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]

Phrase: "Bogardus C"

Phrase: ":"

Phrase: "A calpain-10 gene polymorphism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0678951:gene polymorphism [Genetic Function]
   804   C0032529:Polymorphism [Genetic Function]
   804   C1882417:Polymorphism [Qualitative Concept]

Phrase: "is"

Phrase: "associated with reduced muscle mRNA levels"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0026845:Muscle [Tissue]
   753   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0392756:Reduced [Qualitative Concept]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1547707:Level [Geographic Area]
   719 E C1706221:Associate [Professional or Occupational Group]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin resistance."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.283: J Clin Invest 106:R69R73, 2000[Medline] Carafoli E, Molinari M: Calpain: a protease in search of a function? 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "106"

Phrase: ":"

Phrase: "R69R73,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Carafoli E,"

Phrase: "Molinari M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Calpain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "a protease in search of a function?"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C1947941:Protease [Enzyme]
Processing 00000000.tx.284: Biochem Biophys Res Commun 247:193203, 1998[Medline] Sorimachi H, Ishihura S, Suzuki K: Structure and physiological function of calpains. 

Phrase: "Biochem Biophys Res Commun 247"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "193203,"

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sorimachi H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Ishihura S,"

Phrase: "Suzuki K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: ":"

Phrase: "Structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "physiological function of calpains."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]
Processing 00000000.tx.285: Biochem J 328:721732, 1997[Medline] Pontoglio M, Sreenan S, Roe M, Pugh W, Ostrega D, Doyen A, Pick AJ, Baldwin A, Velho G, Froguel P, Levisetti M, Bonner-Weir S, Bell GI, Yaniv M, Polonsky KS: Defective insulin secretion in hepatocyte nuclear factor 1 deficient mice. 

Phrase: "Biochem J 328"

Phrase: ":"

Phrase: "721732,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pontoglio M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Sreenan S,"

Phrase: "Roe M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Pugh W,"

Phrase: "Ostrega D,"

Phrase: "Doyen A,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332197:absence [Quantitative Concept]
   861   C1689985:Absence [Anatomical Abnormality]
   789 E C2699517:ABSENT [Finding]

Phrase: "Pick AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "Baldwin A,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332197:absence [Quantitative Concept]
   861   C1689985:Absence [Anatomical Abnormality]
   789 E C2699517:ABSENT [Finding]

Phrase: "Velho G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Froguel P,"

Phrase: "Levisetti M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bonner-Weir S,"

Phrase: "Bell GI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]

Phrase: "Yaniv M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Polonsky KS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: ":"

Phrase: "Defective insulin secretion in hepatocyte nuclear factor 1 deficient mice."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C1256369:insulin secretion [Cell Function]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0036536:secretion [Biologic Function]
   739   C0036537:Secretion [Body Substance]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.286: J Clin Invest 101:22152222, 1998[Abstract/Free FullText] Sreenan SK, Cockburn BN, Baldwin AC, Ostrega DM, Levisetti M, Grupe A, Bell GI, Stewart TA, Roe MW, Polonsky KS: Adaptation to hyperglycemia enhances insulin secretion in glucokinase-deficient mutant mice. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "101"

Phrase: ":"

Phrase: "22152222,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Sreenan SK,"

Phrase: "Cockburn BN,"

Phrase: "Baldwin AC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1412573:AC [Gene or Genome]
   861   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539770:AC [Gene or Genome]

Phrase: "Ostrega DM,"

Phrase: "Levisetti M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Grupe A,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332197:absence [Quantitative Concept]
   861   C1689985:Absence [Anatomical Abnormality]
   789 E C2699517:ABSENT [Finding]

Phrase: "Bell GI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]

Phrase: "Stewart TA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]

Phrase: "Roe MW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024548:MW [Geographic Area]
   861   C0026385:mw [Quantitative Concept]
   861   C0556966:mW [Quantitative Concept]

Phrase: "Polonsky KS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: ":"

Phrase: "Adaptation to hyperglycemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0000934:adaptation [Organism Function]
   790   C0392673:Adaptation [Biologic Function]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "insulin secretion in glucokinase-deficient mutant mice."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C1256369:insulin secretion [Cell Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.287: Diabetes 47:18811888, 1998[Abstract] Dukes ID, Sreenan S, Roe MW, Levisetti M, Zhou Y-P, Ostrega D, Bell GI, Pontoglio M, Yaniv M, Philipson L, Polonsky KS: Defective pancreatic -cell glycolytic signaling in hepatocyte nuclear factor-1-deficient mice. 

Phrase: "Diabetes 47"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "18811888,"

Phrase: "1998"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Dukes ID,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600091:ID [Intellectual Product]

Phrase: "Sreenan S,"

Phrase: "Roe MW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024548:MW [Geographic Area]
   861   C0026385:mw [Quantitative Concept]
   861   C0556966:mW [Quantitative Concept]

Phrase: "Levisetti M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Zhou Y-P,"

Phrase: "Ostrega D,"

Phrase: "Bell GI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]

Phrase: "Pontoglio M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Yaniv M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Philipson L,"

Phrase: "Polonsky KS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: ":"

Phrase: "Defective pancreatic -cell glycolytic signaling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C0037083:Cell Signaling [Cell Function]
           Signaling
   804   C3537152:signaling [Biologic Function]

Phrase: "in hepatocyte nuclear factor-1-deficient mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
   734   C0065110:Hepatocyte Nuclear Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420631:HEPATOCYTE NUCLEAR FACTOR 1 [Gene or Genome]
Processing 00000000.tx.288: J Biol Chem 273:2445724464, 1998[Abstract/Free FullText] Rosser BG, Powers SP, Gores GJ: Calpain activity increases in hepatocytes following addition of ATP: demonstration by a novel fluorescent approach. 

Phrase: "J Biol Chem 273"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "2445724464,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Rosser BG,"

Phrase: "Powers SP,"

Phrase: "Gores GJ"

Phrase: ":"

Phrase: "Calpain activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150129:calpain activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "increases in hepatocytes"
Meta Candidates (Total=10; Excluded=8; Pruned=0; Remaining=2)
   790   C0227525:Hepatocytes [Cell]
   790   C0442805:Increase [Functional Concept]
   756 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   734 E C1517378:Gain [Quantitative Concept]
   706 E C0205217:Increased [Quantitative Concept]
   706 E C0439661:Acquired [Temporal Concept]
   706 E C0442808:Increasing [Functional Concept]
   706 E C1301820:Obtain [Functional Concept]
   706 E C1706701:Acquire [Activity]
   706 E C3245488:acquired [Intellectual Product]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "addition of ATP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1883712:Addition [Functional Concept]
   718 E C1524062:Additional [Functional Concept]

Phrase: ":"

Phrase: "demonstration by a novel fluorescent approach."
Processing 00000000.tx.289: J Biol Chem 268:2359323600, 1993[Abstract/Free FullText] Zhou Y-P, Priestman DA, Randle PJ, Grill VE: Fasting and decreased B cell sensitivity: important role for fatty acid-induced inhibition of PDH activity. 

Phrase: "J Biol Chem 268"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "2359323600,"

Phrase: "1993"

Phrase: "[Abstract/Free FullText"

Phrase: "] Zhou Y-P,"

Phrase: "Priestman DA,"

Phrase: "Randle PJ,"

Phrase: "Grill VE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0042469:VE [Geographic Area]

Phrase: ":"

Phrase: "Fasting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015663:Fasting [Finding]
  1000   C1550565:fasting [Intellectual Product]
   966 E C0456962:Fast [Qualitative Concept]

Phrase: "and"

Phrase: "decreased B cell sensitivity"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   902   C0020580:Decreased Sensitivity [Finding]
   902   C1880261:DECREASED SENSITIVITY [Phenomenon or Process]
   902   C2348085:DECREASED SENSITIVITY [Phenomenon or Process]
   812   C0036667:Sensitivity [Quantitative Concept]
   812   C0312418:Sensitivity [Mental Process]
   812   C0427965:Sensitivity [Finding]
   812   C1511883:Sensitivity [Quantitative Concept]
   812   C1522640:Sensitivity [Qualitative Concept]
   812   C2346484:SENSITIVITY [Phenomenon or Process]
   812   C2349185:Sensitivity [Qualitative Concept]
   741 E C0332324:Sensitive [Functional Concept]
   741 E C1550474:sensitive [Idea or Concept]

Phrase: ":"

Phrase: "important role for fatty acid-induced inhibition of PDH activity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0035820:Role [Social Behavior]
   739   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.290: Am J Physiol 270:E988E994, 1996[Abstract/Free FullText] Joshi C, Fernandez JM: Capacitance measurements: an analysis of the phase detector technique used to study exocytosis and endocytosis. 

Phrase: "Am"

Phrase: "J Physiol 270"

Phrase: ":"

Phrase: "E988E994,"

Phrase: "1996"

Phrase: "[Abstract/Free FullText"

Phrase: "] Joshi C,"

Phrase: "Fernandez JM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: ":"

Phrase: "Capacitance measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242485:measurements [Functional Concept]

Phrase: ":"

Phrase: "an analysis of the phase detector technique"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C2986798:Phase Analysis [Occupational Activity]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "exocytosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015283:Exocytosis [Cell Function]

Phrase: "and"

Phrase: "endocytosis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014139:Endocytosis [Cell Function]
  1000   C2984285:Endocytosis [Functional Concept]
Processing 00000000.tx.291: Biophys J 53:885892, 1988[Abstract] Neher E, Marty A: Discrete changes of cell membrane capacitance observed under conditions of enhanced secretion in bovine adrenal chromaffin cells. 

Phrase: "Biophys J 53"

Phrase: ":"

Phrase: "885892,"

Phrase: "1988"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Neher E,"

Phrase: "Marty A"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332197:absence [Quantitative Concept]
   861   C1689985:Absence [Anatomical Abnormality]
   789 E C2699517:ABSENT [Finding]

Phrase: ":"

Phrase: "Discrete changes of cell membrane capacitance"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "observed under conditions of enhanced secretion"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   753   C1441672:Observed [Functional Concept]
   753   C2349975:Enhanced [Activity]
   719   C0012634:condition [Disease or Syndrome]
   719   C0348080:Condition [Qualitative Concept]
   719   C1705253:Condition [Conceptual Entity]

Phrase: "in bovine adrenal chromaffin cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0376604:Chromaffin Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.292: Proc Natl Acad Sci U S A 79:67126716, 1982[Abstract] Artalejo CR, Adams ME, Fox AP: Three types of Ca2+ channel trigger secretion with different efficacies in chromaffin cells. 

Phrase: "Proc Natl Acad Sci U S A 79"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0041703:U S [Geographic Area]
   793   C0268596:ACAD [Disease or Syndrome]
   793   C0332197:absence [Quantitative Concept]
   793   C1418943:PROC [Gene or Genome]
   793   C1689985:Absence [Anatomical Abnormality]
   793   C2700624:ACAD [Cell Function]
   793   C3642273:SCI [Professional or Occupational Group]
   721 E C2699517:ABSENT [Finding]

Phrase: ":"

Phrase: "67126716,"

Phrase: "1982"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Artalejo CR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0201975:Cr [Laboratory Procedure]
   861   C3539604:CR [Gene or Genome]

Phrase: "Adams"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331762:Adams [Health Care Related Organization]

Phrase: "ME,"

Phrase: "Fox AP"

Phrase: ":"

Phrase: "Three types of Ca2+ channel trigger secretion"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0332307:Types [Qualitative Concept]
   714 E C1547052:*Type [Quantitative Concept]

Phrase: "with different efficacies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1280519:Efficacy [Qualitative Concept]
   827   C1707887:EFFICACY [Research Activity]

Phrase: "in chromaffin cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0376604:Chromaffin Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.293: Nature 367:7276, 1994[Medline] Burant CF, Lemmon SK, Treutelaar MK, Buse MG: Insulin resistance of denervated rat muscle: a model for impaired receptor-function coupling. 

Phrase: "Nature 367"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "7276,"

Phrase: "1994"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Burant CF,"

Phrase: "Lemmon SK,"

Phrase: "Treutelaar MK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539059:MK [Idea or Concept]

Phrase: "Buse MG"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ":"

Phrase: "Insulin resistance of denervated rat muscle"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0021655:Insulin Resistance [Pathologic Function]
   790   C2700570:INSULIN RESISTANCE [Gene or Genome]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0237834:Resistance [Mental Process]
   753   C1514892:Resistance [Physiologic Function]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: ":"

Phrase: "a model for impaired receptor-function coupling."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3161035:Model [Intellectual Product]
Processing 00000000.tx.294: Am J Physiol 247:E657E666, 1984[Abstract/Free FullText] Rodbell M: Metabolism of isolated fat cells. 

Phrase: "Am"

Phrase: "J Physiol 247"

Phrase: ":"

Phrase: "E657E666,"

Phrase: "1984"

Phrase: "[Abstract/Free FullText"

Phrase: "] Rodbell M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Metabolism of isolated fat cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0598783:Fat metabolism [Molecular Function]
   760   C0025519:Metabolism [Organism Function]
   760   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.295: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.296: Effects of hormones on glucose metabolism and lipolysis. 

Phrase: "Effects of hormones"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "on glucose metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596620:glucose metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "lipolysis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023796:Lipolysis [Organism Function]
Processing 00000000.tx.297: J Biol Chem 239:375380, 1964[Free FullText] Young DA, Uhl JJ, Cartee GD, Holloszy JO: Activation of glucose transport in muscle by prolonged exposure to insulin: effects of glucose and insulin concentrations. 

Phrase: "J Biol Chem 239"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "375380,"

Phrase: "1964"

Phrase: "[Free FullText"

Phrase: "] Young DA,"

Phrase: "Uhl JJ,"

Phrase: "Cartee GD,"

Phrase: "Holloszy JO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022418:JO [Geographic Area]

Phrase: ":"

Phrase: "Activation of glucose transport"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   881   C2259159:activation of transport [Cell Function]
   770   C1879547:Activation [Activity]

Phrase: "in muscle"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026845:Muscle [Tissue]
   928 E C0442025:Muscular [Spatial Concept]

Phrase: "by prolonged exposure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0274281:Exposure, NOS [Injury or Poisoning]
   861   C0332157:Exposure [Clinical Attribute]
   861   C0439590:Prolonged [Temporal Concept]

Phrase: "to insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ":"

Phrase: "effects of glucose"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   841   C1158774:glucose effect [Genetic Function]
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "insulin concentrations."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.298: J Biol Chem 261:1604916053, 1986[Abstract/Free FullText] Gromada J, Holst JJ, Rorsman P: Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1. 

Phrase: "J Biol Chem 261"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1604916053,"

Phrase: "1986"

Phrase: "[Abstract/Free FullText"

Phrase: "] Gromada J,"

Phrase: "Holst JJ,"

Phrase: "Rorsman P"

Phrase: ":"

Phrase: "Cellular regulation of islet hormone secretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   858   C1325897:regulation of hormone secretion [Cell Function]
   820   C1523071:regulation of secretion [Cell Function]
   790   C0596286:Cellular Regulation [Cell Function]
   783   C0920552:hormone regulation [Organism Function]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "by the incretin hormone glucagon-like peptide 1."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0061355:Glucagon-Like Peptide 1 [Amino Acid, Peptide, or Protein]
   901   C1333664:glucagon-like peptide 1 [Gene or Genome]
   861   C0014361:glucagon like peptide [Amino Acid, Peptide, or Protein,Hormone]
   799   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   799   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   799   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.299: Pflgers Arch 435:583594, 1998[Medline] Wollheim CB, Biden TJ: Second messenger function of inositol 1,4,5-triphosphate. 

Phrase: "Pflgers Arch 435"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0230467:arch [Body Location or Region]
   827   C0741204:ARCH [Body Space or Junction]

Phrase: ":"

Phrase: "583594,"

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wollheim CB,"

Phrase: "Biden TJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039247:TJ [Geographic Area]

Phrase: ":"

Phrase: "Second messenger function of inositol 1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "4,"

Phrase: "5-triphosphate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0146894:triphosphate [Inorganic Chemical]
Processing 00000000.tx.300: J Biol Chem 261:83148319, 1986[Abstract/Free FullText] Hill PA, Buttle DJ, Jones SJ, Boyde A, Murata M, Reynolds JJ, Meikle MC: Inhibition of bone resorption by selective inactivators of cysteine proteinases. 

Phrase: "J Biol Chem 261"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "83148319,"

Phrase: "1986"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hill PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: "Buttle DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Jones SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Boyde A,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332197:absence [Quantitative Concept]
   861   C1689985:Absence [Anatomical Abnormality]
   789 E C2699517:ABSENT [Finding]

Phrase: "Murata M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Reynolds JJ,"

Phrase: "Meikle MC"

Phrase: ":"

Phrase: "Inhibition of bone resorption"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C3537067:inhibition of bone resorption [Organ or Tissue Function]
           Bone Resorption Inhibition
   881   C1371283:Bone Resorption Inhibition [Organ or Tissue Function]
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "by selective inactivators"

Phrase: "of cysteine proteinases."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C2717970:Cysteine Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030940:Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteinases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827 E C1622131:proteinase [Molecular Function]
   827 E C1947941:Proteinase [Enzyme]
Processing 00000000.tx.301: J Cell Biochem 56:118130, 1994[Medline] Shulman GI: Cellular mechanisms of insulin resistance. 

Phrase: "J Cell Biochem 56"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "118130,"

Phrase: "1994"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shulman GI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]

Phrase: ":"

Phrase: "Cellular mechanisms of insulin resistance."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   781   C1522618:resistance mechanism [Clinical Attribute]
   760   C0441712:Mechanisms [Functional Concept]
   726 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.302: J Clin Invest 106:171176, 2000[Free FullText] Lee AD, Hansen PA, Holloszy JO: Wortmannin inhibits insulin-stimulated but not contraction-stimulated glucose transport activity in skeletal muscle. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "106"

Phrase: ":"

Phrase: "171176,"

Phrase: "2000"

Phrase: "[Free FullText"

Phrase: "] Lee AD,"

Phrase: "Hansen PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: "Holloszy JO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022418:JO [Geographic Area]

Phrase: ":"

Phrase: "Wortmannin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "insulin-stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "but"

Phrase: "not contraction-stimulated glucose transport activity in skeletal muscle."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]
   726   C0005529:Active Transport [Physiologic Function]
   726   C0231484:Muscular activity [Organ or Tissue Function]
Processing 00000000.tx.303: FEBS Lett 361:5154, 1995[Medline] Yeh JI, Gulve EA, Rameh L, Birnbaum MJ: The effects of wortmannin on rat skeletal muscle: dissociation of signaling pathways for insulin- and contraction-activated hexose transport. 

Phrase: "FEBS Lett 361"

Phrase: ":"

Phrase: "5154,"

Phrase: "1995"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yeh JI,"

Phrase: "Gulve EA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014963:EA [Organic Chemical,Pharmacologic Substance]
   861   C1457900:EA [Quantitative Concept]

Phrase: "Rameh L,"

Phrase: "Birnbaum MJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: ":"

Phrase: "The effects of wortmannin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on rat skeletal muscle"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C1882854:Rat Skeletal Muscle [Body Part, Organ, or Organ Component]
   901   C0242692:Muscle, Skeletal [Tissue]
   901   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   827   C0026845:Muscle [Tissue]
   827   C0037253:skeletal [Body System]
   827   C0521324:Skeletal [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: ":"

Phrase: "dissociation of signaling pathways"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "for insulin-"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "contraction-activated hexose transport."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1159521:hexose transport [Cell Function]
   812   C0005528:Transport, NOS [Cell Function]
   812   C1317949:Transport [Manufactured Object]
   812   C3495449:transport [Medical Device]
Processing 00000000.tx.304: J Biol Chem 270:21072111, 1995[Abstract/Free FullText]

Phrase: "J Biol Chem 270"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "21072111,"

Phrase: "1995"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

